data_2ltr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ltr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.493 1.449 0 CA-C-O 120.855 0.273 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.7 tp -65.3 -23.09 66.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.569 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.4 tpt -62.25 -34.85 77.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.351 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -68.21 -35.77 72.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.982 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 tp -69.94 -51.74 30.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.206 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -52.8 -40.14 62.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.599 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.32 -32.56 58.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.124 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.428 ' O ' ' CG2' ' A' ' 55' ' ' VAL . . . -71.07 -48.74 50.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.179 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.28 -31.56 72.44 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.914 0.388 . . . . 0.0 110.667 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 57' ' ' GLN . 62.4 mttm -78.67 -57.19 3.89 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.42 -21.47 64.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 25.5 m -86.02 -53.67 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.823 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.456 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 2.6 m-85 -126.38 4.65 6.96 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 53' ' ' LYS . 88.9 mm-40 59.42 32.76 22.01 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.579 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -125.53 151.37 46.44 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.325 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.04 156.05 74.67 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.953 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.06 168.7 24.15 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.901 2.401 . . . . 0.0 112.107 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.73 124.9 44.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.806 0.336 . . . . 0.0 111.257 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -117.36 152.62 34.56 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.872 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.88 129.78 3.65 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.1 m -102.65 118.72 37.46 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.058 0.456 . . . . 0.0 111.435 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.64 148.34 12.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.276 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 66' ' ' GLU . 4.3 pt-20 -114.81 110.01 19.05 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.627 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -133.17 158.66 75.22 Favored Pre-proline 0 CA--C 1.529 0.16 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -52.25 -20.19 10.71 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.481 1.454 . . . . 0.0 111.331 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -81.16 -19.94 42.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.123 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.64 -114.73 1.25 Allowed Glycine 0 C--N 1.33 0.23 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -133.03 136.5 46.02 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -117.12 128.11 54.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.135 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 3.4 tpt -96.8 128.62 43.93 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.661 -0.415 . . . . 0.0 109.988 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 m -107.49 120.27 41.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.7 tp -113.39 128.03 56.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 mp -123.51 133.53 68.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 79' ' ' GLU . 20.6 mt -139.93 88.71 2.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.334 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 56.87 -83.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.627 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 77' ' ' LEU . 91.3 mt-10 -111.44 -17.07 13.18 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.5 mt -98.44 128.11 50.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.275 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.3 t -132.52 131.53 41.69 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -137.26 153.96 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.325 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -134.45 149.47 50.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.854 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.61 142.41 9.93 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -104.87 138.09 41.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.303 . . . . 0.0 110.402 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.73 166.16 34.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.669 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 t -101.0 0.2 37.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.812 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.6 p -130.82 157.97 41.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.763 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -76.13 -45.64 32.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.974 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -61.79 -46.88 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.387 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.68 -21.18 59.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.162 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.22 -48.68 69.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.275 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -73.1 -43.14 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.757 0.313 . . . . 0.0 111.217 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.474 HE21 ' HG ' ' A' ' 131' ' ' SER . 56.0 tt0 -53.17 -45.7 68.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.961 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -65.82 -36.47 83.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.82 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.53 -51.16 38.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.242 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.73 -30.1 60.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.735 0.302 . . . . 0.0 111.32 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.2 t -72.06 -47.48 54.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.486 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -55.63 -35.14 65.58 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.155 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -63.58 -58.06 8.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.103 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.474 ' N ' ' CG ' ' A' ' 100' ' ' TYR . 14.4 mt -48.79 -39.25 24.54 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.564 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -60.14 -45.14 94.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.763 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.92 -29.09 68.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.97 0.414 . . . . 0.0 110.782 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.98 -54.52 28.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.757 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.1 t -54.05 -37.15 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.83 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -62.1 -32.89 73.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.332 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -96.64 20.93 10.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.806 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.72 49.43 8.86 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.408 ' C ' ' N ' ' A' ' 111' ' ' GLU . 9.8 mtpm? -133.23 23.45 4.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.375 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -48.85 -17.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.77 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.408 ' N ' ' C ' ' A' ' 109' ' ' LYS . 83.8 mt-10 -79.13 23.34 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.563 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.443 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -50.34 -44.73 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.71 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.536 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 1.9 p90 -117.77 -19.54 9.24 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.536 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 70.4 t80 118.66 48.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.85 1.344 . . . . 0.0 110.285 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 52.5 mt -62.32 113.01 7.47 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.61 128.99 10.6 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.627 1.551 . . . . 0.0 113.252 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.1 90.97 0.13 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.433 ' OG1' ' OE1' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -56.53 -28.75 60.75 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.19 -179.31 5.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.887 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -64.82 -59.7 3.91 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.622 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.417 ' O ' ' OG ' ' A' ' 125' ' ' SER . 88.4 mt-10 -56.75 -26.56 57.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.194 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.433 ' OE1' ' OG1' ' A' ' 118' ' ' THR . 69.3 mt-10 -66.72 -42.58 86.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.68 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.33 79.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.551 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 3.0 mp -65.88 -58.7 4.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.991 0.901 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 20.7 m -52.73 -41.35 63.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.95 -1.477 . . . . 0.0 111.05 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -55.52 -58.52 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.481 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 mt -55.79 -50.92 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.445 0.641 . . . . 0.0 109.898 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -46.84 -37.4 8.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.9 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -71.74 -26.96 62.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.542 0.21 . . . . 0.0 111.005 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.9 -25.47 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.474 ' HG ' HE21 ' A' ' 94' ' ' GLN . 31.2 t . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.66 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 120.899 0.291 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.6 tp -71.44 -20.55 62.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.424 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 tpt -58.46 -33.16 69.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.939 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.5 t -63.58 -54.99 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.4 tp -57.87 -52.3 66.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.955 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -54.4 -51.03 66.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.418 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -65.67 -32.51 74.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.086 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.62 -47.08 61.91 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.244 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 -33.91 69.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.859 0.362 . . . . 0.0 110.717 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.51 -47.21 27.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.111 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 -20.99 59.43 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 20.8 m -85.62 -53.86 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.533 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.436 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -125.85 -3.51 7.1 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 71.1 20.8 5.07 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.828 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -109.51 -173.76 2.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.311 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.417 ' H ' ' HG1' ' A' ' 59' ' ' THR . 0.5 OUTLIER -121.5 156.24 58.44 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.522 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 168.66 24.21 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 112.305 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.14 118.67 31.16 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.31 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -110.5 137.84 47.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.285 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.5 129.33 4.99 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.2 m -99.95 118.16 35.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.369 . . . . 0.0 111.541 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.93 148.4 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.831 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -113.71 109.95 19.41 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.621 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.29 155.31 81.44 Favored Pre-proline 0 C--O 1.227 -0.127 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.38 -7.25 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.851 1.701 . . . . 0.0 111.531 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.488 ' OE2' ' NE2' ' A' ' 85' ' ' GLN . 75.1 tt0 -94.72 -17.35 22.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.916 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.99 -117.77 1.61 Allowed Glycine 0 C--N 1.333 0.365 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -132.12 137.61 47.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -118.44 121.8 41.2 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.8 mtt -93.13 133.08 36.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.491 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.4 m -111.98 123.58 50.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.9 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -114.76 126.09 54.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.006 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.6 mm -118.02 131.66 70.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 tp -175.38 136.29 0.35 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.591 0.557 . . . . 0.0 110.904 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.6 t30 54.24 35.31 22.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.339 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 68.52 6.13 5.24 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.286 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.4 mt -99.27 137.72 25.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.01 129.65 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.498 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.7 m -132.68 161.47 41.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.87 0.367 . . . . 0.0 110.815 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -129.9 139.66 51.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.935 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.16 108.09 0.73 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.488 ' NE2' ' OE2' ' A' ' 69' ' ' GLU . 11.3 pt20 -91.91 136.36 33.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.444 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.53 171.98 16.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.674 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.47 -7.48 47.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.367 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.0 p -129.21 152.84 48.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.205 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -71.85 -42.77 66.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.274 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -60.0 -47.74 84.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.307 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.54 -25.63 62.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.975 0.417 . . . . 0.0 110.707 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.06 -35.04 73.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.053 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -74.26 -46.61 40.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.046 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -53.07 -47.51 68.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.915 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -64.99 -32.28 73.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.723 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.21 -51.95 21.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.926 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.25 -31.11 69.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.043 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.4 t -71.26 -51.42 34.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.932 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -55.55 -34.35 64.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.03 0.443 . . . . 0.0 110.352 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.28 -55.54 27.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.512 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.1 mt -50.59 -36.19 33.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.633 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -62.75 -45.21 93.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.499 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -60.37 -28.02 67.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 110.951 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.92 -53.65 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.243 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.39 -37.51 44.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.602 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.53 -28.76 69.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.553 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -96.73 20.04 11.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.615 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 45.58 44.81 12.03 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -133.12 23.93 4.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.707 0.289 . . . . 0.0 110.549 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -50.76 -15.75 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -79.87 22.53 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.293 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.437 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -50.93 -45.86 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.431 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 1.0 OUTLIER -118.26 -20.29 8.62 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.538 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 72.3 t80 117.27 51.31 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.871 1.357 . . . . 0.0 109.874 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 21.5 mt -62.85 118.17 39.46 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.23 128.05 12.56 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.336 1.357 . . . . 0.0 112.62 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.88 94.55 0.15 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.0 m -49.28 -38.24 26.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.149 0.5 . . . . 0.0 109.701 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.409 ' H ' ' HB3' ' A' ' 122' ' ' GLU . 11.4 p -133.46 176.08 8.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.877 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -54.69 -57.25 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.832 0.348 . . . . 0.0 110.623 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.44 ' O ' ' OG ' ' A' ' 125' ' ' SER . 95.5 mt-10 -61.76 -34.7 76.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.275 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.409 ' HB3' ' H ' ' A' ' 119' ' ' THR . 13.0 tp10 -63.34 -31.63 72.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.673 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.28 -53.74 7.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.023 0.439 . . . . 0.0 111.144 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.437 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 4.1 pp -66.95 -26.12 66.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.861 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 71.9 m -76.31 -28.85 57.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.947 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -65.05 -51.03 63.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.028 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.4 pt -59.14 -35.48 57.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.923 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -61.71 -41.14 97.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.295 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -71.75 -26.08 62.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.612 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.22 -23.63 27.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.033 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.4 p . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 -179.855 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 N--CA 1.497 1.678 0 N-CA-C 112.758 0.253 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tp -71.93 -19.89 61.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 62.4 mtp -58.58 -33.11 69.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.867 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.73 -57.33 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 tp -58.04 -51.72 68.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.674 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -57.99 -40.83 81.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 111.041 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -70.76 -35.74 72.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.962 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.8 -47.56 45.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.017 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.0 70.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.092 0.473 . . . . 0.0 110.36 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -74.83 -45.01 46.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.753 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.47 -22.13 54.94 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 21.1 m -85.86 -53.73 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.708 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.425 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -124.92 -7.69 7.24 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.737 -178.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER 73.24 19.81 3.45 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.876 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -110.07 149.65 29.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.455 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 p -81.87 152.37 68.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.869 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.22 169.8 21.74 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.849 2.366 . . . . 0.0 111.63 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.54 123.26 42.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.398 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -126.05 148.16 49.39 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.623 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.49 135.58 5.53 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.9 m -102.65 121.88 43.3 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.828 0.346 . . . . 0.0 111.343 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.76 148.92 11.51 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.439 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -114.48 112.67 23.35 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.66 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -133.0 158.2 76.46 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -52.02 -21.67 12.87 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.548 1.498 . . . . 0.0 111.502 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' OE1' ' OE1' ' A' ' 85' ' ' GLN . 57.3 mt-10 -82.78 -17.15 45.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.537 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.18 -115.72 1.35 Allowed Glycine 0 C--N 1.331 0.304 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -132.86 136.94 46.52 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.28 121.65 41.75 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.5 mmt -93.3 133.3 36.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.945 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.1 m -116.63 130.07 56.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.783 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -127.01 132.14 50.83 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.173 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.444 ' N ' ' CD1' ' A' ' 75' ' ' LEU . 28.8 mt -128.38 148.98 32.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.4 tp -172.0 128.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.367 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 34.9 t30 55.78 -92.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.292 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -136.29 1.9 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.143 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 53.0 mt -96.96 128.85 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.878 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.43 ' O ' ' CG2' ' A' ' 81' ' ' THR . 6.2 t -132.32 126.88 34.35 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.73 164.11 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.292 0.568 . . . . 0.0 110.97 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -165.35 163.9 19.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.691 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.82 166.9 35.71 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.421 ' OE1' ' OE1' ' A' ' 69' ' ' GLU . 36.5 mt-30 -114.5 141.59 47.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.507 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.88 167.36 30.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.513 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.7 p -97.53 -2.41 41.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.639 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -125.98 149.97 48.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.178 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -77.05 -43.69 33.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 111.183 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -62.11 -47.34 85.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.582 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.08 -21.32 60.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.686 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.12 -37.64 72.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.028 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -73.99 -44.17 55.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.931 0.396 . . . . 0.0 110.591 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -57.58 -39.82 77.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.829 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -65.67 -39.43 91.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.041 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.39 -48.53 49.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 110.999 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.11 -33.76 69.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 76.3 t -71.68 -46.18 63.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.516 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -54.72 -35.56 63.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.047 0.451 . . . . 0.0 109.88 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.51 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.74 -60.4 3.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.089 179.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.51 ' N ' ' CG ' ' A' ' 100' ' ' TYR . 16.5 mt -48.17 -38.19 17.53 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.397 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -60.01 -43.7 95.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.841 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -63.44 -27.7 69.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.83 0.348 . . . . 0.0 110.899 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.63 -53.78 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.437 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -53.46 -41.47 45.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.77 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.56 -26.33 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.125 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -93.78 18.04 10.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.853 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.91 39.69 11.6 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 111' ' ' GLU . 47.6 mtpt -133.28 22.51 4.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.784 0.326 . . . . 0.0 110.812 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -49.82 -16.13 0.24 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.495 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 109' ' ' LYS . 97.3 mt-10 -80.07 23.78 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.075 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.428 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -49.21 -44.02 16.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.899 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.544 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 1.4 p90 -118.33 -20.43 8.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.544 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 74.3 t80 117.09 51.67 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.829 1.33 . . . . 0.0 109.633 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 24.0 mt -62.16 113.48 8.79 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -51.48 127.89 23.99 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.175 1.25 . . . . 0.0 111.735 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.58 90.98 0.13 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.485 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.1 p -78.33 -32.79 49.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.9 p -139.88 175.45 9.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.329 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -58.92 -60.48 3.79 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.233 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -55.5 -24.78 33.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.544 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -66.39 -49.51 66.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.722 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.12 66.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.775 0.321 . . . . 0.0 110.778 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -59.57 -56.5 21.14 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.947 0.88 . . . . 0.0 108.996 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.5 t -51.8 -36.79 49.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.82 -1.536 . . . . 0.0 110.428 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -54.93 -58.81 6.09 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.23 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.6 mt -59.06 -45.82 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.484 0.659 . . . . 0.0 109.553 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -47.27 -46.53 24.84 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.486 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -71.99 -29.18 63.97 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.343 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 75.7 mt -65.23 -23.1 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.396 179.78 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 N--CA 1.487 1.139 0 CA-C-O 120.834 0.264 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.6 tp -77.05 -20.74 55.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.189 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 61.1 mtt -58.57 -33.23 69.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.263 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.2 -50.15 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.372 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.7 tp -52.18 -50.65 61.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.431 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -59.44 -52.84 63.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.527 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -60.94 -38.93 87.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.752 0.31 . . . . 0.0 111.164 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 55' ' ' VAL . . . -69.23 -47.24 65.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.21 -31.02 72.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.345 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -74.25 -49.34 23.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.338 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -21.12 59.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.469 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 20.3 m -85.35 -53.94 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 119.974 -0.69 . . . . 0.0 112.213 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.469 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 7.6 m-85 -126.01 -1.03 7.18 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 58.26 40.84 24.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.298 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 -177.0 3.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.368 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.79 119.53 41.01 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.41 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.89 168.44 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.578 1.519 . . . . 0.0 111.641 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 m -113.25 140.75 47.71 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.814 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -135.55 154.67 51.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.722 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.34 135.64 4.93 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -105.4 114.64 28.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.869 0.366 . . . . 0.0 111.328 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.19 148.48 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.012 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -114.02 110.71 20.47 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.62 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.42 156.03 80.57 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.25 -7.05 2.38 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.845 1.697 . . . . 0.0 111.211 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.457 ' H ' ' C ' ' A' ' 67' ' ' LEU . 50.7 mt-10 -94.38 -14.95 24.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.2 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.97 -121.08 2.38 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -132.75 134.16 44.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -114.12 120.59 41.07 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.247 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -89.63 125.03 35.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.91 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.4 m -117.51 131.6 56.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.414 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -132.92 144.9 50.46 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.391 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.4 mt -123.07 147.25 27.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.0 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.3 tp -160.12 108.98 1.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.7 t30 62.74 -80.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.879 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -142.53 3.99 1.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.792 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.8 mt -101.22 127.75 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.1 m -132.78 129.04 38.07 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.62 164.27 31.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.199 0.523 . . . . 0.0 111.157 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -132.92 145.53 50.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.296 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -139.5 121.8 2.13 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -94.66 135.14 36.47 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.0 163.76 39.3 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.917 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.4 -8.41 44.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.439 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.1 p -133.08 158.85 41.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.4 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -67.35 -45.31 76.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.351 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -57.45 -43.53 84.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.196 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.87 -20.01 59.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.4 -54.65 25.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.136 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -70.61 -39.34 73.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.23 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -54.32 -52.17 62.35 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.389 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -63.6 -41.46 98.32 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.73 -52.21 27.46 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.79 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.05 -37.14 66.34 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.213 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.8 t -65.51 -47.01 88.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.541 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -54.55 -36.91 64.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 110.326 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.556 ' CD2' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -60.11 -54.35 46.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.943 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.556 ' N ' ' CD2' ' A' ' 100' ' ' TYR . 6.4 mt -48.76 -39.67 25.88 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.525 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -60.5 -45.63 93.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.679 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -58.81 -27.77 65.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 110.639 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.46 -54.56 22.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.391 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.47 -39.93 64.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.535 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -67.54 -26.31 66.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.691 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -97.93 19.04 14.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.861 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.07 46.93 15.26 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -131.44 21.31 4.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.925 0.393 . . . . 0.0 110.612 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -54.45 -16.0 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.769 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.33 22.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.654 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.482 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.2 pp -68.15 -46.41 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.732 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.522 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 0.9 OUTLIER -120.25 -18.36 8.02 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.522 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 13.9 t80 97.83 64.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.15 0.907 . . . . 0.0 110.983 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -63.36 115.16 15.99 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -50.51 127.74 21.45 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 120.973 1.115 . . . . 0.0 111.816 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.9 91.24 0.13 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 43.9 p -76.08 -35.19 59.47 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.545 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -130.81 172.33 12.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.808 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -56.31 -59.7 4.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.295 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 125' ' ' SER . 98.7 mt-10 -60.31 -24.16 64.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.37 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.545 ' CB ' ' H ' ' A' ' 119' ' ' THR . 15.1 tp10 -61.65 -45.05 95.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.656 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.9 -51.38 48.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.783 0.325 . . . . 0.0 110.838 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -58.55 -54.94 41.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.155 0.978 . . . . 0.0 109.045 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 46.8 t -51.9 -26.75 10.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.813 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.65 -59.4 3.63 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.597 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -47.41 48.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -54.16 -48.87 70.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.26 -1.337 . . . . 0.0 111.211 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -71.85 -27.25 62.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.652 0.263 . . . . 0.0 111.197 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.9 mt -66.12 -19.14 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.212 -179.685 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 N--CA 1.493 1.444 0 CA-C-O 120.688 0.203 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.8 tp -70.93 -21.35 62.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.341 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.3 tpt -59.06 -33.17 70.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.419 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.67 -43.57 96.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.74 -52.15 58.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.862 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.8 -43.91 97.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.474 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.93 -40.44 60.83 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.52 -48.28 28.0 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.295 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.24 -33.11 67.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.059 0.456 . . . . 0.0 110.123 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -77.44 -44.28 29.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.643 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.7 -22.07 56.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 16.0 m -85.41 -53.86 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.47 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 2.8 m-85 -125.8 1.61 7.42 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 60.35 37.24 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.018 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -122.42 -167.83 1.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.107 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.29 159.72 51.05 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.42 ' CG ' ' CZ2' ' A' ' 62' ' ' TRP . 94.4 Cg_endo -76.65 169.26 22.13 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 123.047 2.498 . . . . 0.0 111.967 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.95 111.94 17.68 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.541 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.42 ' CZ2' ' CG ' ' A' ' 60' ' ' PRO . 6.7 m0 -109.89 155.13 22.1 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.191 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.31 131.65 3.37 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.28 111.97 24.19 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.476 ' O ' ' CB ' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -91.11 146.3 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.47 178.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -120.68 120.0 34.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.796 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 69' ' ' GLU . 4.7 mt -133.2 150.13 74.53 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.55 -7.16 1.23 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.476 1.451 . . . . 0.0 111.921 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -108.22 -7.18 16.05 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.787 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.21 -145.1 13.73 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.476 ' CB ' ' O ' ' A' ' 65' ' ' VAL . 6.9 p90 -141.87 151.92 43.14 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.116 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -120.27 114.96 22.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.047 0.451 . . . . 0.0 111.084 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.8 mmt -78.79 128.38 33.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -109.91 120.42 42.42 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.434 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -115.7 128.23 55.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.6 mt -124.47 143.3 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 79' ' ' GLU . 6.5 tp -158.77 -149.83 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.2 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.525 ' C ' ' H ' ' A' ' 80' ' ' ILE . 27.5 t-20 -48.01 83.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.555 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 77' ' ' LEU . 48.1 tt0 57.58 -1.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.033 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.525 ' H ' ' C ' ' A' ' 78' ' ' ASN . 62.8 mt -100.97 131.8 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.587 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.7 p -132.95 130.53 39.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.01 162.4 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.153 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -134.07 145.75 49.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.014 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.74 106.02 0.5 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -86.86 140.29 29.82 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.33 -179.6 2.31 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.987 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.6 p -120.09 10.18 11.35 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.804 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 91.2 p -131.25 153.76 49.17 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -72.06 -50.47 28.08 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.965 0.412 . . . . 0.0 111.103 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -55.64 -44.42 77.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.371 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.17 -20.14 60.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.893 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.39 -55.02 23.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.618 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -73.41 -42.29 62.27 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.763 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -53.19 -42.31 66.13 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.442 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -72.99 -35.99 66.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.383 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.16 -52.85 14.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.28 -38.94 85.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.0 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -66.29 -49.04 78.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -54.7 -33.87 61.53 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.227 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -63.0 -56.97 12.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.241 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.5 mt -52.65 -35.67 55.38 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.301 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -59.76 -46.27 89.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.621 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -61.69 -28.62 69.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.528 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.87 -54.6 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.4 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 t -52.66 -41.32 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.76 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.55 -25.9 67.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 110.059 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -96.72 20.49 10.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.737 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.44 40.54 3.72 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.41 ' C ' ' N ' ' A' ' 111' ' ' GLU . 32.4 tttp -133.94 24.08 3.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.416 ' C ' ' H ' ' A' ' 112' ' ' ILE . 10.8 p80 -48.4 -19.29 0.3 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.066 0.46 . . . . 0.0 110.171 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 109' ' ' LYS . 82.6 mt-10 -75.65 25.03 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.48 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.483 HG13 ' H ' ' A' ' 113' ' ' PHE . 2.3 pt -48.96 -46.6 16.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.957 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.526 ' O ' ' CD2' ' A' ' 114' ' ' PHE . 44.7 p90 -121.75 11.47 10.46 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 113' ' ' PHE . 3.6 m-85 85.96 54.2 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.043 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 24.8 mt -63.29 122.29 74.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.46 128.39 14.43 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.372 1.381 . . . . 0.0 112.919 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.75 91.16 0.13 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 62.4 m -59.55 -38.43 81.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.0 p -131.03 -172.68 2.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.792 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -67.42 -59.73 3.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.928 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -55.11 -24.5 26.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.93 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -68.63 -41.07 79.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.065 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.72 -52.43 30.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.761 0.315 . . . . 0.0 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 1.9 mp -55.91 -56.92 14.86 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.924 0.869 . . . . 0.0 108.717 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.2 t -51.7 -28.58 15.32 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.39 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.23 -50.29 74.24 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.849 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.415 ' N ' ' CD1' ' A' ' 127' ' ' ILE . 1.9 mp -58.62 -44.12 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-O 121.353 0.597 . . . . 0.0 109.7 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -53.13 -47.68 68.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.205 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -71.57 -29.3 64.57 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.166 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 43.2 mt -64.26 -20.04 26.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.038 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.462 0.171 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.437 -179.502 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.496 1.64 0 N-CA-C 112.673 0.22 . . . . 0.0 112.673 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.48 -22.15 63.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.864 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.5 ttp -63.43 -34.23 77.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.735 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 t -65.56 -30.79 51.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.257 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 tp -75.54 -51.98 11.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.54 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -54.26 -37.76 65.06 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.283 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -77.23 -41.11 42.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.26 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.403 ' O ' ' CG1' ' A' ' 55' ' ' VAL . . . -65.69 -48.71 71.12 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.117 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.67 -30.68 71.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 0.0 111.006 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 57' ' ' GLN . 29.1 ttpt -78.36 -57.82 3.58 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.005 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.29 -21.78 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.462 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 23.8 m -86.13 -53.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.782 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.462 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 2.1 m-85 -125.72 -1.1 7.36 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 71.04 19.33 5.63 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.175 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -110.79 -167.95 1.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.08 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.15 162.3 42.42 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.008 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.04 169.13 22.73 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.991 2.461 . . . . 0.0 112.049 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.13 131.39 53.27 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.004 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -120.74 141.06 50.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.798 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.67 128.98 4.65 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 p -96.87 119.36 35.2 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.895 0.378 . . . . 0.0 111.5 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.54 148.09 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.229 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -114.19 110.29 19.74 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.618 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.54 156.34 80.2 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -51.59 -15.64 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.614 1.542 . . . . 0.0 111.6 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.61 -17.62 31.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.842 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.42 -114.71 1.26 Allowed Glycine 0 C--N 1.33 0.205 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -133.16 136.49 45.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -120.38 118.59 30.76 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.5 mtt -93.38 134.4 35.66 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.332 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.5 p -107.96 128.16 54.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.806 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.0 tp -116.63 125.98 52.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.4 mt -120.52 133.16 68.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 120.905 0.383 . . . . 0.0 109.972 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' GLU . 13.0 mt -140.83 -165.56 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.607 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.515 ' C ' ' H ' ' A' ' 80' ' ' ILE . 5.6 p30 -49.0 91.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.731 0.301 . . . . 0.0 111.116 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 77' ' ' LEU . 69.5 mm-40 60.43 -6.21 0.09 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.257 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.515 ' H ' ' C ' ' A' ' 78' ' ' ASN . 96.2 mt -99.15 130.6 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.031 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 t -132.43 129.39 39.21 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.4 m -141.78 162.79 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.243 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.76 162.84 40.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.194 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.63 149.17 20.98 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -106.75 138.49 42.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.684 0.278 . . . . 0.0 110.342 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.89 160.97 31.61 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.93 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.9 m -74.01 -26.77 60.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.702 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.4 p -117.97 155.49 30.17 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.446 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -37.24 66.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.272 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -59.79 -48.14 82.88 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.678 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.71 -22.44 61.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.262 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.81 76.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.998 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -74.17 -45.68 46.99 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.782 0.325 . . . . 0.0 111.035 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -52.8 -48.77 66.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.869 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -62.67 -35.04 78.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.583 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.34 -49.44 49.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.229 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.14 -31.91 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.103 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.21 -49.95 50.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.735 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -55.14 -33.17 62.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.311 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.43 ' CD1' ' C ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -63.33 -56.91 12.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.005 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 mt -52.07 -36.45 50.73 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.704 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -61.05 -45.63 93.96 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.61 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -62.76 -27.86 69.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.766 0.317 . . . . 0.0 111.241 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -64.61 -54.1 34.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.399 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 t -53.9 -41.13 47.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.494 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -60.0 -28.15 67.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.28 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -97.33 20.33 11.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.211 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.85 44.19 5.53 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 111' ' ' GLU . 11.8 tttp -133.37 20.32 3.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.414 . . . . 0.0 110.182 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.421 ' CD2' ' H ' ' A' ' 110' ' ' HIS . 6.0 p80 -48.53 -15.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.901 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 109' ' ' LYS . 90.4 mt-10 -79.71 22.9 0.45 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.622 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.408 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -50.98 -45.09 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.145 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.572 ' O ' ' CG ' ' A' ' 114' ' ' PHE . 2.0 p90 -118.32 -7.01 10.77 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.572 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 6.7 m-85 98.06 54.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.612 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.6 mt -62.6 114.82 13.27 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.491 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -50.72 128.62 24.62 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.304 1.336 . . . . 0.0 112.32 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.74 91.29 0.13 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 m -91.92 -30.05 16.34 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.9 m -140.65 162.99 34.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.422 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -53.37 -60.65 3.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.486 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.44 ' O ' ' OG ' ' A' ' 125' ' ' SER . 83.8 mt-10 -56.72 -25.74 55.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.493 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -72.14 -51.38 21.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.42 -51.46 69.75 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -62.83 -58.51 7.15 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.575 0.703 . . . . 0.0 110.396 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 37.3 m -52.15 -36.58 51.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.996 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -58.15 -55.74 31.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.365 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.431 HG21 HD11 ' A' ' 127' ' ' ILE . 27.1 pt -69.1 -34.2 62.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.068 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -61.8 -39.3 91.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.712 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -69.47 -25.21 63.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.742 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.0 mt -73.68 -23.98 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.064 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.016 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.495 1.56 0 CA-C-O 120.732 0.222 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.9 tp -70.05 -25.36 63.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.519 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.1 mmt -64.64 -33.7 76.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.39 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.98 -56.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.456 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.06 -51.31 64.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.269 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -54.81 -42.49 71.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.775 0.321 . . . . 0.0 111.139 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -71.77 -37.87 70.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.032 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.405 ' O ' ' CG1' ' A' ' 55' ' ' VAL . . . -69.17 -47.35 65.19 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.72 -31.69 68.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.04 0.447 . . . . 0.0 110.301 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -77.12 -47.18 21.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.954 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.95 -21.13 59.36 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 17.4 m -85.26 -53.81 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.239 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.47 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 3.1 m-85 -126.08 -4.8 6.81 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.404 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 19.5 tp60 71.96 19.89 4.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.67 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -111.02 -167.53 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.299 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.89 161.07 51.14 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.691 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.51 169.01 21.79 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.808 2.339 . . . . 0.0 111.462 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.09 117.07 26.24 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.944 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -112.8 152.78 28.76 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.796 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.68 125.37 2.03 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 78.1 m -97.77 120.7 38.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.058 0.456 . . . . 0.0 111.281 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.8 t -107.59 150.63 10.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.365 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.475 ' N ' ' OE1' ' A' ' 66' ' ' GLU . 14.7 mp0 -119.76 114.21 21.8 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -127.27 160.63 58.92 Favored Pre-proline 0 C--N 1.345 0.403 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.08 -8.21 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.097 1.865 . . . . 0.0 111.234 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -99.65 -10.79 21.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.636 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.32 -120.72 1.83 Allowed Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 3.9 m-85 -141.71 145.09 34.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -119.69 145.72 46.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 7.8 tpp -114.64 133.8 55.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.9 p -116.82 125.89 52.26 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tp -121.37 135.89 55.03 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.58 149.43 33.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 79' ' ' GLU . 35.8 tp -169.11 125.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.751 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 65.1 t30 58.78 -80.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.841 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -147.55 -0.62 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 110.533 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.1 mt -100.18 134.24 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.41 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.15 131.74 42.55 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.34 162.35 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.13 0.49 . . . . 0.0 111.186 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -160.58 160.81 32.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.047 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.85 155.48 26.32 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.671 ' H ' HE21 ' A' ' 85' ' ' GLN . 0.0 OUTLIER -104.2 140.14 38.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.738 0.304 . . . . 0.0 110.231 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.65 165.51 25.68 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.763 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.4 p -104.14 -0.78 28.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -115.89 152.24 33.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.219 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -80.24 -51.21 9.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.247 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -59.64 -45.77 91.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.112 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.07 67.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.829 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.98 -42.75 90.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.434 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -73.99 -45.85 47.43 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.035 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -53.59 -43.26 68.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.77 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -64.03 -36.23 83.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.675 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.57 -50.3 32.34 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.681 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.43 -41.39 89.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.451 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.63 -46.14 90.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.812 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -55.08 -36.2 65.37 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.248 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -60.84 -58.34 8.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.68 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.428 ' N ' ' CG ' ' A' ' 100' ' ' TYR . 19.0 mt -48.9 -36.22 16.66 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.672 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -61.83 -44.62 96.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.403 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -61.86 -27.7 68.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.894 0.378 . . . . 0.0 110.975 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.48 -54.41 26.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.682 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -53.66 -39.79 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.499 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -68.29 -22.9 64.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.462 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -97.25 14.17 26.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.63 40.16 47.36 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.179 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 111' ' ' GLU . 0.5 OUTLIER -133.62 26.48 4.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.815 0.34 . . . . 0.0 110.327 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -48.9 -16.86 0.14 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 109' ' ' LYS . 88.3 mt-10 -84.3 23.81 1.04 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.551 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.43 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -49.8 -45.02 21.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.863 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 1.0 OUTLIER -118.73 -17.02 9.3 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.533 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 50.9 t80 110.77 52.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.7 1.25 . . . . 0.0 110.257 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.407 ' CG1' ' CE2' ' A' ' 113' ' ' PHE . 35.2 mt -62.49 112.69 6.98 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -51.45 128.56 26.18 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.27 1.314 . . . . 0.0 111.907 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.68 91.53 0.13 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.668 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.8 m -77.25 -38.07 51.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.88 170.56 13.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.449 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.45 -60.5 3.74 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.494 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.411 ' O ' ' OG ' ' A' ' 125' ' ' SER . 93.6 mt-10 -56.43 -24.53 45.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.984 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -69.92 -44.2 70.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.02 83.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 2.9 mp -66.22 -58.98 4.2 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.906 0.86 . . . . 0.0 109.964 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 91.0 p -52.86 -38.35 61.43 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.804 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -57.54 -58.74 6.96 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.774 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' ILE . 12.2 mt -54.78 -51.69 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.501 0.667 . . . . 0.0 110.1 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -47.15 -35.25 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.589 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -71.71 -27.41 63.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.773 0.32 . . . . 0.0 110.552 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 127' ' ' ILE . 56.4 mt -67.92 -28.66 42.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.2 p . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.564 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.493 1.495 0 CA-C-O 120.788 0.245 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.5 tp -71.39 -21.99 61.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.332 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.1 tpt -62.39 -34.32 76.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.112 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -68.51 -50.65 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.428 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.8 tp -56.07 -52.17 65.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.434 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -60.65 -43.97 96.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 111.557 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.42 -33.84 73.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.048 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.48 -47.68 31.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.26 72.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.993 0.425 . . . . 0.0 109.915 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -77.36 -44.45 29.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.949 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.79 -21.82 57.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.452 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 19.6 m -85.51 -53.86 9.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.452 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 3.2 m-85 -125.68 -2.45 7.29 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.688 -0.405 . . . . 0.0 112.035 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 67.22 23.39 9.44 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.348 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -108.93 176.7 5.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.346 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.51 159.42 32.28 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.985 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.31 169.55 19.93 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.054 2.503 . . . . 0.0 111.983 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.05 119.79 33.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.76 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -114.19 150.89 33.56 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.45 130.39 3.93 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.6 t -100.38 115.4 29.92 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 111.33 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.06 148.29 10.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.267 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.31 111.42 21.46 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.667 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.8 156.23 80.31 Favored Pre-proline 0 N--CA 1.456 -0.153 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.232 -178.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -51.78 -16.1 3.65 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.516 1.477 . . . . 0.0 111.625 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.07 -15.46 33.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.788 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.35 -116.87 1.51 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -134.0 135.78 43.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -117.95 121.22 40.12 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 44.7 tpp -93.47 130.04 39.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.82 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.2 m -107.63 126.05 52.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.421 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -119.07 130.52 55.66 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.306 0.379 . . . . 0.0 110.203 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.8 mt -123.22 138.04 54.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.073 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 79' ' ' GLU . 5.1 tp -150.22 -154.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' ILE . 19.9 p-10 -48.52 83.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.775 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 77' ' ' LEU . 5.9 tp10 60.86 -3.33 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.85 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASN . 71.8 mt -102.67 131.84 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.078 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 p -132.58 132.49 42.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -141.65 160.97 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.464 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -134.54 150.0 50.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.989 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -142.78 133.19 5.43 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -102.74 137.81 40.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.83 164.08 36.08 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.978 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 74.0 p -87.18 -10.88 51.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.364 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.3 m -128.56 155.53 44.76 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.227 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.485 ' H ' ' CD ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -70.31 -42.13 72.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -57.43 -47.93 80.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.98 62.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.696 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.5 74.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -73.33 -43.1 61.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.725 0.297 . . . . 0.0 111.524 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -52.27 -45.03 65.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.278 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -70.34 -34.92 73.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 111.166 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.65 -48.15 67.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.339 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.17 82.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.338 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.91 -50.67 76.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.676 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -55.35 -37.82 67.97 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.678 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -55.0 40.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.369 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.2 mt -50.4 -35.41 28.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.255 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.515 ' NH1' ' OE2' ' A' ' 106' ' ' GLU . 64.9 ttp85 -62.18 -47.04 86.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.441 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -27.54 65.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.673 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.56 -54.49 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.683 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -52.4 -40.77 33.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.567 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.515 ' OE2' ' NH1' ' A' ' 102' ' ' ARG . 97.9 mt-10 -66.25 -24.96 66.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.107 0.48 . . . . 0.0 109.787 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -93.77 19.72 8.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.419 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.7 38.92 2.44 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 111' ' ' GLU . 9.3 tptp -132.91 25.1 4.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.534 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -48.82 -15.77 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.611 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 109' ' ' LYS . 77.0 mm-40 -80.04 23.5 0.46 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.113 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.404 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -50.04 -44.53 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.518 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 1.3 p90 -118.15 -19.88 8.86 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.538 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 68.7 t80 116.87 51.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.799 1.312 . . . . 0.0 109.583 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 22.8 mt -62.75 121.0 65.27 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.48 128.87 13.14 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.552 1.501 . . . . 0.0 112.701 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.32 91.31 0.13 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.464 ' HG1' ' N ' ' A' ' 119' ' ' THR . 64.5 p -61.49 -34.51 75.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.113 0.482 . . . . 0.0 109.723 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.464 ' N ' ' HG1' ' A' ' 118' ' ' THR . 0.0 OUTLIER -135.81 172.05 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.895 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -57.15 -59.8 4.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.211 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.423 ' O ' ' OG ' ' A' ' 125' ' ' SER . 80.2 tt0 -56.09 -25.19 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.529 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -69.58 -47.97 61.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.13 74.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.236 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.542 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 1.2 mp -65.16 -58.24 6.52 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.912 0.863 . . . . 0.0 109.884 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 44.8 m -53.07 -36.57 60.8 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.0 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -63.13 -59.53 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.673 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.3 pt -60.47 -35.0 60.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.375 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -61.98 -33.23 73.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.891 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -71.0 -25.75 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.538 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 58.2 mt -70.19 -30.09 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.7 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.826 179.933 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 N--CA 1.494 1.507 0 N-CA-C 112.762 0.255 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.08 -23.47 62.13 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.31 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.0 mmt -65.75 -34.5 78.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.972 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.8 t -68.21 -43.53 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.3 -52.05 66.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.167 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -56.34 -53.33 58.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.865 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -61.97 -35.68 79.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.044 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' O ' ' CG1' ' A' ' 55' ' ' VAL . . . -68.65 -47.37 66.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.997 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.78 -31.37 72.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.039 0.447 . . . . 0.0 109.892 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -77.26 -45.68 25.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.456 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.15 -21.79 58.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.454 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 19.4 m -85.61 -53.3 10.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.454 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 2.1 m-85 -125.15 -1.31 7.71 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.5 41.14 7.65 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.168 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -127.89 -179.12 4.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.09 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.54 156.86 39.75 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.95 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 168.59 23.69 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.68 2.254 . . . . 0.0 112.059 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.1 117.26 28.26 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.918 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -114.85 140.63 48.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.8 121.76 1.99 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 m -97.35 112.21 24.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.115 0.483 . . . . 0.0 111.462 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 t -93.16 147.77 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.826 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -122.98 118.81 28.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.572 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 69' ' ' GLU . 4.4 mt -133.41 149.61 72.83 Favored Pre-proline 0 CA--C 1.529 0.16 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.29 -7.15 1.72 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.316 1.344 . . . . 0.0 110.953 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.474 ' H ' ' C ' ' A' ' 67' ' ' LEU . 80.3 mm-40 -105.17 -11.48 16.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.776 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.17 -150.28 22.53 Favored Glycine 0 C--N 1.332 0.352 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 14.4 m-85 -129.07 147.63 50.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.88 0.34 . . . . 0.0 110.262 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -118.07 112.72 20.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.031 0.444 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -84.63 129.54 34.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.0 p -113.79 129.77 56.54 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.145 0.278 . . . . 0.0 110.766 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.434 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -122.01 126.82 49.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.2 mt -121.66 132.66 70.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 79' ' ' GLU . 3.2 tp -147.74 -159.41 1.02 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.685 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.539 ' C ' ' H ' ' A' ' 80' ' ' ILE . 2.9 p30 -46.15 84.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.877 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 77' ' ' LEU . 17.5 tp10 61.27 -7.14 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.904 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.539 ' H ' ' C ' ' A' ' 78' ' ' ASN . 73.0 mt -99.5 128.37 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.009 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 p -132.64 128.03 36.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.7 m -141.2 167.05 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.193 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -162.76 168.75 21.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.071 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.36 163.08 33.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.456 ' CD ' ' H ' ' A' ' 85' ' ' GLN . 0.5 OUTLIER -109.25 138.69 45.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.836 0.35 . . . . 0.0 110.292 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.0 161.51 39.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.715 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.9 p -97.15 -1.01 45.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.996 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.4 m -130.86 151.92 50.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.077 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -71.95 -39.71 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 0.0 111.28 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -57.92 -47.74 81.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.344 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.13 -20.03 59.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.086 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.38 -53.55 46.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.403 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -72.93 -44.28 61.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.573 0.225 . . . . 0.0 111.152 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -53.06 -47.21 68.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.807 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -63.43 -34.99 78.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.794 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.73 -50.37 30.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.168 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.59 76.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.45 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.52 -48.96 69.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.503 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -54.25 -34.99 62.01 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.279 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.49 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.58 -57.97 8.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.548 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.49 ' N ' ' CG ' ' A' ' 100' ' ' TYR . 13.8 mt -47.94 -37.93 15.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.184 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -60.79 -44.95 96.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.428 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -60.17 -27.72 67.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.02 0.438 . . . . 0.0 110.91 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -68.81 -53.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.615 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.84 -41.37 56.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.697 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -62.85 -27.5 69.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 109.865 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -94.15 20.34 8.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.709 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.53 38.96 5.59 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 111' ' ' GLU . 2.6 tptm -133.73 25.59 4.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.734 0.302 . . . . 0.0 110.897 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.448 ' C ' ' H ' ' A' ' 112' ' ' ILE . 8.2 p80 -49.29 -16.06 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.797 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 109' ' ' LYS . 6.1 pt-20 -75.4 23.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.444 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.448 ' H ' ' C ' ' A' ' 110' ' ' HIS . 1.3 pp -49.95 -44.36 21.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.844 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.53 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 1.4 p90 -117.48 -19.59 9.41 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.536 ' O ' ' CD2' ' A' ' 114' ' ' PHE . 75.8 t80 118.03 50.05 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.888 1.367 . . . . 0.0 109.543 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 25.0 mt -62.33 113.4 8.67 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.29 129.26 10.22 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.765 1.643 . . . . 0.0 113.024 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.15 90.67 0.13 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 69.7 m -58.1 -37.02 73.73 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.76 161.46 27.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.84 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -53.8 -59.54 4.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.864 0.364 . . . . 0.0 110.47 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.69 -24.56 49.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.7 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -71.84 -44.77 63.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.013 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.83 -51.17 71.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.092 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -63.4 -56.76 13.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.019 0.914 . . . . 0.0 109.393 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.1 t -52.11 -37.73 55.08 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.155 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -62.77 -57.59 10.41 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.545 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.5 pt -59.46 -33.99 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 0.0 110.493 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -72.96 -32.59 65.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.85 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -70.02 -25.67 63.69 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.5 pt -90.45 -18.93 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.154 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.874 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 N--CA 1.496 1.643 0 CA-C-O 120.758 0.233 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -61.67 -20.34 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.204 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.1 tpt -58.79 -33.97 70.94 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -58.76 -31.16 43.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.6 tp -78.78 -51.85 9.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.479 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -60.07 -32.28 70.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -76.29 -43.01 43.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.336 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.35 -48.36 50.75 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.231 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.48 -32.2 68.55 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.312 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -78.02 -47.34 18.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.316 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.21 -20.66 60.82 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.855 -0.528 . . . . 0.0 112.387 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 18.2 m -85.75 -52.94 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.16 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.507 ' CD1' ' OD1' ' A' ' 78' ' ' ASN . 0.7 OUTLIER -125.49 -7.42 6.91 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.034 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 6.9 tt0 75.27 19.96 2.13 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.308 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -115.28 173.91 6.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.134 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 161.95 21.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.743 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.37 168.74 22.6 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.793 2.328 . . . . 0.0 112.1 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.39 115.95 23.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.533 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -109.32 149.54 29.32 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.08 124.66 1.86 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.3 m -104.25 114.39 28.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.387 . . . . 0.0 111.825 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.93 151.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.488 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -117.2 113.42 22.2 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -129.64 158.44 73.51 Favored Pre-proline 0 C--N 1.347 0.469 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.24 -15.59 8.35 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.93 1.753 . . . . 0.0 111.818 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -96.57 -10.98 26.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.558 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.83 -125.97 2.99 Favored Glycine 0 C--N 1.329 0.16 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 16.0 m-85 -138.52 145.23 40.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -110.2 129.32 55.74 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.202 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 2.0 mpp? -92.09 133.38 35.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.988 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 m -119.19 118.84 32.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.5 tp -120.63 130.88 54.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.5 mt -127.33 135.23 63.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 79' ' ' GLU . 13.8 mt -141.51 101.08 3.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.144 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.507 ' OD1' ' CD1' ' A' ' 56' ' ' TYR . 14.1 m-80 57.86 -82.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.239 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 77' ' ' LEU . 6.8 tp10 -125.5 -10.51 6.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.399 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.429 HD12 HG23 ' A' ' 80' ' ' ILE . 87.6 mt -94.59 130.35 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.613 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.4 p -132.17 131.34 42.12 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.0 m -136.46 158.86 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.028 0.442 . . . . 0.0 110.932 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -162.24 166.41 25.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.785 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.504 ' O ' ' SD ' ' A' ' 73' ' ' MET . . . -169.28 177.97 42.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -106.63 135.11 48.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.585 0.231 . . . . 0.0 110.435 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -149.96 160.16 43.82 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.957 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.9 p -118.77 9.39 12.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.566 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.4 t -128.33 154.73 45.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.26 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -80.69 -53.62 6.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.958 0.409 . . . . 0.0 111.385 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -59.76 -44.31 93.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.553 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.09 -20.99 60.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.344 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.11 -49.89 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.496 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -73.15 -43.62 61.25 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.304 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -56.8 -48.01 78.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.251 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -62.12 -34.64 76.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.003 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.24 -50.83 43.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.856 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.95 -30.08 63.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.03 -51.59 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.205 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.93 -34.84 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.855 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -56.78 17.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.247 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.6 mt -51.36 -37.02 45.8 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 123.6 0.563 . . . . 0.0 111.907 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -61.34 -47.04 87.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.721 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -60.64 -28.12 68.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.349 . . . . 0.0 110.611 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.3 -53.21 50.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.808 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.5 t -52.87 -37.17 25.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.581 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -71.47 -24.8 62.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -95.97 19.78 11.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.297 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.62 39.2 2.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -130.86 30.95 4.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.062 0.458 . . . . 0.0 110.011 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -48.86 -15.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.286 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -83.37 23.47 0.91 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.422 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.5 pp -50.22 -47.54 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.02 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.535 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 0.8 OUTLIER -120.23 -16.89 8.42 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.535 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 34.9 t80 105.28 57.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.468 1.105 . . . . 0.0 110.277 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.41 ' CG1' ' CE2' ' A' ' 113' ' ' PHE . 22.3 mt -64.41 114.1 13.0 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.659 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -51.35 130.33 32.3 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.447 1.431 . . . . 0.0 112.017 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.47 94.72 0.15 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.783 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.8 m -78.4 -35.23 47.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.168 0.508 . . . . 0.0 109.713 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.45 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -136.22 175.93 9.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.617 179.26 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.78 -60.18 4.25 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.338 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.415 ' O ' ' OG ' ' A' ' 125' ' ' SER . 94.5 mt-10 -58.87 -25.15 63.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.476 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.45 ' CB ' ' H ' ' A' ' 119' ' ' THR . 17.4 tp10 -62.05 -47.69 83.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.706 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.78 -49.49 74.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.986 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 1.5 mp -63.19 -58.04 8.53 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 109.568 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 27.4 m -52.49 -36.51 55.25 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.996 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -61.91 -58.64 7.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.612 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.7 pt -66.11 -35.69 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.782 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -58.58 -40.29 82.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -72.47 -25.97 61.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.178 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 53.8 mt -68.77 -23.92 28.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.767 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.6 ttt85 -54.45 -41.27 69.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.352 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.6 m -130.09 150.51 51.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.478 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -56.67 -34.16 67.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.679 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 tp -54.89 -38.04 67.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.28 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -58.79 -41.73 87.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.298 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.5 mtp -57.75 -38.77 75.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.531 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -68.45 -43.28 77.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.725 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.504 ' C ' ' H ' ' A' ' 42' ' ' LYS . 8.4 mp -67.75 -17.66 64.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.566 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -69.86 10.56 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.434 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.504 ' H ' ' C ' ' A' ' 40' ' ' LEU . 48.3 tttp -56.21 -43.18 78.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.994 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.21 154.44 40.48 Favored Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.673 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.38 -25.61 15.24 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.34 2.026 . . . . 0.0 112.138 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.7 tp -65.3 -23.09 66.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.569 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.4 tpt -62.25 -34.85 77.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.351 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 t -68.21 -35.77 72.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.982 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 tp -69.94 -51.74 30.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.206 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -52.8 -40.14 62.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.599 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.32 -32.56 58.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.124 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.428 ' O ' ' CG2' ' A' ' 55' ' ' VAL . . . -71.07 -48.74 50.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.179 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.28 -31.56 72.44 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.914 0.388 . . . . 0.0 110.667 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 57' ' ' GLN . 62.4 mttm -78.67 -57.19 3.89 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.42 -21.47 64.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.456 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 25.5 m -86.02 -53.67 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.823 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.456 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 2.6 m-85 -126.38 4.65 6.96 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 53' ' ' LYS . 88.9 mm-40 59.42 32.76 22.01 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.579 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -125.53 151.37 46.44 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.325 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.04 156.05 74.67 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.953 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.06 168.7 24.15 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.901 2.401 . . . . 0.0 112.107 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.73 124.9 44.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.806 0.336 . . . . 0.0 111.257 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -117.36 152.62 34.56 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.872 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.88 129.78 3.65 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.1 m -102.65 118.72 37.46 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.058 0.456 . . . . 0.0 111.435 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.64 148.34 12.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.276 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.459 ' O ' ' CG ' ' A' ' 66' ' ' GLU . 4.3 pt-20 -114.81 110.01 19.05 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.627 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -133.17 158.66 75.22 Favored Pre-proline 0 CA--C 1.529 0.16 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -52.25 -20.19 10.71 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.481 1.454 . . . . 0.0 111.331 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -81.16 -19.94 42.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.123 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.64 -114.73 1.25 Allowed Glycine 0 C--N 1.33 0.23 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -133.03 136.5 46.02 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -117.12 128.11 54.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.135 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 3.4 tpt -96.8 128.62 43.93 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.661 -0.415 . . . . 0.0 109.988 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 m -107.49 120.27 41.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.7 tp -113.39 128.03 56.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 mp -123.51 133.53 68.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 79' ' ' GLU . 20.6 mt -139.93 88.71 2.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.334 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 56.87 -83.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.627 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 77' ' ' LEU . 91.3 mt-10 -111.44 -17.07 13.18 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.5 mt -98.44 128.11 50.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.275 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.3 t -132.52 131.53 41.69 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -137.26 153.96 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.325 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -134.45 149.47 50.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.854 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.61 142.41 9.93 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -104.87 138.09 41.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.303 . . . . 0.0 110.402 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.73 166.16 34.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.669 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 t -101.0 0.2 37.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.812 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 92.6 p -130.82 157.97 41.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.763 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -76.13 -45.64 32.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.974 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -61.79 -46.88 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.387 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.68 -21.18 59.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.162 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.22 -48.68 69.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.275 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -73.1 -43.14 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.757 0.313 . . . . 0.0 111.217 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.474 HE21 ' HG ' ' A' ' 131' ' ' SER . 56.0 tt0 -53.17 -45.7 68.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.961 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -65.82 -36.47 83.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.82 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.53 -51.16 38.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.242 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.73 -30.1 60.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.735 0.302 . . . . 0.0 111.32 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.2 t -72.06 -47.48 54.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.486 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -55.63 -35.14 65.58 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.155 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -63.58 -58.06 8.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.103 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.474 ' N ' ' CG ' ' A' ' 100' ' ' TYR . 14.4 mt -48.79 -39.25 24.54 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.564 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -60.14 -45.14 94.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.763 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.92 -29.09 68.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.97 0.414 . . . . 0.0 110.782 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -64.98 -54.52 28.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.757 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.1 t -54.05 -37.15 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.83 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -62.1 -32.89 73.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.332 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -96.64 20.93 10.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.806 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.72 49.43 8.86 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.408 ' C ' ' N ' ' A' ' 111' ' ' GLU . 9.8 mtpm? -133.23 23.45 4.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.375 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -48.85 -17.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.77 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.408 ' N ' ' C ' ' A' ' 109' ' ' LYS . 83.8 mt-10 -79.13 23.34 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.563 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.443 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -50.34 -44.73 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.71 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.536 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 1.9 p90 -117.77 -19.54 9.24 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.536 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 70.4 t80 118.66 48.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.85 1.344 . . . . 0.0 110.285 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 52.5 mt -62.32 113.01 7.47 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.61 128.99 10.6 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.627 1.551 . . . . 0.0 113.252 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.1 90.97 0.13 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.433 ' OG1' ' OE1' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -56.53 -28.75 60.75 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.19 -179.31 5.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.887 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -64.82 -59.7 3.91 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.622 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.417 ' O ' ' OG ' ' A' ' 125' ' ' SER . 88.4 mt-10 -56.75 -26.56 57.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.194 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.433 ' OE1' ' OG1' ' A' ' 118' ' ' THR . 69.3 mt-10 -66.72 -42.58 86.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.68 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.33 79.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.551 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 3.0 mp -65.88 -58.7 4.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.991 0.901 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 20.7 m -52.73 -41.35 63.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.95 -1.477 . . . . 0.0 111.05 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -55.52 -58.52 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.481 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 mt -55.79 -50.92 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.445 0.641 . . . . 0.0 109.898 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -46.84 -37.4 8.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.9 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -71.74 -26.96 62.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.542 0.21 . . . . 0.0 111.005 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.9 -25.47 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.474 ' HG ' HE21 ' A' ' 94' ' ' GLN . 31.2 t -83.85 -44.37 14.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.66 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 134' ' ' ALA . 82.7 m-20 -66.43 -36.87 83.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -68.9 1.69 3.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.687 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -54.32 -37.59 65.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.521 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -91.05 -84.29 0.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.447 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.491 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -52.62 -39.06 61.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.567 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.81 115.63 18.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.704 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -104.55 11.56 34.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.435 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.476 ' CD1' ' N ' ' A' ' 36' ' ' LEU . 9.6 mp -75.14 -38.04 61.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.257 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -57.6 -50.41 73.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.158 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.479 ' SD ' ' O ' ' A' ' 38' ' ' MET . 0.8 OUTLIER -58.42 -40.11 81.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.331 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -60.19 -43.14 96.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.712 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mt -73.29 -43.05 61.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.097 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 42' ' ' LYS . 20.4 mmtp -71.7 -24.11 61.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.695 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 37.6 49.38 1.03 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.728 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.25 98.58 52.07 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.686 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.86 -24.48 13.66 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.014 1.809 . . . . 0.0 111.862 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.6 tp -71.44 -20.55 62.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.424 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 tpt -58.46 -33.16 69.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.939 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.5 t -63.58 -54.99 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.4 tp -57.87 -52.3 66.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.955 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -54.4 -51.03 66.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.418 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -65.67 -32.51 74.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.086 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.62 -47.08 61.91 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.244 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 -33.91 69.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.859 0.362 . . . . 0.0 110.717 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.51 -47.21 27.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.111 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 -20.99 59.43 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 20.8 m -85.62 -53.86 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.533 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.436 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -125.85 -3.51 7.1 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 71.1 20.8 5.07 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.828 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -109.51 -173.76 2.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.311 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.417 ' H ' ' HG1' ' A' ' 59' ' ' THR . 0.5 OUTLIER -121.5 156.24 58.44 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.522 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 168.66 24.21 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 112.305 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.14 118.67 31.16 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.31 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.7 m0 -110.5 137.84 47.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.285 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.5 129.33 4.99 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.2 m -99.95 118.16 35.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.369 . . . . 0.0 111.541 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.93 148.4 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.831 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -113.71 109.95 19.41 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.621 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.29 155.31 81.44 Favored Pre-proline 0 C--O 1.227 -0.127 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.38 -7.25 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.851 1.701 . . . . 0.0 111.531 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' OE2' ' NE2' ' A' ' 85' ' ' GLN . 75.1 tt0 -94.72 -17.35 22.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.916 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.99 -117.77 1.61 Allowed Glycine 0 C--N 1.333 0.365 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -132.12 137.61 47.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -118.44 121.8 41.2 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.8 mtt -93.13 133.08 36.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.491 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.4 m -111.98 123.58 50.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.9 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -114.76 126.09 54.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.006 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.6 mm -118.02 131.66 70.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 tp -175.38 136.29 0.35 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.591 0.557 . . . . 0.0 110.904 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.6 t30 54.24 35.31 22.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.339 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 68.52 6.13 5.24 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.286 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.4 mt -99.27 137.72 25.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.01 129.65 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.498 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.7 m -132.68 161.47 41.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.87 0.367 . . . . 0.0 110.815 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -129.9 139.66 51.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.935 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.16 108.09 0.73 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.488 ' NE2' ' OE2' ' A' ' 69' ' ' GLU . 11.3 pt20 -91.91 136.36 33.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.444 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.53 171.98 16.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.674 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.47 -7.48 47.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.367 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.0 p -129.21 152.84 48.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.205 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -71.85 -42.77 66.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.274 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -60.0 -47.74 84.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.307 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.54 -25.63 62.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.975 0.417 . . . . 0.0 110.707 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.06 -35.04 73.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.053 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -74.26 -46.61 40.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.046 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -53.07 -47.51 68.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.915 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -64.99 -32.28 73.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.723 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.21 -51.95 21.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.926 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.25 -31.11 69.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.043 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.4 t -71.26 -51.42 34.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.932 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -55.55 -34.35 64.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.03 0.443 . . . . 0.0 110.352 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.28 -55.54 27.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.512 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.1 mt -50.59 -36.19 33.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.633 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -62.75 -45.21 93.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.499 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -60.37 -28.02 67.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 110.951 -179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.92 -53.65 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.243 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.39 -37.51 44.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.602 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.53 -28.76 69.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.553 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -96.73 20.04 11.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.615 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 45.58 44.81 12.03 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -133.12 23.93 4.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.707 0.289 . . . . 0.0 110.549 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -50.76 -15.75 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -79.87 22.53 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.293 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.437 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -50.93 -45.86 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.431 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 1.0 OUTLIER -118.26 -20.29 8.62 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.538 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 72.3 t80 117.27 51.31 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.871 1.357 . . . . 0.0 109.874 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 21.5 mt -62.85 118.17 39.46 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.23 128.05 12.56 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.336 1.357 . . . . 0.0 112.62 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.88 94.55 0.15 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.0 m -49.28 -38.24 26.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.149 0.5 . . . . 0.0 109.701 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.409 ' H ' ' HB3' ' A' ' 122' ' ' GLU . 11.4 p -133.46 176.08 8.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.877 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -54.69 -57.25 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.832 0.348 . . . . 0.0 110.623 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.44 ' O ' ' OG ' ' A' ' 125' ' ' SER . 95.5 mt-10 -61.76 -34.7 76.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.275 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.409 ' HB3' ' H ' ' A' ' 119' ' ' THR . 13.0 tp10 -63.34 -31.63 72.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.673 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.28 -53.74 7.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.023 0.439 . . . . 0.0 111.144 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.437 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 4.1 pp -66.95 -26.12 66.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.861 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 71.9 m -76.31 -28.85 57.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.947 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -65.05 -51.03 63.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.028 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.4 pt -59.14 -35.48 57.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.923 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -61.71 -41.14 97.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.295 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -71.75 -26.08 62.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.612 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.22 -23.63 27.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.033 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.531 ' HG ' ' N ' ' A' ' 132' ' ' ASP . 52.4 p -106.27 -43.84 4.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.531 ' N ' ' HG ' ' A' ' 131' ' ' SER . 47.0 t0 -56.54 -34.67 67.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.148 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 135' ' ' GLU . 16.7 mttm -54.25 -63.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.672 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 40.62 22.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.492 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 133' ' ' LYS . 49.7 tt0 62.5 43.67 7.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.621 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.516 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.5 t30 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.57 9.77 7.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.456 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.7 p -95.63 25.14 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.549 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -84.48 8.87 15.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.681 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.1 mt -65.81 -47.05 76.37 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.955 0.407 . . . . 0.0 110.028 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 38' ' ' MET . 12.2 pt-20 -62.35 -40.15 95.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.113 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.408 ' N ' ' CG ' ' A' ' 37' ' ' GLU . 2.0 ttp -57.31 -40.05 77.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.678 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -61.56 -46.51 89.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.689 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 tp -68.67 -41.13 79.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.933 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -70.71 -23.79 62.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.236 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 mttt 47.86 72.13 0.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.803 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' SD ' ' A' ' 46' ' ' MET . 1.5 p -140.57 84.72 13.67 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.805 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.14 -17.65 2.65 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.67 2.247 . . . . 0.0 112.758 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tp -71.93 -19.89 61.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.448 ' SD ' ' OG1' ' A' ' 43' ' ' THR . 62.4 mtp -58.58 -33.11 69.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.867 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.8 t -58.73 -57.33 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 tp -58.04 -51.72 68.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.674 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -57.99 -40.83 81.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 111.041 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -70.76 -35.74 72.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.962 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.8 -47.56 45.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.017 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.0 70.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.092 0.473 . . . . 0.0 110.36 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -74.83 -45.01 46.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.753 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.47 -22.13 54.94 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 21.1 m -85.86 -53.73 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.708 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.425 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -124.92 -7.69 7.24 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.737 -178.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER 73.24 19.81 3.45 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.876 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -110.07 149.65 29.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.455 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 p -81.87 152.37 68.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.869 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.22 169.8 21.74 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.849 2.366 . . . . 0.0 111.63 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.54 123.26 42.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.398 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -126.05 148.16 49.39 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.623 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.49 135.58 5.53 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.9 m -102.65 121.88 43.3 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.828 0.346 . . . . 0.0 111.343 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.76 148.92 11.51 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.439 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -114.48 112.67 23.35 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.66 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -133.0 158.2 76.46 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -52.02 -21.67 12.87 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.548 1.498 . . . . 0.0 111.502 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.421 ' OE1' ' OE1' ' A' ' 85' ' ' GLN . 57.3 mt-10 -82.78 -17.15 45.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.537 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.18 -115.72 1.35 Allowed Glycine 0 C--N 1.331 0.304 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -132.86 136.94 46.52 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.28 121.65 41.75 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.5 mmt -93.3 133.3 36.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.945 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.1 m -116.63 130.07 56.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.783 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -127.01 132.14 50.83 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.173 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.444 ' N ' ' CD1' ' A' ' 75' ' ' LEU . 28.8 mt -128.38 148.98 32.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.4 tp -172.0 128.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.367 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 34.9 t30 55.78 -92.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.292 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -136.29 1.9 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.143 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 53.0 mt -96.96 128.85 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.878 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.43 ' O ' ' CG2' ' A' ' 81' ' ' THR . 6.2 t -132.32 126.88 34.35 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.73 164.11 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.292 0.568 . . . . 0.0 110.97 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -165.35 163.9 19.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.691 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.82 166.9 35.71 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.421 ' OE1' ' OE1' ' A' ' 69' ' ' GLU . 36.5 mt-30 -114.5 141.59 47.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.507 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.88 167.36 30.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.513 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.7 p -97.53 -2.41 41.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.639 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.3 m -125.98 149.97 48.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.178 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -77.05 -43.69 33.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 111.183 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -62.11 -47.34 85.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.582 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.08 -21.32 60.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.686 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.12 -37.64 72.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.028 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -73.99 -44.17 55.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.931 0.396 . . . . 0.0 110.591 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -57.58 -39.82 77.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.829 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -65.67 -39.43 91.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.041 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.39 -48.53 49.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 110.999 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.11 -33.76 69.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 76.3 t -71.68 -46.18 63.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.516 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -54.72 -35.56 63.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.047 0.451 . . . . 0.0 109.88 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.51 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.74 -60.4 3.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.089 179.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.51 ' N ' ' CG ' ' A' ' 100' ' ' TYR . 16.5 mt -48.17 -38.19 17.53 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.397 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -60.01 -43.7 95.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.841 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -63.44 -27.7 69.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.83 0.348 . . . . 0.0 110.899 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.63 -53.78 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.437 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -53.46 -41.47 45.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.77 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.56 -26.33 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.125 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -93.78 18.04 10.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.853 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.91 39.69 11.6 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 111' ' ' GLU . 47.6 mtpt -133.28 22.51 4.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.784 0.326 . . . . 0.0 110.812 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -49.82 -16.13 0.24 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.495 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.418 ' H ' ' C ' ' A' ' 109' ' ' LYS . 97.3 mt-10 -80.07 23.78 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.075 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.428 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -49.21 -44.02 16.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.899 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.544 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 1.4 p90 -118.33 -20.43 8.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.544 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 74.3 t80 117.09 51.67 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.829 1.33 . . . . 0.0 109.633 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 24.0 mt -62.16 113.48 8.79 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -51.48 127.89 23.99 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.175 1.25 . . . . 0.0 111.735 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.58 90.98 0.13 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.485 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 44.1 p -78.33 -32.79 49.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.9 p -139.88 175.45 9.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.329 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -58.92 -60.48 3.79 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.233 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -55.5 -24.78 33.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.544 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -66.39 -49.51 66.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.722 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.12 66.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.775 0.321 . . . . 0.0 110.778 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -59.57 -56.5 21.14 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.947 0.88 . . . . 0.0 108.996 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.5 t -51.8 -36.79 49.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.82 -1.536 . . . . 0.0 110.428 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.519 ' ND2' ' OE2' ' A' ' 135' ' ' GLU . 15.4 t-20 -54.93 -58.81 6.09 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.23 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.6 mt -59.06 -45.82 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.484 0.659 . . . . 0.0 109.553 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -47.27 -46.53 24.84 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.486 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 134' ' ' ALA . 95.6 mm-40 -71.99 -29.18 63.97 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.343 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 75.7 mt -65.23 -23.1 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 t -97.82 -33.06 11.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.396 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.85 -70.89 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.664 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -103.01 -70.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.795 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 129' ' ' GLN . . . 175.74 -45.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.623 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.519 ' OE2' ' ND2' ' A' ' 126' ' ' ASN . 44.5 tp10 -168.4 -75.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.418 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.454 179.937 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m120 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 -61.72 -43.49 98.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.689 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.4 p -138.97 82.55 1.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.424 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -109.41 26.99 10.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.873 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.7 mt -71.67 -47.61 53.05 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.735 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -62.73 -39.91 95.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.546 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 56.3 mtm -68.29 -31.41 70.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.368 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -47.75 84.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.504 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.68 -25.32 65.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.165 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 42' ' ' LYS . 8.5 tttt -90.34 13.44 15.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.285 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' LYS . 14.7 mtmm 60.66 142.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.116 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.4 p -135.92 67.96 63.96 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.466 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -80.99 -75.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.777 2.318 . . . . 0.0 111.658 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.6 tp -77.05 -20.74 55.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.189 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 61.1 mtt -58.57 -33.23 69.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.263 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.2 -50.15 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.372 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.7 tp -52.18 -50.65 61.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.431 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -59.44 -52.84 63.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.527 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -60.94 -38.93 87.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.752 0.31 . . . . 0.0 111.164 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 55' ' ' VAL . . . -69.23 -47.24 65.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.21 -31.02 72.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.345 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -74.25 -49.34 23.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.338 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -21.12 59.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.469 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 20.3 m -85.35 -53.94 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 119.974 -0.69 . . . . 0.0 112.213 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.469 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 7.6 m-85 -126.01 -1.03 7.18 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 58.26 40.84 24.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.298 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 -177.0 3.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.368 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.79 119.53 41.01 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.41 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.89 168.44 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.578 1.519 . . . . 0.0 111.641 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 m -113.25 140.75 47.71 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.814 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -135.55 154.67 51.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.722 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.34 135.64 4.93 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -105.4 114.64 28.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.869 0.366 . . . . 0.0 111.328 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 t -99.19 148.48 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.012 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -114.02 110.71 20.47 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.62 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.42 156.03 80.57 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.25 -7.05 2.38 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.845 1.697 . . . . 0.0 111.211 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.457 ' H ' ' C ' ' A' ' 67' ' ' LEU . 50.7 mt-10 -94.38 -14.95 24.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.2 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.97 -121.08 2.38 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -132.75 134.16 44.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -114.12 120.59 41.07 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.247 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -89.63 125.03 35.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.91 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.4 m -117.51 131.6 56.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.414 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -132.92 144.9 50.46 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.391 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.4 mt -123.07 147.25 27.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.0 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.3 tp -160.12 108.98 1.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.7 t30 62.74 -80.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.879 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -142.53 3.99 1.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.792 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.8 mt -101.22 127.75 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.1 m -132.78 129.04 38.07 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.62 164.27 31.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.199 0.523 . . . . 0.0 111.157 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -132.92 145.53 50.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.296 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -139.5 121.8 2.13 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -94.66 135.14 36.47 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.0 163.76 39.3 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.917 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.4 -8.41 44.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.439 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.1 p -133.08 158.85 41.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.4 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -67.35 -45.31 76.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.351 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -57.45 -43.53 84.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.196 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.87 -20.01 59.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.4 -54.65 25.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.136 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -70.61 -39.34 73.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.23 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -54.32 -52.17 62.35 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.389 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -63.6 -41.46 98.32 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.73 -52.21 27.46 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.79 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.05 -37.14 66.34 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.213 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.8 t -65.51 -47.01 88.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.541 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -54.55 -36.91 64.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 110.326 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.556 ' CD2' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -60.11 -54.35 46.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.943 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.556 ' N ' ' CD2' ' A' ' 100' ' ' TYR . 6.4 mt -48.76 -39.67 25.88 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.525 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -60.5 -45.63 93.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.679 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -58.81 -27.77 65.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 110.639 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -67.46 -54.56 22.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.391 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.6 t -56.47 -39.93 64.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.535 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -67.54 -26.31 66.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.691 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -97.93 19.04 14.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.861 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.07 46.93 15.26 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -131.44 21.31 4.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.925 0.393 . . . . 0.0 110.612 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -54.45 -16.0 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.769 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.33 22.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.654 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.482 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.2 pp -68.15 -46.41 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.732 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.522 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 0.9 OUTLIER -120.25 -18.36 8.02 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.522 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 13.9 t80 97.83 64.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.15 0.907 . . . . 0.0 110.983 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -63.36 115.16 15.99 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -50.51 127.74 21.45 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 120.973 1.115 . . . . 0.0 111.816 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.9 91.24 0.13 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 43.9 p -76.08 -35.19 59.47 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.545 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -130.81 172.33 12.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.808 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -56.31 -59.7 4.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.295 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 125' ' ' SER . 98.7 mt-10 -60.31 -24.16 64.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.37 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.545 ' CB ' ' H ' ' A' ' 119' ' ' THR . 15.1 tp10 -61.65 -45.05 95.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.656 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.9 -51.38 48.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.783 0.325 . . . . 0.0 110.838 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -58.55 -54.94 41.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.155 0.978 . . . . 0.0 109.045 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 46.8 t -51.9 -26.75 10.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.813 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.65 -59.4 3.63 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.597 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -47.41 48.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.428 ' OD1' ' OD2' ' A' ' 132' ' ' ASP . 48.6 t0 -54.16 -48.87 70.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.26 -1.337 . . . . 0.0 111.211 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 134' ' ' ALA . 91.1 mt-30 -71.85 -27.25 62.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.652 0.263 . . . . 0.0 111.197 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.9 mt -66.12 -19.14 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.9 t -112.54 -32.47 6.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.212 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.428 ' OD2' ' OD1' ' A' ' 128' ' ' ASP . 88.3 m-20 -84.14 -70.76 0.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.546 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 135' ' ' GLU . 89.3 mttt -95.28 -71.42 0.67 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.845 0.355 . . . . 0.0 111.113 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' A' ' 129' ' ' GLN . . . 72.55 -15.93 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.509 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 133' ' ' LYS . 96.5 mt-10 -105.85 -27.54 11.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.366 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 . . . . . 0 N--CA 1.464 0.238 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.568 -179.855 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.7 m120 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -59.84 -38.23 81.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.39 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.427 ' O ' ' CG2' ' A' ' 34' ' ' THR . 10.0 t -135.15 109.01 8.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -106.8 16.7 24.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.502 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.4 tp -61.57 -43.06 99.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.711 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -66.13 -44.19 84.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.551 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.49 ' O ' ' N ' ' A' ' 42' ' ' LYS . 27.5 ttt -57.8 -41.25 81.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.727 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -66.06 -38.76 89.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.712 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 tp -64.58 -45.25 87.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.077 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 42' ' ' LYS . 37.3 mttp -88.91 -23.67 22.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.242 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' MET . 11.9 pttm 30.92 69.32 0.1 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.686 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.81 156.61 68.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.688 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.41 -21.95 22.16 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.357 2.038 . . . . 0.0 112.538 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.8 tp -70.93 -21.35 62.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.341 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.3 tpt -59.06 -33.17 70.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.419 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.67 -43.57 96.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.74 -52.15 58.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.862 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.8 -43.91 97.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.474 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.93 -40.44 60.83 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.52 -48.28 28.0 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.295 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.24 -33.11 67.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.059 0.456 . . . . 0.0 110.123 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -77.44 -44.28 29.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.643 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.7 -22.07 56.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 16.0 m -85.41 -53.86 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.47 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 2.8 m-85 -125.8 1.61 7.42 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 60.35 37.24 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.018 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -122.42 -167.83 1.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.107 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.29 159.72 51.05 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.42 ' CG ' ' CZ2' ' A' ' 62' ' ' TRP . 94.4 Cg_endo -76.65 169.26 22.13 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 123.047 2.498 . . . . 0.0 111.967 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.95 111.94 17.68 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.541 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.42 ' CZ2' ' CG ' ' A' ' 60' ' ' PRO . 6.7 m0 -109.89 155.13 22.1 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.191 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.31 131.65 3.37 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.28 111.97 24.19 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.476 ' O ' ' CB ' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -91.11 146.3 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.47 178.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -120.68 120.0 34.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.796 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 69' ' ' GLU . 4.7 mt -133.2 150.13 74.53 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.55 -7.16 1.23 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.476 1.451 . . . . 0.0 111.921 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -108.22 -7.18 16.05 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.787 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.21 -145.1 13.73 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.476 ' CB ' ' O ' ' A' ' 65' ' ' VAL . 6.9 p90 -141.87 151.92 43.14 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.116 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -120.27 114.96 22.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.047 0.451 . . . . 0.0 111.084 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.8 mmt -78.79 128.38 33.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -109.91 120.42 42.42 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.434 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -115.7 128.23 55.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.6 mt -124.47 143.3 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 79' ' ' GLU . 6.5 tp -158.77 -149.83 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.2 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.525 ' C ' ' H ' ' A' ' 80' ' ' ILE . 27.5 t-20 -48.01 83.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.555 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 77' ' ' LEU . 48.1 tt0 57.58 -1.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.033 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.525 ' H ' ' C ' ' A' ' 78' ' ' ASN . 62.8 mt -100.97 131.8 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.587 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.7 p -132.95 130.53 39.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.01 162.4 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.153 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -134.07 145.75 49.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.014 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.74 106.02 0.5 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -86.86 140.29 29.82 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.33 -179.6 2.31 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.987 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.6 p -120.09 10.18 11.35 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.804 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 91.2 p -131.25 153.76 49.17 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -72.06 -50.47 28.08 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.965 0.412 . . . . 0.0 111.103 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -55.64 -44.42 77.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.371 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.17 -20.14 60.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.893 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.39 -55.02 23.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.618 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -73.41 -42.29 62.27 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.763 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -53.19 -42.31 66.13 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.442 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -72.99 -35.99 66.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.383 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.16 -52.85 14.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.28 -38.94 85.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.0 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -66.29 -49.04 78.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -54.7 -33.87 61.53 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.227 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -63.0 -56.97 12.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.241 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.5 mt -52.65 -35.67 55.38 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.301 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -59.76 -46.27 89.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.621 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -61.69 -28.62 69.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.528 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.87 -54.6 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.4 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 t -52.66 -41.32 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.76 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.55 -25.9 67.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 110.059 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -96.72 20.49 10.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.737 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.44 40.54 3.72 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.41 ' C ' ' N ' ' A' ' 111' ' ' GLU . 32.4 tttp -133.94 24.08 3.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.416 ' C ' ' H ' ' A' ' 112' ' ' ILE . 10.8 p80 -48.4 -19.29 0.3 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.066 0.46 . . . . 0.0 110.171 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 109' ' ' LYS . 82.6 mt-10 -75.65 25.03 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.48 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.483 HG13 ' H ' ' A' ' 113' ' ' PHE . 2.3 pt -48.96 -46.6 16.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.957 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.526 ' O ' ' CD2' ' A' ' 114' ' ' PHE . 44.7 p90 -121.75 11.47 10.46 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 113' ' ' PHE . 3.6 m-85 85.96 54.2 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.043 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 24.8 mt -63.29 122.29 74.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.46 128.39 14.43 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.372 1.381 . . . . 0.0 112.919 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.75 91.16 0.13 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 62.4 m -59.55 -38.43 81.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.0 p -131.03 -172.68 2.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.792 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -67.42 -59.73 3.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.928 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -55.11 -24.5 26.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.93 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -68.63 -41.07 79.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.065 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.72 -52.43 30.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.761 0.315 . . . . 0.0 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 1.9 mp -55.91 -56.92 14.86 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.924 0.869 . . . . 0.0 108.717 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.2 t -51.7 -28.58 15.32 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.39 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.23 -50.29 74.24 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.849 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.415 ' N ' ' CD1' ' A' ' 127' ' ' ILE . 1.9 mp -58.62 -44.12 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-O 121.353 0.597 . . . . 0.0 109.7 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -53.13 -47.68 68.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.205 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 134' ' ' ALA . 79.2 mm-40 -71.57 -29.3 64.57 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.166 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 43.2 mt -64.26 -20.04 26.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.038 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.5 p -118.39 -24.98 6.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.437 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -87.71 -70.93 0.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.258 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.482 ' O ' ' CB ' ' A' ' 134' ' ' ALA . 48.7 mttp -114.19 -63.15 1.49 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.796 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 129' ' ' GLN . . . 80.36 3.02 1.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.483 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -120.57 50.63 1.3 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.244 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.747 -179.86 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.513 ' CG ' ' H ' ' A' ' 33' ' ' ARG . 54.8 t30 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.513 ' H ' ' CG ' ' A' ' 32' ' ' ASN . 49.7 ttt180 -54.26 -35.28 62.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.349 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -92.5 65.06 4.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.48 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.27 18.02 10.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.493 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mt -72.19 -36.52 69.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.494 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -62.21 -48.09 81.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.392 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.43 ' O ' ' N ' ' A' ' 42' ' ' LYS . 24.7 ttp -57.99 -40.8 81.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.317 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -68.56 -22.95 64.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.583 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -48.1 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.869 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -88.44 -23.9 23.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.114 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 38' ' ' MET . 67.9 mttm 45.53 47.29 11.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.73 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.2 152.51 73.71 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.737 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.81 -17.32 22.9 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.645 2.23 . . . . 0.0 112.673 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.48 -22.15 63.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.864 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.5 ttp -63.43 -34.23 77.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.735 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 t -65.56 -30.79 51.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.257 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 tp -75.54 -51.98 11.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.54 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -54.26 -37.76 65.06 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.283 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -77.23 -41.11 42.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.26 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.403 ' O ' ' CG1' ' A' ' 55' ' ' VAL . . . -65.69 -48.71 71.12 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.117 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.67 -30.68 71.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 0.0 111.006 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 57' ' ' GLN . 29.1 ttpt -78.36 -57.82 3.58 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.005 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.29 -21.78 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.462 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 23.8 m -86.13 -53.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.782 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.462 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 2.1 m-85 -125.72 -1.1 7.36 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 71.04 19.33 5.63 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.175 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -110.79 -167.95 1.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.08 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.15 162.3 42.42 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.008 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.04 169.13 22.73 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.991 2.461 . . . . 0.0 112.049 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.13 131.39 53.27 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.004 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -120.74 141.06 50.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.798 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.67 128.98 4.65 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 p -96.87 119.36 35.2 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.895 0.378 . . . . 0.0 111.5 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.54 148.09 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.229 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -114.19 110.29 19.74 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.618 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.54 156.34 80.2 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -51.59 -15.64 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.614 1.542 . . . . 0.0 111.6 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.61 -17.62 31.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.842 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.42 -114.71 1.26 Allowed Glycine 0 C--N 1.33 0.205 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -133.16 136.49 45.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -120.38 118.59 30.76 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.5 mtt -93.38 134.4 35.66 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.332 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.5 p -107.96 128.16 54.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.806 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.0 tp -116.63 125.98 52.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.4 mt -120.52 133.16 68.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 120.905 0.383 . . . . 0.0 109.972 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' GLU . 13.0 mt -140.83 -165.56 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.607 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.515 ' C ' ' H ' ' A' ' 80' ' ' ILE . 5.6 p30 -49.0 91.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.731 0.301 . . . . 0.0 111.116 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 77' ' ' LEU . 69.5 mm-40 60.43 -6.21 0.09 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.257 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.515 ' H ' ' C ' ' A' ' 78' ' ' ASN . 96.2 mt -99.15 130.6 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.031 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 t -132.43 129.39 39.21 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.4 m -141.78 162.79 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.243 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.76 162.84 40.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.194 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.63 149.17 20.98 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -106.75 138.49 42.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.684 0.278 . . . . 0.0 110.342 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.89 160.97 31.61 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.93 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.9 m -74.01 -26.77 60.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.702 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.4 p -117.97 155.49 30.17 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.446 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -37.24 66.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.272 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -59.79 -48.14 82.88 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.678 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.71 -22.44 61.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.262 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.81 76.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.998 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -74.17 -45.68 46.99 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.782 0.325 . . . . 0.0 111.035 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -52.8 -48.77 66.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.869 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -62.67 -35.04 78.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.583 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.34 -49.44 49.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.229 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.14 -31.91 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.103 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.21 -49.95 50.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.735 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -55.14 -33.17 62.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.311 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.43 ' CD1' ' C ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -63.33 -56.91 12.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.005 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 mt -52.07 -36.45 50.73 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.704 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -61.05 -45.63 93.96 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.61 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -62.76 -27.86 69.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.766 0.317 . . . . 0.0 111.241 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -64.61 -54.1 34.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.399 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.4 t -53.9 -41.13 47.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.494 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -60.0 -28.15 67.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.28 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -97.33 20.33 11.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.211 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.85 44.19 5.53 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 111' ' ' GLU . 11.8 tttp -133.37 20.32 3.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.414 . . . . 0.0 110.182 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.421 ' CD2' ' H ' ' A' ' 110' ' ' HIS . 6.0 p80 -48.53 -15.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.901 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 109' ' ' LYS . 90.4 mt-10 -79.71 22.9 0.45 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.622 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.408 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -50.98 -45.09 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.145 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.572 ' O ' ' CG ' ' A' ' 114' ' ' PHE . 2.0 p90 -118.32 -7.01 10.77 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.572 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 6.7 m-85 98.06 54.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.612 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 15.6 mt -62.6 114.82 13.27 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.491 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -50.72 128.62 24.62 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.304 1.336 . . . . 0.0 112.32 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.74 91.29 0.13 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 m -91.92 -30.05 16.34 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.9 m -140.65 162.99 34.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.422 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -53.37 -60.65 3.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.486 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.44 ' O ' ' OG ' ' A' ' 125' ' ' SER . 83.8 mt-10 -56.72 -25.74 55.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.493 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -72.14 -51.38 21.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.42 -51.46 69.75 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -62.83 -58.51 7.15 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.575 0.703 . . . . 0.0 110.396 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 37.3 m -52.15 -36.58 51.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.996 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -58.15 -55.74 31.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.365 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.431 HG21 HD11 ' A' ' 127' ' ' ILE . 27.1 pt -69.1 -34.2 62.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.068 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.438 ' O ' ' OD2' ' A' ' 132' ' ' ASP . 69.9 m-20 -61.8 -39.3 91.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.712 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -69.47 -25.21 63.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.742 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.0 mt -73.68 -23.98 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.064 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.516 ' C ' ' H ' ' A' ' 133' ' ' LYS . 0.7 OUTLIER -105.02 -60.71 1.57 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.016 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.438 ' OD2' ' O ' ' A' ' 128' ' ' ASP . 1.7 p30 -72.03 15.37 0.16 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.749 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 131' ' ' SER . 23.9 tttp -39.56 -35.17 0.28 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.749 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 63.39 70.49 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.407 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -57.67 -31.32 66.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.658 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.514 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -119.08 -38.75 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.671 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.0 t -135.64 159.97 39.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.575 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -66.2 -31.57 72.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.1 mt -55.28 -37.55 67.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.396 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -60.32 -42.36 95.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.062 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.5 tpt -60.01 -39.0 84.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.535 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -67.34 -37.88 83.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.398 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 42' ' ' LYS . 12.5 mt -71.49 -23.48 61.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.887 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.507 ' NZ ' ' OE1' ' A' ' 50' ' ' GLU . 60.7 mttm -69.17 13.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.194 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 40' ' ' LEU . 19.2 mttm -46.35 -25.42 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.0 155.81 41.04 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.641 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.5 -22.39 14.01 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.377 2.051 . . . . 0.0 112.399 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.9 tp -70.05 -25.36 63.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.519 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.1 mmt -64.64 -33.7 76.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.39 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.98 -56.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.456 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.06 -51.31 64.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.269 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -54.81 -42.49 71.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.775 0.321 . . . . 0.0 111.139 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' ' NZ ' ' A' ' 41' ' ' LYS . 76.9 tt0 -71.77 -37.87 70.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.032 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.405 ' O ' ' CG1' ' A' ' 55' ' ' VAL . . . -69.17 -47.35 65.19 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.72 -31.69 68.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.04 0.447 . . . . 0.0 110.301 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -77.12 -47.18 21.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.954 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.95 -21.13 59.36 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 17.4 m -85.26 -53.81 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.239 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.47 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 3.1 m-85 -126.08 -4.8 6.81 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.404 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 19.5 tp60 71.96 19.89 4.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.67 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -111.02 -167.53 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.299 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.89 161.07 51.14 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.691 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.51 169.01 21.79 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.808 2.339 . . . . 0.0 111.462 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.09 117.07 26.24 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.944 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -112.8 152.78 28.76 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.796 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.68 125.37 2.03 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 78.1 m -97.77 120.7 38.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.058 0.456 . . . . 0.0 111.281 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.8 t -107.59 150.63 10.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.365 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.475 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 14.7 mp0 -119.76 114.21 21.8 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -127.27 160.63 58.92 Favored Pre-proline 0 C--N 1.345 0.403 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.08 -8.21 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.097 1.865 . . . . 0.0 111.234 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -99.65 -10.79 21.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.636 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.32 -120.72 1.83 Allowed Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 3.9 m-85 -141.71 145.09 34.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -119.69 145.72 46.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 7.8 tpp -114.64 133.8 55.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.9 p -116.82 125.89 52.26 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.7 tp -121.37 135.89 55.03 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.3 mt -131.58 149.43 33.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 79' ' ' GLU . 35.8 tp -169.11 125.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.751 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 65.1 t30 58.78 -80.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.841 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -147.55 -0.62 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 110.533 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.1 mt -100.18 134.24 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.41 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.15 131.74 42.55 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.34 162.35 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.13 0.49 . . . . 0.0 111.186 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -160.58 160.81 32.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.047 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.85 155.48 26.32 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.671 ' H ' HE21 ' A' ' 85' ' ' GLN . 0.0 OUTLIER -104.2 140.14 38.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.738 0.304 . . . . 0.0 110.231 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.65 165.51 25.68 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.763 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.4 p -104.14 -0.78 28.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -115.89 152.24 33.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.219 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -80.24 -51.21 9.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.247 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -59.64 -45.77 91.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.112 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.07 67.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.829 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.98 -42.75 90.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.434 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -73.99 -45.85 47.43 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.035 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -53.59 -43.26 68.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.77 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -64.03 -36.23 83.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.675 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.57 -50.3 32.34 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.681 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.43 -41.39 89.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.451 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.63 -46.14 90.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.812 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -55.08 -36.2 65.37 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.248 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -60.84 -58.34 8.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.68 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.428 ' N ' ' CG ' ' A' ' 100' ' ' TYR . 19.0 mt -48.9 -36.22 16.66 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.672 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -61.83 -44.62 96.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.403 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -61.86 -27.7 68.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.894 0.378 . . . . 0.0 110.975 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.48 -54.41 26.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.682 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -53.66 -39.79 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.499 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -68.29 -22.9 64.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.462 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -97.25 14.17 26.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.63 40.16 47.36 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.179 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 111' ' ' GLU . 0.5 OUTLIER -133.62 26.48 4.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.815 0.34 . . . . 0.0 110.327 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -48.9 -16.86 0.14 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 109' ' ' LYS . 88.3 mt-10 -84.3 23.81 1.04 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.551 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.43 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -49.8 -45.02 21.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.863 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 1.0 OUTLIER -118.73 -17.02 9.3 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.533 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 50.9 t80 110.77 52.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.7 1.25 . . . . 0.0 110.257 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.407 ' CG1' ' CE2' ' A' ' 113' ' ' PHE . 35.2 mt -62.49 112.69 6.98 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -51.45 128.56 26.18 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.27 1.314 . . . . 0.0 111.907 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.68 91.53 0.13 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.668 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.8 m -77.25 -38.07 51.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.88 170.56 13.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.449 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.45 -60.5 3.74 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.494 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.411 ' O ' ' OG ' ' A' ' 125' ' ' SER . 93.6 mt-10 -56.43 -24.53 45.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.984 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -69.92 -44.2 70.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.02 83.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 2.9 mp -66.22 -58.98 4.2 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.906 0.86 . . . . 0.0 109.964 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 91.0 p -52.86 -38.35 61.43 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.804 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -57.54 -58.74 6.96 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.774 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' ILE . 12.2 mt -54.78 -51.69 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.501 0.667 . . . . 0.0 110.1 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -47.15 -35.25 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.589 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -71.71 -27.41 63.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.773 0.32 . . . . 0.0 110.552 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 127' ' ' ILE . 56.4 mt -67.92 -28.66 42.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.2 p -92.8 -27.29 17.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.564 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -65.39 -31.87 73.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.565 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -62.34 -12.67 22.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.817 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.42 -68.11 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.666 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -170.98 63.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.538 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.554 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' THR . 32.5 p-10 . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 48.62 -90.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.639 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 32' ' ' ASN . 49.1 m -73.43 131.14 41.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.552 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -71.56 -33.01 68.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.737 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 tp -55.51 -40.18 71.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.585 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -61.73 -42.52 99.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.407 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.4 tpp -58.8 -29.24 66.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 0.0 110.454 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -76.63 -33.45 58.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.105 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' A' ' 42' ' ' LYS . 2.0 mm? -81.73 -6.98 59.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.702 0.287 . . . . 0.0 111.283 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.31 14.12 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.994 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 40' ' ' LEU . 46.2 mttt -47.98 -58.17 4.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.176 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.13 157.74 56.33 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.908 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.14 -18.71 18.21 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.615 2.21 . . . . 0.0 112.53 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.5 tp -71.39 -21.99 61.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.332 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.1 tpt -62.39 -34.32 76.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.112 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -68.51 -50.65 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.428 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.8 tp -56.07 -52.17 65.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.434 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -60.65 -43.97 96.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 111.557 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.42 -33.84 73.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.048 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.48 -47.68 31.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.26 72.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.993 0.425 . . . . 0.0 109.915 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -77.36 -44.45 29.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.949 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.79 -21.82 57.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.452 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 19.6 m -85.51 -53.86 9.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.452 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 3.2 m-85 -125.68 -2.45 7.29 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.688 -0.405 . . . . 0.0 112.035 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 67.22 23.39 9.44 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.348 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -108.93 176.7 5.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.346 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.51 159.42 32.28 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.985 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.31 169.55 19.93 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.054 2.503 . . . . 0.0 111.983 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.05 119.79 33.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.76 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -114.19 150.89 33.56 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.45 130.39 3.93 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.6 t -100.38 115.4 29.92 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 111.33 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.06 148.29 10.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.267 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.31 111.42 21.46 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.667 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.8 156.23 80.31 Favored Pre-proline 0 N--CA 1.456 -0.153 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.232 -178.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -51.78 -16.1 3.65 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.516 1.477 . . . . 0.0 111.625 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.07 -15.46 33.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.788 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.35 -116.87 1.51 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -134.0 135.78 43.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -117.95 121.22 40.12 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 44.7 tpp -93.47 130.04 39.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.82 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.2 m -107.63 126.05 52.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.421 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -119.07 130.52 55.66 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.306 0.379 . . . . 0.0 110.203 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.8 mt -123.22 138.04 54.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.073 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 79' ' ' GLU . 5.1 tp -150.22 -154.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' A' ' 80' ' ' ILE . 19.9 p-10 -48.52 83.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.775 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 77' ' ' LEU . 5.9 tp10 60.86 -3.33 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.85 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.51 ' H ' ' C ' ' A' ' 78' ' ' ASN . 71.8 mt -102.67 131.84 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.078 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 p -132.58 132.49 42.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -141.65 160.97 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.464 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -134.54 150.0 50.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.989 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -142.78 133.19 5.43 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -102.74 137.81 40.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.83 164.08 36.08 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.978 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 74.0 p -87.18 -10.88 51.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.364 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.3 m -128.56 155.53 44.76 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.227 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.485 ' CD ' ' H ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -70.31 -42.13 72.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -57.43 -47.93 80.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.98 62.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.696 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.93 -46.5 74.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -73.33 -43.1 61.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.725 0.297 . . . . 0.0 111.524 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -52.27 -45.03 65.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.278 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -70.34 -34.92 73.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 111.166 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.65 -48.15 67.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.339 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.17 82.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.338 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.91 -50.67 76.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.676 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -55.35 -37.82 67.97 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.678 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -55.0 40.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.369 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.2 mt -50.4 -35.41 28.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.255 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.515 ' NH1' ' OE2' ' A' ' 106' ' ' GLU . 64.9 ttp85 -62.18 -47.04 86.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.441 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -27.54 65.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.673 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.56 -54.49 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.683 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -52.4 -40.77 33.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.567 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.515 ' OE2' ' NH1' ' A' ' 102' ' ' ARG . 97.9 mt-10 -66.25 -24.96 66.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.107 0.48 . . . . 0.0 109.787 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -93.77 19.72 8.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.419 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.7 38.92 2.44 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 111' ' ' GLU . 9.3 tptp -132.91 25.1 4.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.534 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -48.82 -15.77 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.611 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 109' ' ' LYS . 77.0 mm-40 -80.04 23.5 0.46 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.113 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.404 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -50.04 -44.53 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.518 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 1.3 p90 -118.15 -19.88 8.86 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.538 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 68.7 t80 116.87 51.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.799 1.312 . . . . 0.0 109.583 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 22.8 mt -62.75 121.0 65.27 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.48 128.87 13.14 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.552 1.501 . . . . 0.0 112.701 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.32 91.31 0.13 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.464 ' HG1' ' N ' ' A' ' 119' ' ' THR . 64.5 p -61.49 -34.51 75.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.113 0.482 . . . . 0.0 109.723 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.464 ' N ' ' HG1' ' A' ' 118' ' ' THR . 0.0 OUTLIER -135.81 172.05 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.895 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -57.15 -59.8 4.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.211 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.423 ' O ' ' OG ' ' A' ' 125' ' ' SER . 80.2 tt0 -56.09 -25.19 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.529 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -69.58 -47.97 61.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.13 74.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.236 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.542 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 1.2 mp -65.16 -58.24 6.52 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.912 0.863 . . . . 0.0 109.884 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 44.8 m -53.07 -36.57 60.8 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.0 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -63.13 -59.53 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.673 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.3 pt -60.47 -35.0 60.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.375 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -61.98 -33.23 73.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.891 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -71.0 -25.75 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.538 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 58.2 mt -70.19 -30.09 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.7 p -93.02 -35.35 13.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.826 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -87.9 14.46 8.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.715 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 134' ' ' ALA . 13.1 tptt -52.4 -29.52 24.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.591 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 133' ' ' LYS . . . 79.72 77.39 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.299 0.571 . . . . 0.0 110.654 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -62.66 -31.31 72.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.589 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.672 179.91 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -56.39 -41.37 76.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.778 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.3 p -64.95 147.92 52.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.613 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -110.52 -40.45 4.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.887 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.464 ' CD1' ' N ' ' A' ' 36' ' ' LEU . 9.9 mp -71.29 -45.04 64.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.871 0.367 . . . . 0.0 110.636 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -64.54 -26.13 68.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.671 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 40.7 ttm -70.89 -41.7 70.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.373 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -64.77 -45.51 86.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.465 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.9 mt -67.27 -37.46 83.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.772 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -87.71 11.2 15.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.945 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -66.19 80.42 0.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.434 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.52 156.81 42.15 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.951 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.4 -44.06 7.16 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.261 1.974 . . . . 0.0 112.762 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.08 -23.47 62.13 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.31 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.0 mmt -65.75 -34.5 78.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.972 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.8 t -68.21 -43.53 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.7 tp -61.3 -52.05 66.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.167 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -56.34 -53.33 58.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.865 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -61.97 -35.68 79.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.044 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' O ' ' CG1' ' A' ' 55' ' ' VAL . . . -68.65 -47.37 66.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.997 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.78 -31.37 72.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.039 0.447 . . . . 0.0 109.892 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -77.26 -45.68 25.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.456 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.15 -21.79 58.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.454 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 19.4 m -85.61 -53.3 10.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.454 ' N ' ' CG2' ' A' ' 55' ' ' VAL . 2.1 m-85 -125.15 -1.31 7.71 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.5 41.14 7.65 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.168 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -127.89 -179.12 4.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.09 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.54 156.86 39.75 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.95 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 168.59 23.69 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.68 2.254 . . . . 0.0 112.059 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.1 117.26 28.26 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.918 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -114.85 140.63 48.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.8 121.76 1.99 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 m -97.35 112.21 24.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.115 0.483 . . . . 0.0 111.462 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 t -93.16 147.77 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.826 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -122.98 118.81 28.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.572 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 69' ' ' GLU . 4.4 mt -133.41 149.61 72.83 Favored Pre-proline 0 CA--C 1.529 0.16 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.29 -7.15 1.72 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.316 1.344 . . . . 0.0 110.953 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.474 ' H ' ' C ' ' A' ' 67' ' ' LEU . 80.3 mm-40 -105.17 -11.48 16.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.776 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.17 -150.28 22.53 Favored Glycine 0 C--N 1.332 0.352 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 14.4 m-85 -129.07 147.63 50.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.88 0.34 . . . . 0.0 110.262 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -118.07 112.72 20.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.031 0.444 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -84.63 129.54 34.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.0 p -113.79 129.77 56.54 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.145 0.278 . . . . 0.0 110.766 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.434 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -122.01 126.82 49.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.2 mt -121.66 132.66 70.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 79' ' ' GLU . 3.2 tp -147.74 -159.41 1.02 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.685 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.539 ' C ' ' H ' ' A' ' 80' ' ' ILE . 2.9 p30 -46.15 84.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.877 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 77' ' ' LEU . 17.5 tp10 61.27 -7.14 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.904 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.539 ' H ' ' C ' ' A' ' 78' ' ' ASN . 73.0 mt -99.5 128.37 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.009 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 p -132.64 128.03 36.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.7 m -141.2 167.05 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.193 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -162.76 168.75 21.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.071 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.36 163.08 33.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.456 ' CD ' ' H ' ' A' ' 85' ' ' GLN . 0.5 OUTLIER -109.25 138.69 45.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.836 0.35 . . . . 0.0 110.292 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.0 161.51 39.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.715 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.9 p -97.15 -1.01 45.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.996 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.4 m -130.86 151.92 50.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.077 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -71.95 -39.71 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 0.0 111.28 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -57.92 -47.74 81.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.344 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.13 -20.03 59.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.086 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.38 -53.55 46.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.403 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -72.93 -44.28 61.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.573 0.225 . . . . 0.0 111.152 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -53.06 -47.21 68.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.807 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -63.43 -34.99 78.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.794 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.73 -50.37 30.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.168 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.59 76.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.45 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.52 -48.96 69.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.503 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -54.25 -34.99 62.01 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.279 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.49 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.58 -57.97 8.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.548 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.49 ' N ' ' CG ' ' A' ' 100' ' ' TYR . 13.8 mt -47.94 -37.93 15.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.184 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -60.79 -44.95 96.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.428 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -60.17 -27.72 67.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.02 0.438 . . . . 0.0 110.91 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -68.81 -53.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.615 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.84 -41.37 56.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.697 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -62.85 -27.5 69.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 109.865 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -94.15 20.34 8.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.709 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.53 38.96 5.59 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 111' ' ' GLU . 2.6 tptm -133.73 25.59 4.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.734 0.302 . . . . 0.0 110.897 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.448 ' C ' ' H ' ' A' ' 112' ' ' ILE . 8.2 p80 -49.29 -16.06 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.797 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 109' ' ' LYS . 6.1 pt-20 -75.4 23.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.444 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.448 ' H ' ' C ' ' A' ' 110' ' ' HIS . 1.3 pp -49.95 -44.36 21.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.844 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.53 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 1.4 p90 -117.48 -19.59 9.41 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.536 ' O ' ' CD2' ' A' ' 114' ' ' PHE . 75.8 t80 118.03 50.05 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.888 1.367 . . . . 0.0 109.543 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 25.0 mt -62.33 113.4 8.67 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.29 129.26 10.22 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.765 1.643 . . . . 0.0 113.024 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.15 90.67 0.13 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 69.7 m -58.1 -37.02 73.73 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.76 161.46 27.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.84 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -53.8 -59.54 4.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.864 0.364 . . . . 0.0 110.47 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.69 -24.56 49.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.7 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -71.84 -44.77 63.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.013 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.83 -51.17 71.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.092 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -63.4 -56.76 13.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.019 0.914 . . . . 0.0 109.393 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.1 t -52.11 -37.73 55.08 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.155 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -62.77 -57.59 10.41 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.545 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.5 pt -59.46 -33.99 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 0.0 110.493 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -72.96 -32.59 65.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.85 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -70.02 -25.67 63.69 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.5 pt -90.45 -18.93 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.154 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.0 m -94.83 -53.45 3.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 134' ' ' ALA . 56.4 t0 -87.5 15.21 6.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -40.79 -28.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 132' ' ' ASP . . . -105.89 -90.92 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.765 0.317 . . . . 0.0 110.39 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -172.48 -78.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.48 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.197 179.802 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -67.09 -28.7 68.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.861 0.363 . . . . 0.0 110.333 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 34' ' ' THR . 2.0 t -84.31 33.64 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.823 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -81.82 3.2 26.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.475 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.51 -38.19 77.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.107 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.03 -40.41 68.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.528 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.513 ' O ' ' N ' ' A' ' 42' ' ' LYS . 35.3 ttm -57.95 -38.12 75.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.581 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -68.76 -49.25 60.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.636 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.2 tp -61.77 -39.22 90.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.701 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.4 -23.29 23.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.937 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 38' ' ' MET . 22.1 tttp 51.07 64.44 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.871 -0.331 . . . . 0.0 110.135 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 94.1 m -124.47 84.11 57.14 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.866 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.45 -24.58 16.77 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.413 2.075 . . . . 0.0 112.047 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -61.67 -20.34 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.204 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.1 tpt -58.79 -33.97 70.94 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 t -58.76 -31.16 43.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.6 tp -78.78 -51.85 9.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.479 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -60.07 -32.28 70.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -76.29 -43.01 43.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.336 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.35 -48.36 50.75 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.231 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.48 -32.2 68.55 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.312 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -78.02 -47.34 18.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.316 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.21 -20.66 60.82 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.855 -0.528 . . . . 0.0 112.387 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.431 ' CG2' ' N ' ' A' ' 56' ' ' TYR . 18.2 m -85.75 -52.94 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.16 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.507 ' CD1' ' OD1' ' A' ' 78' ' ' ASN . 0.7 OUTLIER -125.49 -7.42 6.91 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.034 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 6.9 tt0 75.27 19.96 2.13 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.308 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -115.28 173.91 6.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.134 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 161.95 21.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.743 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.37 168.74 22.6 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.793 2.328 . . . . 0.0 112.1 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.39 115.95 23.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.533 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -109.32 149.54 29.32 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.08 124.66 1.86 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.3 m -104.25 114.39 28.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.387 . . . . 0.0 111.825 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.93 151.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.488 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -117.2 113.42 22.2 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -129.64 158.44 73.51 Favored Pre-proline 0 C--N 1.347 0.469 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.24 -15.59 8.35 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.93 1.753 . . . . 0.0 111.818 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -96.57 -10.98 26.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.558 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.83 -125.97 2.99 Favored Glycine 0 C--N 1.329 0.16 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 16.0 m-85 -138.52 145.23 40.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -110.2 129.32 55.74 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.202 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 2.0 mpp? -92.09 133.38 35.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.988 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 m -119.19 118.84 32.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.5 tp -120.63 130.88 54.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.5 mt -127.33 135.23 63.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 79' ' ' GLU . 13.8 mt -141.51 101.08 3.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.144 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.507 ' OD1' ' CD1' ' A' ' 56' ' ' TYR . 14.1 m-80 57.86 -82.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.239 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 77' ' ' LEU . 6.8 tp10 -125.5 -10.51 6.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.399 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.429 HD12 HG23 ' A' ' 80' ' ' ILE . 87.6 mt -94.59 130.35 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.613 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.4 p -132.17 131.34 42.12 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.0 m -136.46 158.86 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.028 0.442 . . . . 0.0 110.932 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -162.24 166.41 25.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.785 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.504 ' O ' ' SD ' ' A' ' 73' ' ' MET . . . -169.28 177.97 42.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -106.63 135.11 48.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.585 0.231 . . . . 0.0 110.435 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -149.96 160.16 43.82 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.957 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.9 p -118.77 9.39 12.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.566 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.4 t -128.33 154.73 45.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.26 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -80.69 -53.62 6.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.958 0.409 . . . . 0.0 111.385 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -59.76 -44.31 93.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.553 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.09 -20.99 60.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.344 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.11 -49.89 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.496 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -73.15 -43.62 61.25 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.304 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -56.8 -48.01 78.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.251 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -62.12 -34.64 76.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.003 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.24 -50.83 43.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.856 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.95 -30.08 63.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.03 -51.59 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.205 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.93 -34.84 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.855 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.57 -56.78 17.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.247 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.6 mt -51.36 -37.02 45.8 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 123.6 0.563 . . . . 0.0 111.907 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -61.34 -47.04 87.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.721 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -60.64 -28.12 68.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.349 . . . . 0.0 110.611 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.3 -53.21 50.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.808 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.5 t -52.87 -37.17 25.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.581 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -71.47 -24.8 62.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -95.97 19.78 11.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.297 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.62 39.2 2.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -130.86 30.95 4.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.062 0.458 . . . . 0.0 110.011 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -48.86 -15.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.286 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -83.37 23.47 0.91 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.422 ' CD1' ' H ' ' A' ' 113' ' ' PHE . 1.5 pp -50.22 -47.54 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.02 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.535 ' O ' ' CB ' ' A' ' 114' ' ' PHE . 0.8 OUTLIER -120.23 -16.89 8.42 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.535 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 34.9 t80 105.28 57.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.468 1.105 . . . . 0.0 110.277 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.41 ' CG1' ' CE2' ' A' ' 113' ' ' PHE . 22.3 mt -64.41 114.1 13.0 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.659 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -51.35 130.33 32.3 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.447 1.431 . . . . 0.0 112.017 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.47 94.72 0.15 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.783 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 20.8 m -78.4 -35.23 47.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.168 0.508 . . . . 0.0 109.713 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.45 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -136.22 175.93 9.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.617 179.26 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.78 -60.18 4.25 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.338 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.415 ' O ' ' OG ' ' A' ' 125' ' ' SER . 94.5 mt-10 -58.87 -25.15 63.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.476 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.45 ' CB ' ' H ' ' A' ' 119' ' ' THR . 17.4 tp10 -62.05 -47.69 83.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.706 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.78 -49.49 74.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.986 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.553 ' CD1' ' N ' ' A' ' 124' ' ' LEU . 1.5 mp -63.19 -58.04 8.53 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 109.568 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 27.4 m -52.49 -36.51 55.25 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.996 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -61.91 -58.64 7.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.612 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.7 pt -66.11 -35.69 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.782 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -58.58 -40.29 82.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -72.47 -25.97 61.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.178 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 53.8 mt -68.77 -23.92 28.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m -103.22 -35.77 8.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.767 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -69.18 -68.08 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.401 ' O ' ' CB ' ' A' ' 134' ' ' ALA . 48.3 mttt -126.08 -70.79 0.72 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.995 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 133' ' ' LYS . . . 74.68 10.8 3.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.397 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -74.13 -40.4 62.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.007 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.436 -179.823 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.493 1.449 0 CA-C-O 120.855 0.273 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.453 HD13 ' HD2' ' A' ' 93' ' ' ARG . 24.7 tp -65.3 -23.09 66.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.569 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.4 tpt -62.25 -34.85 77.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.351 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.667 HG11 HD11 ' A' ' 101' ' ' LEU . 2.9 t -68.21 -35.77 72.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.982 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 77' ' ' LEU . 6.8 tp -69.94 -51.74 30.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.206 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -52.8 -40.14 62.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.599 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.32 -32.56 58.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.124 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.676 ' O ' HG22 ' A' ' 55' ' ' VAL . . . -71.07 -48.74 50.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.179 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.28 -31.56 72.44 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.914 0.388 . . . . 0.0 110.667 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 57' ' ' GLN . 62.4 mttm -78.67 -57.19 3.89 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.42 -21.47 64.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 51' ' ' ALA . 25.5 m -86.02 -53.67 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.823 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.648 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.6 m-85 -126.38 4.65 6.96 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 53' ' ' LYS . 88.9 mm-40 59.42 32.76 22.01 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.579 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -125.53 151.37 46.44 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.325 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.04 156.05 74.67 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.953 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.06 168.7 24.15 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.901 2.401 . . . . 0.0 112.107 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.73 124.9 44.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.806 0.336 . . . . 0.0 111.257 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -117.36 152.62 34.56 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.872 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.88 129.78 3.65 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.1 m -102.65 118.72 37.46 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.058 0.456 . . . . 0.0 111.435 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.8 t -108.64 148.34 12.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.276 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 66' ' ' GLU . 4.3 pt-20 -114.81 110.01 19.05 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.881 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -133.17 158.66 75.22 Favored Pre-proline 0 CA--C 1.529 0.16 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -52.25 -20.19 10.71 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.481 1.454 . . . . 0.0 111.331 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -81.16 -19.94 42.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.123 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.64 -114.73 1.25 Allowed Glycine 0 C--N 1.33 0.23 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -133.03 136.5 46.02 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 65' ' ' VAL . 71.9 tt0 -117.12 128.11 54.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.135 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 3.4 tpt -96.8 128.62 43.93 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.661 -0.415 . . . . 0.0 109.988 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 m -107.49 120.27 41.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.7 tp -113.39 128.03 56.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 mp -123.51 133.53 68.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 48' ' ' LEU . 20.6 mt -139.93 88.71 2.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.334 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 56.87 -83.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.627 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 77' ' ' LEU . 91.3 mt-10 -111.44 -17.07 13.18 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.5 mt -98.44 128.11 50.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.275 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 81' ' ' THR . 13.3 t -132.52 131.53 41.69 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -137.26 153.96 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.325 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -134.45 149.47 50.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.854 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.61 142.41 9.93 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -104.87 138.09 41.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.303 . . . . 0.0 110.402 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.73 166.16 34.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.669 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 t -101.0 0.2 37.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.812 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.615 ' OG ' ' HB3' ' A' ' 91' ' ' ALA . 92.6 p -130.82 157.97 41.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.763 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -76.13 -45.64 32.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.974 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -61.79 -46.88 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.387 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.615 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -74.68 -21.18 59.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.162 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -66.22 -48.68 69.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.275 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.453 ' HD2' HD13 ' A' ' 45' ' ' LEU . 55.9 ttp180 -73.1 -43.14 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.757 0.313 . . . . 0.0 111.217 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.576 ' O ' HG23 ' A' ' 98' ' ' VAL . 56.0 tt0 -53.17 -45.7 68.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.961 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -65.82 -36.47 83.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.82 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.53 -51.16 38.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.242 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.73 -30.1 60.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.735 0.302 . . . . 0.0 111.32 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 94' ' ' GLN . 73.2 t -72.06 -47.48 54.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.486 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -55.63 -35.14 65.58 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.155 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -63.58 -58.06 8.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.103 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.667 HD11 HG11 ' A' ' 47' ' ' VAL . 14.4 mt -48.79 -39.25 24.54 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.564 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -60.14 -45.14 94.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.763 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.92 -29.09 68.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.97 0.414 . . . . 0.0 110.782 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.458 HG12 ' C ' ' A' ' 109' ' ' LYS . 2.2 t -64.98 -54.52 28.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.757 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 105' ' ' VAL . 1.1 t -54.05 -37.15 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.83 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -62.1 -32.89 73.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.332 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -96.64 20.93 10.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.806 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.72 49.43 8.86 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.458 ' C ' HG12 ' A' ' 104' ' ' VAL . 9.8 mtpm? -133.23 23.45 4.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.375 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.445 ' CE1' ' HG3' ' A' ' 111' ' ' GLU . 10.7 p-80 -48.85 -17.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.77 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.445 ' HG3' ' CE1' ' A' ' 110' ' ' HIS . 83.8 mt-10 -79.13 23.34 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.563 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 1.012 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -50.34 -44.73 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.71 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 1.012 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.9 p90 -117.77 -19.54 9.24 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.536 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 70.4 t80 118.66 48.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.85 1.344 . . . . 0.0 110.285 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.497 HD11 HD22 ' A' ' 101' ' ' LEU . 52.5 mt -62.32 113.01 7.47 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.61 128.99 10.6 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.627 1.551 . . . . 0.0 113.252 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.1 90.97 0.13 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.412 ' CB ' ' OE1' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -56.53 -28.75 60.75 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.448 ' H ' ' HB2' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -135.19 -179.31 5.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.887 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -64.82 -59.7 3.91 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.622 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -56.75 -26.56 57.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.194 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.448 ' HB2' ' H ' ' A' ' 119' ' ' THR . 69.3 mt-10 -66.72 -42.58 86.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.68 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.33 79.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.551 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.534 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 3.0 mp -65.88 -58.7 4.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.991 0.901 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.7 m -52.73 -41.35 63.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.95 -1.477 . . . . 0.0 111.05 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -55.52 -58.52 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.481 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 mt -55.79 -50.92 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.445 0.641 . . . . 0.0 109.898 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -46.84 -37.4 8.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.9 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -71.74 -26.96 62.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.542 0.21 . . . . 0.0 111.005 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.9 -25.47 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.453 ' OG ' ' NE2' ' A' ' 94' ' ' GLN . 31.2 t . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.66 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 120.899 0.291 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.446 HD21 ' CZ2' ' A' ' 62' ' ' TRP . 16.6 tp -71.44 -20.55 62.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.424 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 tpt -58.46 -33.16 69.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.939 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.586 HG11 HD11 ' A' ' 101' ' ' LEU . 1.5 t -63.58 -54.99 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.439 ' N ' HG12 ' A' ' 47' ' ' VAL . 7.4 tp -57.87 -52.3 66.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.955 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -54.4 -51.03 66.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.418 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -65.67 -32.51 74.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.086 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.703 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -70.62 -47.08 61.91 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.244 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 -33.91 69.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.859 0.362 . . . . 0.0 110.717 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.51 -47.21 27.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.111 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 -20.99 59.43 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 51' ' ' ALA . 20.8 m -85.62 -53.86 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.533 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.629 ' N ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -125.85 -3.51 7.1 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 71.1 20.8 5.07 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.828 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -109.51 -173.76 2.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.311 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.5 156.24 58.44 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.522 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 168.66 24.21 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 112.305 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.14 118.67 31.16 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.31 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.446 ' CZ2' HD21 ' A' ' 45' ' ' LEU . 8.7 m0 -110.5 137.84 47.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.285 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.5 129.33 4.99 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.2 m -99.95 118.16 35.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.369 . . . . 0.0 111.541 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 72' ' ' GLU . 3.3 t -104.93 148.4 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.831 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -113.71 109.95 19.41 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.864 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.29 155.31 81.44 Favored Pre-proline 0 C--O 1.227 -0.127 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.579 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.38 -7.25 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.851 1.701 . . . . 0.0 111.531 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.488 ' OE2' ' NE2' ' A' ' 85' ' ' GLN . 75.1 tt0 -94.72 -17.35 22.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.916 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.99 -117.77 1.61 Allowed Glycine 0 C--N 1.333 0.365 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -132.12 137.61 47.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.8 tt0 -118.44 121.8 41.2 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.8 mtt -93.13 133.08 36.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.491 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.4 m -111.98 123.58 50.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.9 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.864 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -114.76 126.09 54.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.006 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.864 ' N ' HD12 ' A' ' 75' ' ' LEU . 32.6 mm -118.02 131.66 70.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 tp -175.38 136.29 0.35 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.591 0.557 . . . . 0.0 110.904 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.6 t30 54.24 35.31 22.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.339 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 68.52 6.13 5.24 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.286 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.476 HG21 ' HB2' ' A' ' 103' ' ' LYS . 25.4 mt -99.27 137.72 25.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.01 129.65 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.498 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 96' ' ' ALA . 11.7 m -132.68 161.47 41.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.87 0.367 . . . . 0.0 110.815 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -129.9 139.66 51.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.935 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.16 108.09 0.73 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.488 ' NE2' ' OE2' ' A' ' 69' ' ' GLU . 11.3 pt20 -91.91 136.36 33.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.444 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.53 171.98 16.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.674 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.47 -7.48 47.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.367 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.0 p -129.21 152.84 48.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.205 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -71.85 -42.77 66.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.274 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -60.0 -47.74 84.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.307 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.54 -25.63 62.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.975 0.417 . . . . 0.0 110.707 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.06 -35.04 73.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.053 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.414 ' HD3' HD22 ' A' ' 45' ' ' LEU . 40.2 ttm180 -74.26 -46.61 40.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.046 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.526 ' O ' HG23 ' A' ' 98' ' ' VAL . 7.5 tt0 -53.07 -47.51 68.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.915 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -64.99 -32.28 73.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.723 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.571 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.21 -51.95 21.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.926 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.25 -31.11 69.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.043 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 94' ' ' GLN . 45.4 t -71.26 -51.42 34.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.932 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -55.55 -34.35 64.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.03 0.443 . . . . 0.0 110.352 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.28 -55.54 27.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.512 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.639 HD22 HD11 ' A' ' 115' ' ' ILE . 18.1 mt -50.59 -36.19 33.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.633 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -62.75 -45.21 93.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.499 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.476 ' HB2' HG21 ' A' ' 80' ' ' ILE . 16.7 mmtt -60.37 -28.02 67.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 110.951 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.417 HG23 ' H ' ' A' ' 104' ' ' VAL . 2.1 t -65.92 -53.65 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.243 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.5 t -55.39 -37.51 44.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.602 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.53 -28.76 69.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.553 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -96.73 20.04 11.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.615 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 45.58 44.81 12.03 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.41 ' C ' HG12 ' A' ' 104' ' ' VAL . 3.1 mmtp -133.12 23.93 4.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.707 0.289 . . . . 0.0 110.549 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -50.76 -15.75 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -79.87 22.53 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.293 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.951 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -50.93 -45.86 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.431 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.951 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -118.26 -20.29 8.62 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.538 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 72.3 t80 117.27 51.31 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.871 1.357 . . . . 0.0 109.874 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.639 HD11 HD22 ' A' ' 101' ' ' LEU . 21.5 mt -62.85 118.17 39.46 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.23 128.05 12.56 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.336 1.357 . . . . 0.0 112.62 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 123' ' ' ALA . . . -153.88 94.55 0.15 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.0 m -49.28 -38.24 26.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.149 0.5 . . . . 0.0 109.701 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.484 ' H ' ' HB3' ' A' ' 122' ' ' GLU . 11.4 p -133.46 176.08 8.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.877 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -54.69 -57.25 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.832 0.348 . . . . 0.0 110.623 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.424 ' O ' ' OG ' ' A' ' 125' ' ' SER . 95.5 mt-10 -61.76 -34.7 76.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.275 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.534 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 13.0 tp10 -63.34 -31.63 72.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.673 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.486 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . . . -76.28 -53.74 7.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.023 0.439 . . . . 0.0 111.144 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.692 ' C ' HD12 ' A' ' 124' ' ' LEU . 4.1 pp -66.95 -26.12 66.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.861 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.575 ' N ' HD12 ' A' ' 124' ' ' LEU . 71.9 m -76.31 -28.85 57.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.947 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 1.6 m-80 -65.05 -51.03 63.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.028 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.5 ' HA ' HD12 ' A' ' 130' ' ' ILE . 10.4 pt -59.14 -35.48 57.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.923 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -61.71 -41.14 97.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.295 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -71.75 -26.08 62.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.612 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 127' ' ' ILE . 69.7 mt -69.22 -23.63 27.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.033 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.4 p . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 -179.855 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 N--CA 1.497 1.678 0 N-CA-C 112.758 0.253 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tp -71.93 -19.89 61.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 62.4 mtp -58.58 -33.11 69.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.867 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 101' ' ' LEU . 1.8 t -58.73 -57.33 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.453 ' N ' HG12 ' A' ' 47' ' ' VAL . 8.3 tp -58.04 -51.72 68.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.674 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -57.99 -40.83 81.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 111.041 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -70.76 -35.74 72.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.962 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.716 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -72.8 -47.56 45.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.017 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.0 70.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.092 0.473 . . . . 0.0 110.36 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -74.83 -45.01 46.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.753 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.47 -22.13 54.94 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 51' ' ' ALA . 21.1 m -85.86 -53.73 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.708 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.627 ' N ' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -124.92 -7.69 7.24 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.737 -178.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER 73.24 19.81 3.45 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.876 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -110.07 149.65 29.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.455 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 p -81.87 152.37 68.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.869 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.22 169.8 21.74 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.849 2.366 . . . . 0.0 111.63 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.54 123.26 42.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.398 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -126.05 148.16 49.39 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.623 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.49 135.58 5.53 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.9 m -102.65 121.88 43.3 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.828 0.346 . . . . 0.0 111.343 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.8 t -107.76 148.92 11.51 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.439 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -114.48 112.67 23.35 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.882 ' N ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -133.0 158.2 76.46 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.519 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -52.02 -21.67 12.87 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.548 1.498 . . . . 0.0 111.502 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' OE1' ' OE1' ' A' ' 85' ' ' GLN . 57.3 mt-10 -82.78 -17.15 45.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.537 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.18 -115.72 1.35 Allowed Glycine 0 C--N 1.331 0.304 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -132.86 136.94 46.52 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -117.28 121.65 41.75 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.102 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.5 mmt -93.3 133.3 36.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.945 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.1 m -116.63 130.07 56.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.783 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.954 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -127.01 132.14 50.83 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.173 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.954 ' N ' HD12 ' A' ' 75' ' ' LEU . 28.8 mt -128.38 148.98 32.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.4 tp -172.0 128.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.367 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 34.9 t30 55.78 -92.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.292 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -136.29 1.9 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.143 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 53.0 mt -96.96 128.85 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.878 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 81' ' ' THR . 6.2 t -132.32 126.88 34.35 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.553 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.1 m -137.73 164.11 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.292 0.568 . . . . 0.0 110.97 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -165.35 163.9 19.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.691 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.82 166.9 35.71 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.421 ' OE1' ' OE1' ' A' ' 69' ' ' GLU . 36.5 mt-30 -114.5 141.59 47.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.507 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.603 ' HB2' ' HZ1' ' A' ' 95' ' ' LYS . . . -157.88 167.36 30.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.513 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.7 p -97.53 -2.41 41.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.639 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 50.3 m -125.98 149.97 48.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.178 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -77.05 -43.69 33.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 111.183 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -62.11 -47.34 85.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.582 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.08 -21.32 60.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.686 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -71.12 -37.64 72.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.028 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -73.99 -44.17 55.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.931 0.396 . . . . 0.0 110.591 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.641 ' O ' HG23 ' A' ' 98' ' ' VAL . 70.6 mt-30 -57.58 -39.82 77.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.829 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.603 ' HZ1' ' HB2' ' A' ' 86' ' ' ALA . 5.1 ttpm? -65.67 -39.43 91.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.041 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.553 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.39 -48.53 49.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 110.999 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.11 -33.76 69.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 94' ' ' GLN . 76.3 t -71.68 -46.18 63.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.516 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -54.72 -35.56 63.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.047 0.451 . . . . 0.0 109.88 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.51 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.74 -60.4 3.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.089 179.536 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.646 HD22 HD11 ' A' ' 115' ' ' ILE . 16.5 mt -48.17 -38.19 17.53 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.397 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -60.01 -43.7 95.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.841 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -63.44 -27.7 69.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.83 0.348 . . . . 0.0 110.899 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.63 -53.78 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.437 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.7 t -53.46 -41.47 45.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.77 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.56 -26.33 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.125 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -93.78 18.04 10.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.853 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.91 39.69 11.6 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.405 ' C ' ' N ' ' A' ' 111' ' ' GLU . 47.6 mtpt -133.28 22.51 4.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.784 0.326 . . . . 0.0 110.812 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -49.82 -16.13 0.24 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.495 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.405 ' N ' ' C ' ' A' ' 109' ' ' LYS . 97.3 mt-10 -80.07 23.78 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.075 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.938 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -49.21 -44.02 16.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.899 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.938 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.4 p90 -118.33 -20.43 8.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.544 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 74.3 t80 117.09 51.67 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.829 1.33 . . . . 0.0 109.633 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.646 HD11 HD22 ' A' ' 101' ' ' LEU . 24.0 mt -62.16 113.48 8.79 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -51.48 127.89 23.99 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.175 1.25 . . . . 0.0 111.735 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.58 90.98 0.13 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.485 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.442 ' H ' ' HG2' ' A' ' 122' ' ' GLU . 44.1 p -78.33 -32.79 49.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.407 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 17.9 p -139.88 175.45 9.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.329 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -58.92 -60.48 3.79 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.233 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -55.5 -24.78 33.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.544 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 118' ' ' THR . 21.8 tp10 -66.39 -49.51 66.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.722 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.12 66.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.775 0.321 . . . . 0.0 110.778 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.553 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -59.57 -56.5 21.14 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.947 0.88 . . . . 0.0 108.996 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.5 t -51.8 -36.79 49.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.82 -1.536 . . . . 0.0 110.428 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -54.93 -58.81 6.09 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.23 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.597 HG12 HD13 ' A' ' 101' ' ' LEU . 5.6 mt -59.06 -45.82 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.484 0.659 . . . . 0.0 109.553 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -47.27 -46.53 24.84 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.486 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -71.99 -29.18 63.97 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.343 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 127' ' ' ILE . 75.7 mt -65.23 -23.1 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.396 179.78 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 N--CA 1.487 1.139 0 CA-C-O 120.834 0.264 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.6 tp -77.05 -20.74 55.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.189 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 61.1 mtt -58.57 -33.23 69.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.263 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.492 HG11 HD11 ' A' ' 101' ' ' LEU . 1.4 t -63.2 -50.15 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.372 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.459 HD12 ' CE2' ' A' ' 100' ' ' TYR . 9.7 tp -52.18 -50.65 61.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.431 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -59.44 -52.84 63.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.527 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -60.94 -38.93 87.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.752 0.31 . . . . 0.0 111.164 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.755 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -69.23 -47.24 65.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.21 -31.02 72.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.345 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -74.25 -49.34 23.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.338 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -21.12 59.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 51' ' ' ALA . 20.3 m -85.35 -53.94 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 119.974 -0.69 . . . . 0.0 112.213 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.666 ' N ' HG23 ' A' ' 55' ' ' VAL . 7.6 m-85 -126.01 -1.03 7.18 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 58.26 40.84 24.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.298 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 -177.0 3.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.368 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.79 119.53 41.01 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.41 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.89 168.44 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.578 1.519 . . . . 0.0 111.641 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 m -113.25 140.75 47.71 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.814 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -135.55 154.67 51.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.722 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.34 135.64 4.93 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -105.4 114.64 28.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.869 0.366 . . . . 0.0 111.328 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.9 t -99.19 148.48 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.012 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -114.02 110.71 20.47 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.85 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.42 156.03 80.57 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.25 -7.05 2.38 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.845 1.697 . . . . 0.0 111.211 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 67' ' ' LEU . 50.7 mt-10 -94.38 -14.95 24.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.2 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.97 -121.08 2.38 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -132.75 134.16 44.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 65' ' ' VAL . 35.2 tt0 -114.12 120.59 41.07 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.247 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -89.63 125.03 35.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.91 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.4 m -117.51 131.6 56.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -132.92 144.9 50.46 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.391 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 75' ' ' LEU . 36.4 mt -123.07 147.25 27.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.0 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 77' ' ' LEU . 6.3 tp -160.12 108.98 1.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.7 t30 62.74 -80.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.879 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -142.53 3.99 1.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.792 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.8 mt -101.22 127.75 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.1 m -132.78 129.04 38.07 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.628 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.8 m -136.62 164.27 31.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.199 0.523 . . . . 0.0 111.157 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -132.92 145.53 50.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.296 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -139.5 121.8 2.13 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -94.66 135.14 36.47 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.0 163.76 39.3 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.917 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 87' ' ' THR . 0.1 OUTLIER -92.4 -8.41 44.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.439 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.1 p -133.08 158.85 41.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.4 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -67.35 -45.31 76.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.351 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -57.45 -43.53 84.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.196 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.87 -20.01 59.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.4 -54.65 25.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.136 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -70.61 -39.34 73.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.23 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.463 ' O ' HG23 ' A' ' 98' ' ' VAL . 37.7 tt0 -54.32 -52.17 62.35 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.389 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -63.6 -41.46 98.32 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.628 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -69.73 -52.21 27.46 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.79 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.05 -37.14 66.34 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.213 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 94' ' ' GLN . 55.8 t -65.51 -47.01 88.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.541 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -54.55 -36.91 64.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 110.326 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.556 ' CD2' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -60.11 -54.35 46.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.943 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.556 ' N ' ' CD2' ' A' ' 100' ' ' TYR . 6.4 mt -48.76 -39.67 25.88 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.525 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -60.5 -45.63 93.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.679 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -58.81 -27.77 65.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 110.639 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 104' ' ' VAL . 2.1 t -67.46 -54.56 22.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.391 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.6 t -56.47 -39.93 64.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.535 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -67.54 -26.31 66.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.691 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -97.93 19.04 14.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.861 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.07 46.93 15.26 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -131.44 21.31 4.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.925 0.393 . . . . 0.0 110.612 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -54.45 -16.0 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.769 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.33 22.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.654 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.989 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.2 pp -68.15 -46.41 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.732 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.989 ' H ' HD12 ' A' ' 112' ' ' ILE . 0.9 OUTLIER -120.25 -18.36 8.02 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.114 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.522 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 13.9 t80 97.83 64.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.15 0.907 . . . . 0.0 110.983 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -63.36 115.16 15.99 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -50.51 127.74 21.45 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 120.973 1.115 . . . . 0.0 111.816 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.9 91.24 0.13 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.465 ' H ' ' HG2' ' A' ' 122' ' ' GLU . 43.9 p -76.08 -35.19 59.47 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.617 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -130.81 172.33 12.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.808 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -56.31 -59.7 4.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.295 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 125' ' ' SER . 98.7 mt-10 -60.31 -24.16 64.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.37 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.617 ' CB ' ' H ' ' A' ' 119' ' ' THR . 15.1 tp10 -61.65 -45.05 95.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.656 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.9 -51.38 48.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.783 0.325 . . . . 0.0 110.838 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.562 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -58.55 -54.94 41.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.155 0.978 . . . . 0.0 109.045 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 46.8 t -51.9 -26.75 10.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.813 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.65 -59.4 3.63 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.597 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.458 HD13 ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -52.55 -47.41 48.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -54.16 -48.87 70.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.26 -1.337 . . . . 0.0 111.211 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -71.85 -27.25 62.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.652 0.263 . . . . 0.0 111.197 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.9 mt -66.12 -19.14 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.212 -179.685 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 N--CA 1.493 1.444 0 CA-C-O 120.688 0.203 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.428 HD11 ' CZ2' ' A' ' 62' ' ' TRP . 13.8 tp -70.93 -21.35 62.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.341 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.3 tpt -59.06 -33.17 70.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.419 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.67 -43.57 96.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.74 -52.15 58.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.862 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.8 -43.91 97.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.474 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.93 -40.44 60.83 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.786 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -74.52 -48.28 28.0 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.295 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.24 -33.11 67.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.059 0.456 . . . . 0.0 110.123 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -77.44 -44.28 29.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.643 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.7 -22.07 56.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.786 HG13 ' O ' ' A' ' 51' ' ' ALA . 16.0 m -85.41 -53.86 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.656 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.8 m-85 -125.8 1.61 7.42 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 60.35 37.24 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.018 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -122.42 -167.83 1.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.107 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.29 159.72 51.05 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.42 ' CG ' ' CZ2' ' A' ' 62' ' ' TRP . 94.4 Cg_endo -76.65 169.26 22.13 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 123.047 2.498 . . . . 0.0 111.967 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.95 111.94 17.68 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.541 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CZ2' HD11 ' A' ' 45' ' ' LEU . 6.7 m0 -109.89 155.13 22.1 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.191 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.31 131.65 3.37 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.28 111.97 24.19 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.476 ' O ' ' CB ' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -91.11 146.3 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.47 178.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -120.68 120.0 34.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.796 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 69' ' ' GLU . 4.7 mt -133.2 150.13 74.53 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.55 -7.16 1.23 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.476 1.451 . . . . 0.0 111.921 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -108.22 -7.18 16.05 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.787 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.21 -145.1 13.73 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.476 ' CB ' ' O ' ' A' ' 65' ' ' VAL . 6.9 p90 -141.87 151.92 43.14 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.116 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -120.27 114.96 22.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.047 0.451 . . . . 0.0 111.084 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.463 ' HG3' ' HB1' ' A' ' 92' ' ' ALA . 4.8 mmt -78.79 128.38 33.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -109.91 120.42 42.42 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.893 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -115.7 128.23 55.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.893 ' N ' HD12 ' A' ' 75' ' ' LEU . 7.6 mt -124.47 143.3 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 79' ' ' GLU . 6.5 tp -158.77 -149.83 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.2 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 80' ' ' ILE . 27.5 t-20 -48.01 83.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.555 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 77' ' ' LEU . 48.1 tt0 57.58 -1.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.033 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.468 ' H ' ' C ' ' A' ' 78' ' ' ASN . 62.8 mt -100.97 131.8 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.587 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.7 p -132.95 130.53 39.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 96' ' ' ALA . 4.1 m -138.01 162.4 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.153 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -134.07 145.75 49.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.014 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.74 106.02 0.5 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -86.86 140.29 29.82 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.33 -179.6 2.31 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.987 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.6 p -120.09 10.18 11.35 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.804 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.538 ' OG ' ' HB3' ' A' ' 91' ' ' ALA . 91.2 p -131.25 153.76 49.17 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -72.06 -50.47 28.08 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.965 0.412 . . . . 0.0 111.103 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -55.64 -44.42 77.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.371 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.538 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -73.17 -20.14 60.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.893 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.463 ' HB1' ' HG3' ' A' ' 73' ' ' MET . . . -64.39 -55.02 23.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.618 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -73.41 -42.29 62.27 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.763 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -53.19 -42.31 66.13 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.442 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.423 ' NZ ' ' HB1' ' A' ' 91' ' ' ALA . 18.9 mttt -72.99 -35.99 66.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.383 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.584 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -72.16 -52.85 14.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.28 -38.94 85.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.0 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -66.29 -49.04 78.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -54.7 -33.87 61.53 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.227 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -63.0 -56.97 12.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.241 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.49 HD13 HG13 ' A' ' 127' ' ' ILE . 11.5 mt -52.65 -35.67 55.38 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.301 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -59.76 -46.27 89.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.621 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -61.69 -28.62 69.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.528 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.87 -54.6 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.4 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.4 t -52.66 -41.32 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.76 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.55 -25.9 67.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 110.059 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -96.72 20.49 10.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.737 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.44 40.54 3.72 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.41 ' C ' ' N ' ' A' ' 111' ' ' GLU . 32.4 tttp -133.94 24.08 3.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -48.4 -19.29 0.3 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.066 0.46 . . . . 0.0 110.171 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 109' ' ' LYS . 82.6 mt-10 -75.65 25.03 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.48 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.507 HG13 ' H ' ' A' ' 113' ' ' PHE . 2.3 pt -48.96 -46.6 16.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.957 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.526 ' O ' ' CD2' ' A' ' 114' ' ' PHE . 44.7 p90 -121.75 11.47 10.46 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 113' ' ' PHE . 3.6 m-85 85.96 54.2 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.043 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.429 HD11 HD22 ' A' ' 101' ' ' LEU . 24.8 mt -63.29 122.29 74.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.46 128.39 14.43 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.372 1.381 . . . . 0.0 112.919 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.75 91.16 0.13 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 62.4 m -59.55 -38.43 81.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.437 ' H ' ' HB2' ' A' ' 122' ' ' GLU . 3.0 p -131.03 -172.68 2.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.792 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -67.42 -59.73 3.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.928 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -55.11 -24.5 26.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.93 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 119' ' ' THR . 73.7 mm-40 -68.63 -41.07 79.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.065 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.72 -52.43 30.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.761 0.315 . . . . 0.0 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.9 mp -55.91 -56.92 14.86 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.924 0.869 . . . . 0.0 108.717 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.2 t -51.7 -28.58 15.32 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.39 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.23 -50.29 74.24 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.849 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.588 ' N ' HD12 ' A' ' 127' ' ' ILE . 1.9 mp -58.62 -44.12 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-O 121.353 0.597 . . . . 0.0 109.7 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -53.13 -47.68 68.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.205 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -71.57 -29.3 64.57 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.166 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 43.2 mt -64.26 -20.04 26.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.038 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.462 0.171 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.437 -179.502 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.496 1.64 0 N-CA-C 112.673 0.22 . . . . 0.0 112.673 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.531 HD11 ' CZ2' ' A' ' 62' ' ' TRP . 19.0 tp -60.48 -22.15 63.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.864 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.5 ttp -63.43 -34.23 77.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.735 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.542 HG11 HD11 ' A' ' 101' ' ' LEU . 3.7 t -65.56 -30.79 51.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.257 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 75' ' ' LEU . 1.6 tp -75.54 -51.98 11.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.54 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -54.26 -37.76 65.06 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.283 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -77.23 -41.11 42.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.26 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.674 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -65.69 -48.71 71.12 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.117 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.67 -30.68 71.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 0.0 111.006 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 57' ' ' GLN . 29.1 ttpt -78.36 -57.82 3.58 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.005 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.29 -21.78 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 51' ' ' ALA . 23.8 m -86.13 -53.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.782 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.656 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.1 m-85 -125.72 -1.1 7.36 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 71.04 19.33 5.63 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.175 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -110.79 -167.95 1.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.08 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.15 162.3 42.42 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.008 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.04 169.13 22.73 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.991 2.461 . . . . 0.0 112.049 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.13 131.39 53.27 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.004 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.531 ' CZ2' HD11 ' A' ' 45' ' ' LEU . 5.7 m0 -120.74 141.06 50.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.798 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.67 128.98 4.65 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 p -96.87 119.36 35.2 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.895 0.378 . . . . 0.0 111.5 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.8 t -107.54 148.09 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.229 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -114.19 110.29 19.74 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.848 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.54 156.34 80.2 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -51.59 -15.64 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.614 1.542 . . . . 0.0 111.6 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.61 -17.62 31.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.842 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.42 -114.71 1.26 Allowed Glycine 0 C--N 1.33 0.205 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -133.16 136.49 45.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 65' ' ' VAL . 34.7 tt0 -120.38 118.59 30.76 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.5 mtt -93.38 134.4 35.66 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.332 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.5 p -107.96 128.16 54.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.806 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.43 ' CD1' HD21 ' A' ' 48' ' ' LEU . 10.0 tp -116.63 125.98 52.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.4 mt -120.52 133.16 68.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 120.905 0.383 . . . . 0.0 109.972 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' GLU . 13.0 mt -140.83 -165.56 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.607 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 80' ' ' ILE . 5.6 p30 -49.0 91.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.731 0.301 . . . . 0.0 111.116 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 77' ' ' LEU . 69.5 mm-40 60.43 -6.21 0.09 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.257 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.488 ' H ' ' C ' ' A' ' 78' ' ' ASN . 96.2 mt -99.15 130.6 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.031 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 81' ' ' THR . 12.6 t -132.43 129.39 39.21 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.4 m -141.78 162.79 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.243 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.76 162.84 40.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.194 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.63 149.17 20.98 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -106.75 138.49 42.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.684 0.278 . . . . 0.0 110.342 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.89 160.97 31.61 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.93 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.9 m -74.01 -26.77 60.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.702 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.4 p -117.97 155.49 30.17 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.446 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -37.24 66.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.272 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -59.79 -48.14 82.88 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.678 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.71 -22.44 61.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.262 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.81 76.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.998 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -74.17 -45.68 46.99 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.782 0.325 . . . . 0.0 111.035 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -52.8 -48.77 66.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.869 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -62.67 -35.04 78.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.583 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.34 -49.44 49.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.229 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.14 -31.91 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.103 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.21 -49.95 50.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.735 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -55.14 -33.17 62.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.311 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.43 ' CD1' ' C ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -63.33 -56.91 12.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.005 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.542 HD11 HG11 ' A' ' 47' ' ' VAL . 16.6 mt -52.07 -36.45 50.73 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.704 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -61.05 -45.63 93.96 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.61 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -62.76 -27.86 69.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.766 0.317 . . . . 0.0 111.241 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -64.61 -54.1 34.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.399 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.467 ' H ' HG23 ' A' ' 105' ' ' VAL . 1.4 t -53.9 -41.13 47.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.494 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -60.0 -28.15 67.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.28 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -97.33 20.33 11.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.211 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.85 44.19 5.53 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 111' ' ' GLU . 11.8 tttp -133.37 20.32 3.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.414 . . . . 0.0 110.182 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -48.53 -15.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.901 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 109' ' ' LYS . 90.4 mt-10 -79.71 22.9 0.45 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.622 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.929 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -50.98 -45.09 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.145 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.929 ' H ' HD12 ' A' ' 112' ' ' ILE . 2.0 p90 -118.32 -7.01 10.77 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.572 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 6.7 m-85 98.06 54.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.612 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.484 HD13 HG21 ' A' ' 127' ' ' ILE . 15.6 mt -62.6 114.82 13.27 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.491 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -50.72 128.62 24.62 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.304 1.336 . . . . 0.0 112.32 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.74 91.29 0.13 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 m -91.92 -30.05 16.34 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.9 m -140.65 162.99 34.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.422 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -53.37 -60.65 3.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.486 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -56.72 -25.74 55.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.493 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -72.14 -51.38 21.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.42 -51.46 69.75 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.559 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -62.83 -58.51 7.15 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.575 0.703 . . . . 0.0 110.396 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.3 m -52.15 -36.58 51.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.996 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -58.15 -55.74 31.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.365 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.484 HG21 HD13 ' A' ' 115' ' ' ILE . 27.1 pt -69.1 -34.2 62.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.068 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -61.8 -39.3 91.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.712 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -69.47 -25.21 63.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.742 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' A' ' 127' ' ' ILE . 67.0 mt -73.68 -23.98 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.064 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.016 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.495 1.56 0 CA-C-O 120.732 0.222 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.703 HD22 HH11 ' A' ' 93' ' ' ARG . 24.9 tp -70.05 -25.36 63.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.519 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.1 mmt -64.64 -33.7 76.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.39 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 101' ' ' LEU . 2.1 t -63.98 -56.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.456 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.06 -51.31 64.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.269 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -54.81 -42.49 71.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.775 0.321 . . . . 0.0 111.139 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -71.77 -37.87 70.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.032 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.79 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -69.17 -47.35 65.19 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.72 -31.69 68.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.04 0.447 . . . . 0.0 110.301 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -77.12 -47.18 21.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.954 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.95 -21.13 59.36 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.79 HG13 ' O ' ' A' ' 51' ' ' ALA . 17.4 m -85.26 -53.81 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.239 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.649 ' N ' HG23 ' A' ' 55' ' ' VAL . 3.1 m-85 -126.08 -4.8 6.81 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.404 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 3.2 tp-100 71.96 19.89 4.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.67 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -111.02 -167.53 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.299 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.89 161.07 51.14 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.691 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.51 169.01 21.79 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.808 2.339 . . . . 0.0 111.462 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.09 117.07 26.24 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.944 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.598 ' CZ2' HD11 ' A' ' 45' ' ' LEU . 7.9 m0 -112.8 152.78 28.76 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.796 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.68 125.37 2.03 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 78.1 m -97.77 120.7 38.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.058 0.456 . . . . 0.0 111.281 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.548 ' HB ' HD21 ' A' ' 67' ' ' LEU . 1.8 t -107.59 150.63 10.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.365 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.913 ' C ' HD23 ' A' ' 67' ' ' LEU . 14.7 mp0 -119.76 114.21 21.8 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.913 HD23 ' C ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -127.27 160.63 58.92 Favored Pre-proline 0 C--N 1.345 0.403 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.08 -8.21 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.097 1.865 . . . . 0.0 111.234 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -99.65 -10.79 21.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.636 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.32 -120.72 1.83 Allowed Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 3.9 m-85 -141.71 145.09 34.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.643 ' HB2' HD11 ' A' ' 67' ' ' LEU . 60.5 tt0 -119.69 145.72 46.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 7.8 tpp -114.64 133.8 55.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.9 p -116.82 125.89 52.26 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 76' ' ' ILE . 6.7 tp -121.37 135.89 55.03 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 75' ' ' LEU . 3.3 mt -131.58 149.43 33.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 79' ' ' GLU . 35.8 tp -169.11 125.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.751 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 65.1 t30 58.78 -80.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.841 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -147.55 -0.62 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 110.533 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.1 mt -100.18 134.24 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.41 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.15 131.74 42.55 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 96' ' ' ALA . 10.5 m -137.34 162.35 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.13 0.49 . . . . 0.0 111.186 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -160.58 160.81 32.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.047 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.85 155.48 26.32 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.2 140.14 38.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.738 0.304 . . . . 0.0 110.231 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.65 165.51 25.68 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.763 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.4 p -104.14 -0.78 28.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 50.5 m -115.89 152.24 33.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.219 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -80.24 -51.21 9.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.247 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -59.64 -45.77 91.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.112 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.07 67.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.829 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -58.98 -42.75 90.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.434 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.703 HH11 HD22 ' A' ' 45' ' ' LEU . 38.4 ttm180 -73.99 -45.85 47.43 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.035 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 98' ' ' VAL . 94.0 mt-30 -53.59 -43.26 68.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.77 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -64.03 -36.23 83.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.675 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.57 -50.3 32.34 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.681 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.43 -41.39 89.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.451 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 94' ' ' GLN . 79.8 t -65.63 -46.14 90.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.812 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -55.08 -36.2 65.37 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.248 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -60.84 -58.34 8.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.68 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.615 HD22 HD11 ' A' ' 115' ' ' ILE . 19.0 mt -48.9 -36.22 16.66 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.672 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -61.83 -44.62 96.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.403 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -61.86 -27.7 68.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.894 0.378 . . . . 0.0 110.975 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.48 -54.41 26.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.682 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -53.66 -39.79 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.499 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -68.29 -22.9 64.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.462 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -97.25 14.17 26.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.63 40.16 47.36 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.179 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 111' ' ' GLU . 0.5 OUTLIER -133.62 26.48 4.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.815 0.34 . . . . 0.0 110.327 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -48.9 -16.86 0.14 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 109' ' ' LYS . 88.3 mt-10 -84.3 23.81 1.04 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.551 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.942 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -49.8 -45.02 21.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.863 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.942 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -118.73 -17.02 9.3 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.533 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 50.9 t80 110.77 52.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.7 1.25 . . . . 0.0 110.257 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.615 HD11 HD22 ' A' ' 101' ' ' LEU . 35.2 mt -62.49 112.69 6.98 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -51.45 128.56 26.18 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.27 1.314 . . . . 0.0 111.907 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.68 91.53 0.13 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.668 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.8 m -77.25 -38.07 51.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.88 170.56 13.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.449 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.45 -60.5 3.74 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.494 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.411 ' O ' ' OG ' ' A' ' 125' ' ' SER . 93.6 mt-10 -56.43 -24.53 45.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.984 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -69.92 -44.2 70.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.02 83.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.544 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 2.9 mp -66.22 -58.98 4.2 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.906 0.86 . . . . 0.0 109.964 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 91.0 p -52.86 -38.35 61.43 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.804 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -57.54 -58.74 6.96 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.774 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' ILE . 12.2 mt -54.78 -51.69 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.501 0.667 . . . . 0.0 110.1 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -47.15 -35.25 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.589 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -71.71 -27.41 63.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.773 0.32 . . . . 0.0 110.552 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 127' ' ' ILE . 56.4 mt -67.92 -28.66 42.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.2 p . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.564 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.493 1.495 0 CA-C-O 120.788 0.245 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 45' ' ' LEU . 15.5 tp -71.39 -21.99 61.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.332 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.1 tpt -62.39 -34.32 76.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.112 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.407 HG11 HD11 ' A' ' 101' ' ' LEU . 2.1 t -68.51 -50.65 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.428 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.611 HD11 HD22 ' A' ' 77' ' ' LEU . 4.8 tp -56.07 -52.17 65.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.434 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -60.65 -43.97 96.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 111.557 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.42 -33.84 73.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.048 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.756 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -74.48 -47.68 31.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.26 72.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.993 0.425 . . . . 0.0 109.915 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -77.36 -44.45 29.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.949 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.79 -21.82 57.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 51' ' ' ALA . 19.6 m -85.51 -53.86 9.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.659 ' N ' HG23 ' A' ' 55' ' ' VAL . 3.2 m-85 -125.68 -2.45 7.29 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.688 -0.405 . . . . 0.0 112.035 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 67.22 23.39 9.44 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.348 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -108.93 176.7 5.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.346 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.51 159.42 32.28 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.985 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.31 169.55 19.93 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.054 2.503 . . . . 0.0 111.983 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.05 119.79 33.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.76 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -114.19 150.89 33.56 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.45 130.39 3.93 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 64' ' ' THR . 9.6 t -100.38 115.4 29.92 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 111.33 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.9 t -106.06 148.29 10.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.267 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.31 111.42 21.46 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.896 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.8 156.23 80.31 Favored Pre-proline 0 N--CA 1.456 -0.153 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.232 -178.224 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -51.78 -16.1 3.65 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.516 1.477 . . . . 0.0 111.625 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.07 -15.46 33.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.788 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.35 -116.87 1.51 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -134.0 135.78 43.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.7 tt0 -117.95 121.22 40.12 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.404 ' HB2' ' HB1' ' A' ' 92' ' ' ALA . 44.7 tpp -93.47 130.04 39.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.82 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.2 m -107.63 126.05 52.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.924 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -119.07 130.52 55.66 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.306 0.379 . . . . 0.0 110.203 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.924 ' N ' HD12 ' A' ' 75' ' ' LEU . 45.8 mt -123.22 138.04 54.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.073 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.611 HD22 HD11 ' A' ' 48' ' ' LEU . 5.1 tp -150.22 -154.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.464 ' C ' ' H ' ' A' ' 80' ' ' ILE . 19.9 p-10 -48.52 83.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.775 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 77' ' ' LEU . 5.9 tp10 60.86 -3.33 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.85 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.464 ' H ' ' C ' ' A' ' 78' ' ' ASN . 71.8 mt -102.67 131.84 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.078 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 p -132.58 132.49 42.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.7 m -141.65 160.97 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.464 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -134.54 150.0 50.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.989 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -142.78 133.19 5.43 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -102.74 137.81 40.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.83 164.08 36.08 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.978 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 74.0 p -87.18 -10.88 51.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.364 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.3 m -128.56 155.53 44.76 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.227 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.563 ' H ' ' CD ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -70.31 -42.13 72.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -57.43 -47.93 80.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.98 62.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.696 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 73' ' ' MET . . . -66.93 -46.5 74.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -73.33 -43.1 61.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.725 0.297 . . . . 0.0 111.524 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -52.27 -45.03 65.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.278 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -70.34 -34.92 73.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 111.166 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.554 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -67.65 -48.15 67.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.339 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.17 82.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.338 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.91 -50.67 76.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.676 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -55.35 -37.82 67.97 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.678 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -55.0 40.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.369 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 115' ' ' ILE . 13.2 mt -50.4 -35.41 28.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.255 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.515 ' NH1' ' OE2' ' A' ' 106' ' ' GLU . 64.9 ttp85 -62.18 -47.04 86.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.441 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -27.54 65.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.673 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.56 -54.49 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.683 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.489 ' H ' HG23 ' A' ' 105' ' ' VAL . 1.7 t -52.4 -40.77 33.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.567 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.515 ' OE2' ' NH1' ' A' ' 102' ' ' ARG . 97.9 mt-10 -66.25 -24.96 66.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.107 0.48 . . . . 0.0 109.787 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -93.77 19.72 8.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.419 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.7 38.92 2.44 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.417 ' C ' ' N ' ' A' ' 111' ' ' GLU . 9.3 tptp -132.91 25.1 4.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.534 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -48.82 -15.77 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.611 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.417 ' N ' ' C ' ' A' ' 109' ' ' LYS . 77.0 mm-40 -80.04 23.5 0.46 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.113 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.911 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -50.04 -44.53 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.518 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.911 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.3 p90 -118.15 -19.88 8.86 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.538 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 68.7 t80 116.87 51.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.799 1.312 . . . . 0.0 109.583 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.534 HD11 HD22 ' A' ' 101' ' ' LEU . 22.8 mt -62.75 121.0 65.27 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.48 128.87 13.14 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.552 1.501 . . . . 0.0 112.701 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.32 91.31 0.13 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 64.5 p -61.49 -34.51 75.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.113 0.482 . . . . 0.0 109.723 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.421 ' H ' ' HB3' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -135.81 172.05 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.895 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -57.15 -59.8 4.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.211 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -56.09 -25.19 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.529 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.421 ' HB3' ' H ' ' A' ' 119' ' ' THR . 17.9 tp10 -69.58 -47.97 61.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.844 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.13 74.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.236 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.542 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.2 mp -65.16 -58.24 6.52 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.912 0.863 . . . . 0.0 109.884 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 44.8 m -53.07 -36.57 60.8 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.0 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -63.13 -59.53 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.673 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.5 HG21 HD13 ' A' ' 115' ' ' ILE . 40.3 pt -60.47 -35.0 60.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.375 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -61.98 -33.23 73.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.891 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -71.0 -25.75 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.538 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 58.2 mt -70.19 -30.09 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.7 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.826 179.933 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 N--CA 1.494 1.507 0 N-CA-C 112.762 0.255 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.08 -23.47 62.13 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.31 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.0 mmt -65.75 -34.5 78.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.972 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.617 HG11 HD11 ' A' ' 101' ' ' LEU . 1.8 t -68.21 -43.53 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.468 HD12 ' CE2' ' A' ' 100' ' ' TYR . 4.7 tp -61.3 -52.05 66.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.167 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -56.34 -53.33 58.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.865 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -61.97 -35.68 79.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.044 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.742 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -68.65 -47.37 66.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.997 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.78 -31.37 72.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.039 0.447 . . . . 0.0 109.892 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -77.26 -45.68 25.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.456 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.15 -21.79 58.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 51' ' ' ALA . 19.4 m -85.61 -53.3 10.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.648 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.1 m-85 -125.15 -1.31 7.71 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.5 41.14 7.65 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.168 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -127.89 -179.12 4.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.09 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.54 156.86 39.75 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.95 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 168.59 23.69 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.68 2.254 . . . . 0.0 112.059 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.1 117.26 28.26 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.918 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -114.85 140.63 48.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.8 121.76 1.99 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 m -97.35 112.21 24.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.115 0.483 . . . . 0.0 111.462 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 t -93.16 147.77 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.826 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -122.98 118.81 28.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.572 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 69' ' ' GLU . 4.4 mt -133.41 149.61 72.83 Favored Pre-proline 0 CA--C 1.529 0.16 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.29 -7.15 1.72 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.316 1.344 . . . . 0.0 110.953 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 67' ' ' LEU . 80.3 mm-40 -105.17 -11.48 16.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.776 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.17 -150.28 22.53 Favored Glycine 0 C--N 1.332 0.352 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 14.4 m-85 -129.07 147.63 50.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.88 0.34 . . . . 0.0 110.262 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -118.07 112.72 20.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.031 0.444 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -84.63 129.54 34.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.0 p -113.79 129.77 56.54 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.145 0.278 . . . . 0.0 110.766 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -122.01 126.82 49.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.871 ' N ' HD12 ' A' ' 75' ' ' LEU . 7.2 mt -121.66 132.66 70.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 79' ' ' GLU . 3.2 tp -147.74 -159.41 1.02 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.685 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 80' ' ' ILE . 2.9 p30 -46.15 84.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.877 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 77' ' ' LEU . 17.5 tp10 61.27 -7.14 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.904 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.505 ' H ' ' C ' ' A' ' 78' ' ' ASN . 73.0 mt -99.5 128.37 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.009 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 p -132.64 128.03 36.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 96' ' ' ALA . 2.7 m -141.2 167.05 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.193 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -162.76 168.75 21.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.071 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.36 163.08 33.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.507 ' H ' ' CD ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -109.25 138.69 45.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.836 0.35 . . . . 0.0 110.292 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.0 161.51 39.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.715 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.9 p -97.15 -1.01 45.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.996 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.4 m -130.86 151.92 50.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.077 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -71.95 -39.71 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 0.0 111.28 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -57.92 -47.74 81.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.344 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.13 -20.03 59.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.086 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.38 -53.55 46.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.403 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -72.93 -44.28 61.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.573 0.225 . . . . 0.0 111.152 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -53.06 -47.21 68.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.807 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -63.43 -34.99 78.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.794 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.481 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.73 -50.37 30.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.168 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.59 76.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.45 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.52 -48.96 69.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.503 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -54.25 -34.99 62.01 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.279 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.49 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.58 -57.97 8.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.548 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.617 HD11 HG11 ' A' ' 47' ' ' VAL . 13.8 mt -47.94 -37.93 15.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.184 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -60.79 -44.95 96.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.428 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -60.17 -27.72 67.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.02 0.438 . . . . 0.0 110.91 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -68.81 -53.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.615 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 101' ' ' LEU . 2.0 t -54.84 -41.37 56.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.697 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -62.85 -27.5 69.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 109.865 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -94.15 20.34 8.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.709 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.53 38.96 5.59 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.414 ' C ' ' N ' ' A' ' 111' ' ' GLU . 2.6 tptm -133.73 25.59 4.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.734 0.302 . . . . 0.0 110.897 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.409 ' C ' ' H ' ' A' ' 112' ' ' ILE . 8.2 p80 -49.29 -16.06 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.797 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 109' ' ' LYS . 6.1 pt-20 -75.4 23.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.444 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.95 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -49.95 -44.36 21.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.844 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.95 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.4 p90 -117.48 -19.59 9.41 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' A' ' 114' ' ' PHE . 75.8 t80 118.03 50.05 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.888 1.367 . . . . 0.0 109.543 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.567 HD13 HG21 ' A' ' 127' ' ' ILE . 25.0 mt -62.33 113.4 8.67 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.29 129.26 10.22 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.765 1.643 . . . . 0.0 113.024 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.15 90.67 0.13 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 69.7 m -58.1 -37.02 73.73 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.76 161.46 27.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.84 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -53.8 -59.54 4.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.864 0.364 . . . . 0.0 110.47 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.69 -24.56 49.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.7 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -71.84 -44.77 63.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.013 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.83 -51.17 71.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.092 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.554 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -63.4 -56.76 13.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.019 0.914 . . . . 0.0 109.393 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.1 t -52.11 -37.73 55.08 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.155 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -62.77 -57.59 10.41 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.545 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.567 HG21 HD13 ' A' ' 115' ' ' ILE . 38.5 pt -59.46 -33.99 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 0.0 110.493 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -72.96 -32.59 65.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.85 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -70.02 -25.67 63.69 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.5 pt -90.45 -18.93 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.154 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.874 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 N--CA 1.496 1.643 0 CA-C-O 120.758 0.233 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -61.67 -20.34 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.204 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.1 tpt -58.79 -33.97 70.94 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 101' ' ' LEU . 2.1 t -58.76 -31.16 43.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 77' ' ' LEU . 3.6 tp -78.78 -51.85 9.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.479 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -60.07 -32.28 70.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -76.29 -43.01 43.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.336 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -71.35 -48.36 50.75 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.231 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.48 -32.2 68.55 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.312 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -78.02 -47.34 18.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.316 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.21 -20.66 60.82 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.855 -0.528 . . . . 0.0 112.387 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 51' ' ' ALA . 18.2 m -85.75 -52.94 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.16 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.645 ' CD1' ' ND2' ' A' ' 78' ' ' ASN . 0.7 OUTLIER -125.49 -7.42 6.91 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.034 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 6.9 tt0 75.27 19.96 2.13 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.308 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -115.28 173.91 6.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.134 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 161.95 21.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.743 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.37 168.74 22.6 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.793 2.328 . . . . 0.0 112.1 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.39 115.95 23.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.533 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -109.32 149.54 29.32 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.08 124.66 1.86 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.3 m -104.25 114.39 28.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.387 . . . . 0.0 111.825 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.567 ' HB ' HD21 ' A' ' 67' ' ' LEU . 2.0 t -97.93 151.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.488 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.92 ' C ' HD23 ' A' ' 67' ' ' LEU . 36.6 mt-10 -117.2 113.42 22.2 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.92 HD23 ' C ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -129.64 158.44 73.51 Favored Pre-proline 0 C--N 1.347 0.469 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.24 -15.59 8.35 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.93 1.753 . . . . 0.0 111.818 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -96.57 -10.98 26.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.558 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.83 -125.97 2.99 Favored Glycine 0 C--N 1.329 0.16 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 16.0 m-85 -138.52 145.23 40.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HB2' HD11 ' A' ' 67' ' ' LEU . 82.8 tt0 -110.2 129.32 55.74 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.202 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 2.0 mpp? -92.09 133.38 35.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.988 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 m -119.19 118.84 32.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 76' ' ' ILE . 11.5 tp -120.63 130.88 54.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 75' ' ' LEU . 26.5 mt -127.33 135.23 63.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 48' ' ' LEU . 13.8 mt -141.51 101.08 3.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.144 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.645 ' ND2' ' CD1' ' A' ' 56' ' ' TYR . 4.5 m120 57.86 -82.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.239 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 77' ' ' LEU . 6.8 tp10 -125.5 -10.51 6.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.399 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.6 mt -94.59 130.35 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.613 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.4 p -132.17 131.34 42.12 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 100' ' ' TYR . 9.0 m -136.46 158.86 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.028 0.442 . . . . 0.0 110.932 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -162.24 166.41 25.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.785 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.504 ' O ' ' SD ' ' A' ' 73' ' ' MET . . . -169.28 177.97 42.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -106.63 135.11 48.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.585 0.231 . . . . 0.0 110.435 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -149.96 160.16 43.82 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.957 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.9 p -118.77 9.39 12.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.566 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.669 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 48.4 t -128.33 154.73 45.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.26 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -80.69 -53.62 6.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.958 0.409 . . . . 0.0 111.385 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -59.76 -44.31 93.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.553 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 88' ' ' SER . . . -74.09 -20.99 60.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.344 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -66.11 -49.89 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.496 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -73.15 -43.62 61.25 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.304 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.504 ' O ' HG23 ' A' ' 98' ' ' VAL . 98.1 mt-30 -56.8 -48.01 78.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.251 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -62.12 -34.64 76.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.003 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.24 -50.83 43.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.856 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.95 -30.08 63.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 94' ' ' GLN . 54.3 t -68.03 -51.59 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.205 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.93 -34.84 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.855 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.405 ' HA ' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -58.57 -56.78 17.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.247 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.642 HD22 HD11 ' A' ' 115' ' ' ILE . 31.6 mt -51.36 -37.02 45.8 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 123.6 0.563 . . . . 0.0 111.907 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -61.34 -47.04 87.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.721 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -60.64 -28.12 68.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.349 . . . . 0.0 110.611 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 104' ' ' VAL . 3.2 t -62.3 -53.21 50.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.808 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.482 HG13 ' CD2' ' A' ' 110' ' ' HIS . 1.5 t -52.87 -37.17 25.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.581 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -71.47 -24.8 62.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -95.97 19.78 11.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.297 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.62 39.2 2.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -130.86 30.95 4.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.062 0.458 . . . . 0.0 110.011 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.482 ' CD2' HG13 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -48.86 -15.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.286 -179.402 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -83.37 23.47 0.91 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.926 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.5 pp -50.22 -47.54 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.02 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.926 ' H ' HD12 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -120.23 -16.89 8.42 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.595 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.535 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 34.9 t80 105.28 57.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.468 1.105 . . . . 0.0 110.277 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.642 HD11 HD22 ' A' ' 101' ' ' LEU . 22.3 mt -64.41 114.1 13.0 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.659 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -51.35 130.33 32.3 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.447 1.431 . . . . 0.0 112.017 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.47 94.72 0.15 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.783 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.432 ' H ' ' HG2' ' A' ' 122' ' ' GLU . 20.8 m -78.4 -35.23 47.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.168 0.508 . . . . 0.0 109.713 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.517 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -136.22 175.93 9.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.617 179.26 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.78 -60.18 4.25 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.338 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.415 ' O ' ' OG ' ' A' ' 125' ' ' SER . 94.5 mt-10 -58.87 -25.15 63.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.476 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.517 ' CB ' ' H ' ' A' ' 119' ' ' THR . 17.4 tp10 -62.05 -47.69 83.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.706 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.78 -49.49 74.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.986 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.553 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.5 mp -63.19 -58.04 8.53 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 109.568 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 27.4 m -52.49 -36.51 55.25 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.996 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -61.91 -58.64 7.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.612 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.532 ' HA ' HD12 ' A' ' 130' ' ' ILE . 18.7 pt -66.11 -35.69 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.782 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -58.58 -40.29 82.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -72.47 -25.97 61.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.178 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 127' ' ' ILE . 53.8 mt -68.77 -23.92 28.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.767 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 33' ' ' ARG . 27.1 p-10 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.452 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 58.6 ttt85 -54.45 -41.27 69.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.352 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.6 m -130.09 150.51 51.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.478 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -56.67 -34.16 67.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.679 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 tp -54.89 -38.04 67.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.28 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -58.79 -41.73 87.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.298 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.5 mtp -57.75 -38.77 75.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.531 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -68.45 -43.28 77.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.725 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 42' ' ' LYS . 8.4 mp -67.75 -17.66 64.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.566 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -69.86 10.56 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.434 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 40' ' ' LEU . 48.3 tttp -56.21 -43.18 78.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.994 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.21 154.44 40.48 Favored Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.673 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.38 -25.61 15.24 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.34 2.026 . . . . 0.0 112.138 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.453 HD13 ' HD2' ' A' ' 93' ' ' ARG . 24.7 tp -65.3 -23.09 66.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.569 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.4 tpt -62.25 -34.85 77.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.351 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.667 HG11 HD11 ' A' ' 101' ' ' LEU . 2.9 t -68.21 -35.77 72.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.982 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 77' ' ' LEU . 6.8 tp -69.94 -51.74 30.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.206 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -52.8 -40.14 62.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.599 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.32 -32.56 58.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.124 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.676 ' O ' HG22 ' A' ' 55' ' ' VAL . . . -71.07 -48.74 50.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.179 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.28 -31.56 72.44 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.914 0.388 . . . . 0.0 110.667 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 57' ' ' GLN . 62.4 mttm -78.67 -57.19 3.89 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.42 -21.47 64.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 51' ' ' ALA . 25.5 m -86.02 -53.67 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.823 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.648 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.6 m-85 -126.38 4.65 6.96 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 53' ' ' LYS . 88.9 mm-40 59.42 32.76 22.01 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.579 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -125.53 151.37 46.44 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.325 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.04 156.05 74.67 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.953 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.06 168.7 24.15 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.901 2.401 . . . . 0.0 112.107 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.73 124.9 44.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.806 0.336 . . . . 0.0 111.257 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -117.36 152.62 34.56 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.872 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.88 129.78 3.65 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.1 m -102.65 118.72 37.46 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.058 0.456 . . . . 0.0 111.435 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.8 t -108.64 148.34 12.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.276 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 66' ' ' GLU . 4.3 pt-20 -114.81 110.01 19.05 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.881 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -133.17 158.66 75.22 Favored Pre-proline 0 CA--C 1.529 0.16 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -52.25 -20.19 10.71 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.481 1.454 . . . . 0.0 111.331 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -81.16 -19.94 42.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.123 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.64 -114.73 1.25 Allowed Glycine 0 C--N 1.33 0.23 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -133.03 136.5 46.02 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 65' ' ' VAL . 71.9 tt0 -117.12 128.11 54.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.135 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 3.4 tpt -96.8 128.62 43.93 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.661 -0.415 . . . . 0.0 109.988 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 m -107.49 120.27 41.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.7 tp -113.39 128.03 56.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 mp -123.51 133.53 68.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 48' ' ' LEU . 20.6 mt -139.93 88.71 2.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.334 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 56.87 -83.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.627 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 77' ' ' LEU . 91.3 mt-10 -111.44 -17.07 13.18 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.5 mt -98.44 128.11 50.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.275 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 81' ' ' THR . 13.3 t -132.52 131.53 41.69 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -137.26 153.96 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.325 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -134.45 149.47 50.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.854 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.61 142.41 9.93 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -104.87 138.09 41.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.303 . . . . 0.0 110.402 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.73 166.16 34.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.669 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 t -101.0 0.2 37.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.812 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.615 ' OG ' ' HB3' ' A' ' 91' ' ' ALA . 92.6 p -130.82 157.97 41.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.763 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -76.13 -45.64 32.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.974 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -61.79 -46.88 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.387 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.615 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -74.68 -21.18 59.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.162 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -66.22 -48.68 69.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.275 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.453 ' HD2' HD13 ' A' ' 45' ' ' LEU . 55.9 ttp180 -73.1 -43.14 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.757 0.313 . . . . 0.0 111.217 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.576 ' O ' HG23 ' A' ' 98' ' ' VAL . 56.0 tt0 -53.17 -45.7 68.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.961 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -65.82 -36.47 83.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.82 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.53 -51.16 38.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.242 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.73 -30.1 60.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.735 0.302 . . . . 0.0 111.32 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 94' ' ' GLN . 73.2 t -72.06 -47.48 54.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.486 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -55.63 -35.14 65.58 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.155 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -63.58 -58.06 8.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.103 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.667 HD11 HG11 ' A' ' 47' ' ' VAL . 14.4 mt -48.79 -39.25 24.54 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.564 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -60.14 -45.14 94.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.763 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.92 -29.09 68.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.97 0.414 . . . . 0.0 110.782 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.458 HG12 ' C ' ' A' ' 109' ' ' LYS . 2.2 t -64.98 -54.52 28.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.757 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 105' ' ' VAL . 1.1 t -54.05 -37.15 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.83 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -62.1 -32.89 73.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.332 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -96.64 20.93 10.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.806 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.72 49.43 8.86 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.458 ' C ' HG12 ' A' ' 104' ' ' VAL . 9.8 mtpm? -133.23 23.45 4.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.375 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.445 ' CE1' ' HG3' ' A' ' 111' ' ' GLU . 10.7 p-80 -48.85 -17.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.77 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.445 ' HG3' ' CE1' ' A' ' 110' ' ' HIS . 83.8 mt-10 -79.13 23.34 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.563 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 1.012 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -50.34 -44.73 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.71 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 1.012 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.9 p90 -117.77 -19.54 9.24 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.536 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 70.4 t80 118.66 48.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.85 1.344 . . . . 0.0 110.285 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.497 HD11 HD22 ' A' ' 101' ' ' LEU . 52.5 mt -62.32 113.01 7.47 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.61 128.99 10.6 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.627 1.551 . . . . 0.0 113.252 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.1 90.97 0.13 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.412 ' CB ' ' OE1' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -56.53 -28.75 60.75 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.448 ' H ' ' HB2' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -135.19 -179.31 5.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.887 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -64.82 -59.7 3.91 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.622 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -56.75 -26.56 57.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.194 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.448 ' HB2' ' H ' ' A' ' 119' ' ' THR . 69.3 mt-10 -66.72 -42.58 86.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.68 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.33 79.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.551 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.534 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 3.0 mp -65.88 -58.7 4.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.991 0.901 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.7 m -52.73 -41.35 63.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.95 -1.477 . . . . 0.0 111.05 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -55.52 -58.52 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.481 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 mt -55.79 -50.92 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.445 0.641 . . . . 0.0 109.898 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -46.84 -37.4 8.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.9 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -71.74 -26.96 62.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.542 0.21 . . . . 0.0 111.005 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.9 -25.47 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.453 ' OG ' ' NE2' ' A' ' 94' ' ' GLN . 31.2 t -83.85 -44.37 14.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.66 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -66.43 -36.87 83.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -68.9 1.69 3.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.687 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.32 -37.59 65.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.521 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -91.05 -84.29 0.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.447 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.491 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -52.62 -39.06 61.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.567 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.81 115.63 18.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.704 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -104.55 11.56 34.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.435 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 36' ' ' LEU . 9.6 mp -75.14 -38.04 61.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.257 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -57.6 -50.41 73.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.158 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.479 ' O ' ' SD ' ' A' ' 38' ' ' MET . 0.8 OUTLIER -58.42 -40.11 81.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.331 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -60.19 -43.14 96.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.712 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mt -73.29 -43.05 61.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.097 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 42' ' ' LYS . 20.4 mmtp -71.7 -24.11 61.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.695 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 37.6 49.38 1.03 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.728 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.25 98.58 52.07 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.686 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.86 -24.48 13.66 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.014 1.809 . . . . 0.0 111.862 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.446 HD21 ' CZ2' ' A' ' 62' ' ' TRP . 16.6 tp -71.44 -20.55 62.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.424 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 tpt -58.46 -33.16 69.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.939 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.586 HG11 HD11 ' A' ' 101' ' ' LEU . 1.5 t -63.58 -54.99 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.439 ' N ' HG12 ' A' ' 47' ' ' VAL . 7.4 tp -57.87 -52.3 66.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.955 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -54.4 -51.03 66.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.418 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -65.67 -32.51 74.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.086 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.703 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -70.62 -47.08 61.91 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.244 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 -33.91 69.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.859 0.362 . . . . 0.0 110.717 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.51 -47.21 27.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.111 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 -20.99 59.43 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 51' ' ' ALA . 20.8 m -85.62 -53.86 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.533 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.629 ' N ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -125.85 -3.51 7.1 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 71.1 20.8 5.07 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.828 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -109.51 -173.76 2.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.311 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.5 156.24 58.44 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.522 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 168.66 24.21 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 112.305 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.14 118.67 31.16 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.31 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.446 ' CZ2' HD21 ' A' ' 45' ' ' LEU . 8.7 m0 -110.5 137.84 47.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.285 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.5 129.33 4.99 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.2 m -99.95 118.16 35.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.369 . . . . 0.0 111.541 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 72' ' ' GLU . 3.3 t -104.93 148.4 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.831 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -113.71 109.95 19.41 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.864 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.29 155.31 81.44 Favored Pre-proline 0 C--O 1.227 -0.127 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.579 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.38 -7.25 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.851 1.701 . . . . 0.0 111.531 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' OE2' ' NE2' ' A' ' 85' ' ' GLN . 75.1 tt0 -94.72 -17.35 22.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.916 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.99 -117.77 1.61 Allowed Glycine 0 C--N 1.333 0.365 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -132.12 137.61 47.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.8 tt0 -118.44 121.8 41.2 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.8 mtt -93.13 133.08 36.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.491 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.4 m -111.98 123.58 50.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.9 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.864 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -114.76 126.09 54.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.006 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.864 ' N ' HD12 ' A' ' 75' ' ' LEU . 32.6 mm -118.02 131.66 70.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 tp -175.38 136.29 0.35 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.591 0.557 . . . . 0.0 110.904 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.6 t30 54.24 35.31 22.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.339 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 68.52 6.13 5.24 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.286 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.476 HG21 ' HB2' ' A' ' 103' ' ' LYS . 25.4 mt -99.27 137.72 25.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.01 129.65 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.498 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 96' ' ' ALA . 11.7 m -132.68 161.47 41.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.87 0.367 . . . . 0.0 110.815 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -129.9 139.66 51.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.935 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.16 108.09 0.73 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.488 ' NE2' ' OE2' ' A' ' 69' ' ' GLU . 11.3 pt20 -91.91 136.36 33.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.444 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.53 171.98 16.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.674 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.47 -7.48 47.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.367 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.0 p -129.21 152.84 48.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.205 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -71.85 -42.77 66.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.274 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -60.0 -47.74 84.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.307 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.54 -25.63 62.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.975 0.417 . . . . 0.0 110.707 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.06 -35.04 73.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.053 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.414 ' HD3' HD22 ' A' ' 45' ' ' LEU . 40.2 ttm180 -74.26 -46.61 40.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.046 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.526 ' O ' HG23 ' A' ' 98' ' ' VAL . 7.5 tt0 -53.07 -47.51 68.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.915 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -64.99 -32.28 73.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.723 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.571 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.21 -51.95 21.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.926 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.25 -31.11 69.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.043 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 94' ' ' GLN . 45.4 t -71.26 -51.42 34.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.932 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -55.55 -34.35 64.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.03 0.443 . . . . 0.0 110.352 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.28 -55.54 27.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.512 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.639 HD22 HD11 ' A' ' 115' ' ' ILE . 18.1 mt -50.59 -36.19 33.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.633 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -62.75 -45.21 93.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.499 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.476 ' HB2' HG21 ' A' ' 80' ' ' ILE . 16.7 mmtt -60.37 -28.02 67.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 110.951 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.417 HG23 ' H ' ' A' ' 104' ' ' VAL . 2.1 t -65.92 -53.65 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.243 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.5 t -55.39 -37.51 44.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.602 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.53 -28.76 69.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.553 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -96.73 20.04 11.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.615 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 45.58 44.81 12.03 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.41 ' C ' HG12 ' A' ' 104' ' ' VAL . 3.1 mmtp -133.12 23.93 4.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.707 0.289 . . . . 0.0 110.549 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -50.76 -15.75 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -79.87 22.53 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.293 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.951 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -50.93 -45.86 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.431 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.951 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -118.26 -20.29 8.62 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.538 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 72.3 t80 117.27 51.31 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.871 1.357 . . . . 0.0 109.874 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.639 HD11 HD22 ' A' ' 101' ' ' LEU . 21.5 mt -62.85 118.17 39.46 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.23 128.05 12.56 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.336 1.357 . . . . 0.0 112.62 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 123' ' ' ALA . . . -153.88 94.55 0.15 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.0 m -49.28 -38.24 26.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.149 0.5 . . . . 0.0 109.701 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.484 ' H ' ' HB3' ' A' ' 122' ' ' GLU . 11.4 p -133.46 176.08 8.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.877 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -54.69 -57.25 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.832 0.348 . . . . 0.0 110.623 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.424 ' O ' ' OG ' ' A' ' 125' ' ' SER . 95.5 mt-10 -61.76 -34.7 76.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.275 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.534 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 13.0 tp10 -63.34 -31.63 72.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.673 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.486 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . . . -76.28 -53.74 7.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.023 0.439 . . . . 0.0 111.144 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.692 ' C ' HD12 ' A' ' 124' ' ' LEU . 4.1 pp -66.95 -26.12 66.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.861 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.575 ' N ' HD12 ' A' ' 124' ' ' LEU . 71.9 m -76.31 -28.85 57.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.947 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 122' ' ' GLU . 1.6 m-80 -65.05 -51.03 63.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.028 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.5 ' HA ' HD12 ' A' ' 130' ' ' ILE . 10.4 pt -59.14 -35.48 57.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.923 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -61.71 -41.14 97.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.295 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -71.75 -26.08 62.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.612 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 127' ' ' ILE . 69.7 mt -69.22 -23.63 27.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.033 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.4 p -106.27 -43.84 4.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -56.54 -34.67 67.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.148 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 135' ' ' GLU . 16.7 mttm -54.25 -63.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.672 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 40.62 22.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.492 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 133' ' ' LYS . 49.7 tt0 62.5 43.67 7.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.621 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.516 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.5 t30 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.57 9.77 7.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.456 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.7 p -95.63 25.14 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.549 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -84.48 8.87 15.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.681 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.1 mt -65.81 -47.05 76.37 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.955 0.407 . . . . 0.0 110.028 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 38' ' ' MET . 12.2 pt-20 -62.35 -40.15 95.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.113 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.408 ' N ' ' CG ' ' A' ' 37' ' ' GLU . 2.0 ttp -57.31 -40.05 77.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.678 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -61.56 -46.51 89.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.689 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 tp -68.67 -41.13 79.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.933 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -70.71 -23.79 62.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.236 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 mttt 47.86 72.13 0.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.803 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' SD ' ' A' ' 46' ' ' MET . 1.5 p -140.57 84.72 13.67 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.805 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.14 -17.65 2.65 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.67 2.247 . . . . 0.0 112.758 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tp -71.93 -19.89 61.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.448 ' SD ' ' OG1' ' A' ' 43' ' ' THR . 62.4 mtp -58.58 -33.11 69.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.867 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 101' ' ' LEU . 1.8 t -58.73 -57.33 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.453 ' N ' HG12 ' A' ' 47' ' ' VAL . 8.3 tp -58.04 -51.72 68.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.674 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -57.99 -40.83 81.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 111.041 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -70.76 -35.74 72.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.962 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.716 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -72.8 -47.56 45.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.017 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.0 70.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.092 0.473 . . . . 0.0 110.36 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -74.83 -45.01 46.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.753 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.47 -22.13 54.94 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 51' ' ' ALA . 21.1 m -85.86 -53.73 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.708 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.627 ' N ' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -124.92 -7.69 7.24 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.737 -178.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER 73.24 19.81 3.45 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.876 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -110.07 149.65 29.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.455 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 p -81.87 152.37 68.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.869 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.22 169.8 21.74 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.849 2.366 . . . . 0.0 111.63 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.54 123.26 42.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.398 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -126.05 148.16 49.39 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.623 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.49 135.58 5.53 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.9 m -102.65 121.88 43.3 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.828 0.346 . . . . 0.0 111.343 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.8 t -107.76 148.92 11.51 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.439 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -114.48 112.67 23.35 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.882 ' N ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -133.0 158.2 76.46 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -52.02 -21.67 12.87 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.548 1.498 . . . . 0.0 111.502 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.421 ' OE1' ' OE1' ' A' ' 85' ' ' GLN . 57.3 mt-10 -82.78 -17.15 45.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.537 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.18 -115.72 1.35 Allowed Glycine 0 C--N 1.331 0.304 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -132.86 136.94 46.52 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -117.28 121.65 41.75 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.102 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.5 mmt -93.3 133.3 36.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.945 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.1 m -116.63 130.07 56.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.783 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.954 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -127.01 132.14 50.83 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.173 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.954 ' N ' HD12 ' A' ' 75' ' ' LEU . 28.8 mt -128.38 148.98 32.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.4 tp -172.0 128.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.367 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 34.9 t30 55.78 -92.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.292 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -136.29 1.9 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.143 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 53.0 mt -96.96 128.85 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.878 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 81' ' ' THR . 6.2 t -132.32 126.88 34.35 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.553 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.1 m -137.73 164.11 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.292 0.568 . . . . 0.0 110.97 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -165.35 163.9 19.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.691 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.82 166.9 35.71 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.421 ' OE1' ' OE1' ' A' ' 69' ' ' GLU . 36.5 mt-30 -114.5 141.59 47.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.507 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.603 ' HB2' ' HZ1' ' A' ' 95' ' ' LYS . . . -157.88 167.36 30.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.513 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.7 p -97.53 -2.41 41.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.639 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 50.3 m -125.98 149.97 48.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.178 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -77.05 -43.69 33.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 111.183 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -62.11 -47.34 85.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.582 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.08 -21.32 60.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.686 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -71.12 -37.64 72.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.028 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -73.99 -44.17 55.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.931 0.396 . . . . 0.0 110.591 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.641 ' O ' HG23 ' A' ' 98' ' ' VAL . 70.6 mt-30 -57.58 -39.82 77.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.829 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.603 ' HZ1' ' HB2' ' A' ' 86' ' ' ALA . 5.1 ttpm? -65.67 -39.43 91.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.041 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.553 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.39 -48.53 49.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 110.999 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.11 -33.76 69.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 94' ' ' GLN . 76.3 t -71.68 -46.18 63.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.516 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -54.72 -35.56 63.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.047 0.451 . . . . 0.0 109.88 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.51 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.74 -60.4 3.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.089 179.536 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.646 HD22 HD11 ' A' ' 115' ' ' ILE . 16.5 mt -48.17 -38.19 17.53 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.397 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -60.01 -43.7 95.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.841 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -63.44 -27.7 69.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.83 0.348 . . . . 0.0 110.899 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.63 -53.78 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.437 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.7 t -53.46 -41.47 45.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.77 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.56 -26.33 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.125 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -93.78 18.04 10.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.853 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.91 39.69 11.6 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.405 ' C ' ' N ' ' A' ' 111' ' ' GLU . 47.6 mtpt -133.28 22.51 4.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.784 0.326 . . . . 0.0 110.812 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -49.82 -16.13 0.24 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.495 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.405 ' N ' ' C ' ' A' ' 109' ' ' LYS . 97.3 mt-10 -80.07 23.78 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.075 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.938 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -49.21 -44.02 16.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.899 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.938 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.4 p90 -118.33 -20.43 8.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.544 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 74.3 t80 117.09 51.67 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.829 1.33 . . . . 0.0 109.633 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.646 HD11 HD22 ' A' ' 101' ' ' LEU . 24.0 mt -62.16 113.48 8.79 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -51.48 127.89 23.99 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.175 1.25 . . . . 0.0 111.735 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.58 90.98 0.13 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.485 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.442 ' H ' ' HG2' ' A' ' 122' ' ' GLU . 44.1 p -78.33 -32.79 49.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.407 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 17.9 p -139.88 175.45 9.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.329 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -58.92 -60.48 3.79 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.233 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -55.5 -24.78 33.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.544 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 118' ' ' THR . 21.8 tp10 -66.39 -49.51 66.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.722 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.12 66.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.775 0.321 . . . . 0.0 110.778 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.553 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -59.57 -56.5 21.14 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.947 0.88 . . . . 0.0 108.996 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.5 t -51.8 -36.79 49.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.82 -1.536 . . . . 0.0 110.428 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.519 ' ND2' ' OE2' ' A' ' 135' ' ' GLU . 15.4 t-20 -54.93 -58.81 6.09 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.23 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.597 HG12 HD13 ' A' ' 101' ' ' LEU . 5.6 mt -59.06 -45.82 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.484 0.659 . . . . 0.0 109.553 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -47.27 -46.53 24.84 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.486 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 134' ' ' ALA . 95.6 mm-40 -71.99 -29.18 63.97 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.343 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 127' ' ' ILE . 75.7 mt -65.23 -23.1 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 t -97.82 -33.06 11.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.396 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.85 -70.89 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.664 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 61.5 mttm -103.01 -70.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 129' ' ' GLN . . . 175.74 -45.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.623 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.519 ' OE2' ' ND2' ' A' ' 126' ' ' ASN . 44.5 tp10 -168.4 -75.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.418 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.454 179.937 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m120 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 -61.72 -43.49 98.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.689 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.4 p -138.97 82.55 1.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.424 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -109.41 26.99 10.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.873 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.7 mt -71.67 -47.61 53.05 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.735 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -62.73 -39.91 95.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.546 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 56.3 mtm -68.29 -31.41 70.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.368 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -47.75 84.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.504 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.68 -25.32 65.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.165 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 42' ' ' LYS . 8.5 tttt -90.34 13.44 15.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.285 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' LYS . 14.7 mtmm 60.66 142.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.116 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.4 p -135.92 67.96 63.96 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.466 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -80.99 -75.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.777 2.318 . . . . 0.0 111.658 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.6 tp -77.05 -20.74 55.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.189 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 61.1 mtt -58.57 -33.23 69.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.263 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.492 HG11 HD11 ' A' ' 101' ' ' LEU . 1.4 t -63.2 -50.15 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.372 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.459 HD12 ' CE2' ' A' ' 100' ' ' TYR . 9.7 tp -52.18 -50.65 61.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.431 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -59.44 -52.84 63.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.527 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -60.94 -38.93 87.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.752 0.31 . . . . 0.0 111.164 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.755 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -69.23 -47.24 65.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.21 -31.02 72.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.345 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -74.25 -49.34 23.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.338 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -21.12 59.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 51' ' ' ALA . 20.3 m -85.35 -53.94 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 119.974 -0.69 . . . . 0.0 112.213 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.666 ' N ' HG23 ' A' ' 55' ' ' VAL . 7.6 m-85 -126.01 -1.03 7.18 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 58.26 40.84 24.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.298 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 -177.0 3.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.368 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.79 119.53 41.01 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.41 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.89 168.44 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.578 1.519 . . . . 0.0 111.641 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 m -113.25 140.75 47.71 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.814 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -135.55 154.67 51.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.722 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.34 135.64 4.93 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -105.4 114.64 28.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.869 0.366 . . . . 0.0 111.328 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.9 t -99.19 148.48 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.012 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -114.02 110.71 20.47 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.85 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.42 156.03 80.57 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.25 -7.05 2.38 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.845 1.697 . . . . 0.0 111.211 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 67' ' ' LEU . 50.7 mt-10 -94.38 -14.95 24.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.2 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.97 -121.08 2.38 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -132.75 134.16 44.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 65' ' ' VAL . 35.2 tt0 -114.12 120.59 41.07 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.247 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -89.63 125.03 35.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.91 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.4 m -117.51 131.6 56.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -132.92 144.9 50.46 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.391 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 75' ' ' LEU . 36.4 mt -123.07 147.25 27.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.0 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 77' ' ' LEU . 6.3 tp -160.12 108.98 1.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.7 t30 62.74 -80.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.879 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -142.53 3.99 1.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.792 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.8 mt -101.22 127.75 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.1 m -132.78 129.04 38.07 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.628 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.8 m -136.62 164.27 31.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.199 0.523 . . . . 0.0 111.157 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -132.92 145.53 50.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.296 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -139.5 121.8 2.13 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -94.66 135.14 36.47 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.0 163.76 39.3 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.917 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 87' ' ' THR . 0.1 OUTLIER -92.4 -8.41 44.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.439 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.1 p -133.08 158.85 41.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.4 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -67.35 -45.31 76.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.351 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -57.45 -43.53 84.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.196 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.87 -20.01 59.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.4 -54.65 25.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.136 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -70.61 -39.34 73.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.23 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.463 ' O ' HG23 ' A' ' 98' ' ' VAL . 37.7 tt0 -54.32 -52.17 62.35 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.389 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -63.6 -41.46 98.32 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.628 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -69.73 -52.21 27.46 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.79 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.05 -37.14 66.34 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.213 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 94' ' ' GLN . 55.8 t -65.51 -47.01 88.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.541 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -54.55 -36.91 64.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 110.326 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.556 ' CD2' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -60.11 -54.35 46.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.943 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.556 ' N ' ' CD2' ' A' ' 100' ' ' TYR . 6.4 mt -48.76 -39.67 25.88 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.525 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -60.5 -45.63 93.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.679 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -58.81 -27.77 65.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 110.639 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 104' ' ' VAL . 2.1 t -67.46 -54.56 22.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.391 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.6 t -56.47 -39.93 64.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.535 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -67.54 -26.31 66.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.691 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -97.93 19.04 14.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.861 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.07 46.93 15.26 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -131.44 21.31 4.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.925 0.393 . . . . 0.0 110.612 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -54.45 -16.0 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.769 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.33 22.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.654 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.989 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.2 pp -68.15 -46.41 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.732 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.989 ' H ' HD12 ' A' ' 112' ' ' ILE . 0.9 OUTLIER -120.25 -18.36 8.02 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.114 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.522 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 13.9 t80 97.83 64.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.15 0.907 . . . . 0.0 110.983 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -63.36 115.16 15.99 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -50.51 127.74 21.45 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 120.973 1.115 . . . . 0.0 111.816 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.9 91.24 0.13 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.465 ' H ' ' HG2' ' A' ' 122' ' ' GLU . 43.9 p -76.08 -35.19 59.47 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.617 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -130.81 172.33 12.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.808 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -56.31 -59.7 4.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.295 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 125' ' ' SER . 98.7 mt-10 -60.31 -24.16 64.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.37 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.617 ' CB ' ' H ' ' A' ' 119' ' ' THR . 15.1 tp10 -61.65 -45.05 95.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.656 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.9 -51.38 48.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.783 0.325 . . . . 0.0 110.838 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.562 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -58.55 -54.94 41.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.155 0.978 . . . . 0.0 109.045 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 46.8 t -51.9 -26.75 10.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.813 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.65 -59.4 3.63 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.597 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.458 HD13 ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -52.55 -47.41 48.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.428 ' OD1' ' OD2' ' A' ' 132' ' ' ASP . 48.6 t0 -54.16 -48.87 70.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.26 -1.337 . . . . 0.0 111.211 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 134' ' ' ALA . 91.1 mt-30 -71.85 -27.25 62.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.652 0.263 . . . . 0.0 111.197 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.9 mt -66.12 -19.14 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.9 t -112.54 -32.47 6.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.212 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.428 ' OD2' ' OD1' ' A' ' 128' ' ' ASP . 88.3 m-20 -84.14 -70.76 0.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.546 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 89.3 mttt -95.28 -71.42 0.67 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.845 0.355 . . . . 0.0 111.113 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 133' ' ' LYS . . . 72.55 -15.93 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.509 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 133' ' ' LYS . 96.5 mt-10 -105.85 -27.54 11.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.366 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 . . . . . 0 N--CA 1.464 0.238 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.568 -179.855 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.7 m120 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -59.84 -38.23 81.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.39 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 34' ' ' THR . 10.0 t -135.15 109.01 8.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -106.8 16.7 24.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.502 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.4 tp -61.57 -43.06 99.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.711 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -66.13 -44.19 84.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.551 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.49 ' O ' ' N ' ' A' ' 42' ' ' LYS . 27.5 ttt -57.8 -41.25 81.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.727 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -66.06 -38.76 89.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.712 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 tp -64.58 -45.25 87.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.077 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 42' ' ' LYS . 37.3 mttp -88.91 -23.67 22.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.242 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' MET . 11.9 pttm 30.92 69.32 0.1 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.686 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.81 156.61 68.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.688 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.41 -21.95 22.16 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.357 2.038 . . . . 0.0 112.538 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.428 HD11 ' CZ2' ' A' ' 62' ' ' TRP . 13.8 tp -70.93 -21.35 62.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.341 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.3 tpt -59.06 -33.17 70.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.419 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.67 -43.57 96.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.74 -52.15 58.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.862 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.8 -43.91 97.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.474 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.93 -40.44 60.83 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.786 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -74.52 -48.28 28.0 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.295 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.24 -33.11 67.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.059 0.456 . . . . 0.0 110.123 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -77.44 -44.28 29.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.643 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.7 -22.07 56.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.786 HG13 ' O ' ' A' ' 51' ' ' ALA . 16.0 m -85.41 -53.86 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.656 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.8 m-85 -125.8 1.61 7.42 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 60.35 37.24 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.018 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -122.42 -167.83 1.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.107 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.29 159.72 51.05 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.42 ' CG ' ' CZ2' ' A' ' 62' ' ' TRP . 94.4 Cg_endo -76.65 169.26 22.13 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 123.047 2.498 . . . . 0.0 111.967 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.95 111.94 17.68 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.541 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CZ2' HD11 ' A' ' 45' ' ' LEU . 6.7 m0 -109.89 155.13 22.1 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.191 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.31 131.65 3.37 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.28 111.97 24.19 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.476 ' O ' ' CB ' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -91.11 146.3 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.47 178.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -120.68 120.0 34.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.796 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 69' ' ' GLU . 4.7 mt -133.2 150.13 74.53 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.55 -7.16 1.23 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.476 1.451 . . . . 0.0 111.921 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -108.22 -7.18 16.05 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.787 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.21 -145.1 13.73 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.476 ' CB ' ' O ' ' A' ' 65' ' ' VAL . 6.9 p90 -141.87 151.92 43.14 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.116 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -120.27 114.96 22.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.047 0.451 . . . . 0.0 111.084 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.463 ' HG3' ' HB1' ' A' ' 92' ' ' ALA . 4.8 mmt -78.79 128.38 33.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -109.91 120.42 42.42 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.893 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -115.7 128.23 55.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.893 ' N ' HD12 ' A' ' 75' ' ' LEU . 7.6 mt -124.47 143.3 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 79' ' ' GLU . 6.5 tp -158.77 -149.83 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.2 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 80' ' ' ILE . 27.5 t-20 -48.01 83.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.555 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 77' ' ' LEU . 48.1 tt0 57.58 -1.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.033 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.468 ' H ' ' C ' ' A' ' 78' ' ' ASN . 62.8 mt -100.97 131.8 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.587 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.7 p -132.95 130.53 39.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 96' ' ' ALA . 4.1 m -138.01 162.4 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.153 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -134.07 145.75 49.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.014 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.74 106.02 0.5 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -86.86 140.29 29.82 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.33 -179.6 2.31 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.987 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.6 p -120.09 10.18 11.35 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.804 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.538 ' OG ' ' HB3' ' A' ' 91' ' ' ALA . 91.2 p -131.25 153.76 49.17 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -72.06 -50.47 28.08 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.965 0.412 . . . . 0.0 111.103 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -55.64 -44.42 77.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.371 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.538 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -73.17 -20.14 60.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.893 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.463 ' HB1' ' HG3' ' A' ' 73' ' ' MET . . . -64.39 -55.02 23.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.618 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -73.41 -42.29 62.27 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.763 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -53.19 -42.31 66.13 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.442 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.423 ' NZ ' ' HB1' ' A' ' 91' ' ' ALA . 18.9 mttt -72.99 -35.99 66.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.383 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.584 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -72.16 -52.85 14.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.28 -38.94 85.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.0 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -66.29 -49.04 78.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -54.7 -33.87 61.53 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.227 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -63.0 -56.97 12.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.241 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.49 HD13 HG13 ' A' ' 127' ' ' ILE . 11.5 mt -52.65 -35.67 55.38 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.301 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -59.76 -46.27 89.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.621 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -61.69 -28.62 69.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.528 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.87 -54.6 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.4 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.4 t -52.66 -41.32 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.76 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.55 -25.9 67.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 110.059 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -96.72 20.49 10.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.737 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.44 40.54 3.72 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.41 ' C ' ' N ' ' A' ' 111' ' ' GLU . 32.4 tttp -133.94 24.08 3.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -48.4 -19.29 0.3 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.066 0.46 . . . . 0.0 110.171 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 109' ' ' LYS . 82.6 mt-10 -75.65 25.03 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.48 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.507 HG13 ' H ' ' A' ' 113' ' ' PHE . 2.3 pt -48.96 -46.6 16.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.957 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.526 ' O ' ' CD2' ' A' ' 114' ' ' PHE . 44.7 p90 -121.75 11.47 10.46 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 113' ' ' PHE . 3.6 m-85 85.96 54.2 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.043 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.429 HD11 HD22 ' A' ' 101' ' ' LEU . 24.8 mt -63.29 122.29 74.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.46 128.39 14.43 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.372 1.381 . . . . 0.0 112.919 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.75 91.16 0.13 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 62.4 m -59.55 -38.43 81.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.437 ' H ' ' HB2' ' A' ' 122' ' ' GLU . 3.0 p -131.03 -172.68 2.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.792 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -67.42 -59.73 3.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.928 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -55.11 -24.5 26.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.93 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 119' ' ' THR . 73.7 mm-40 -68.63 -41.07 79.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.065 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.72 -52.43 30.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.761 0.315 . . . . 0.0 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.9 mp -55.91 -56.92 14.86 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.924 0.869 . . . . 0.0 108.717 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.2 t -51.7 -28.58 15.32 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.39 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.23 -50.29 74.24 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.849 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.588 ' N ' HD12 ' A' ' 127' ' ' ILE . 1.9 mp -58.62 -44.12 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-O 121.353 0.597 . . . . 0.0 109.7 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -53.13 -47.68 68.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.205 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 134' ' ' ALA . 79.2 mm-40 -71.57 -29.3 64.57 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.166 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 43.2 mt -64.26 -20.04 26.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.038 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.5 p -118.39 -24.98 6.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.437 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -87.71 -70.93 0.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.258 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 48.7 mttp -114.19 -63.15 1.49 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.796 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 133' ' ' LYS . . . 80.36 3.02 1.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.483 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -120.57 50.63 1.3 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.244 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.747 -179.86 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' ARG . 54.8 t30 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASN . 49.7 ttt180 -54.26 -35.28 62.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.349 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 34' ' ' THR . 4.4 t -92.5 65.06 4.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.48 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.27 18.02 10.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.493 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mt -72.19 -36.52 69.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.494 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -62.21 -48.09 81.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.392 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.43 ' O ' ' N ' ' A' ' 42' ' ' LYS . 24.7 ttp -57.99 -40.8 81.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.317 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -68.56 -22.95 64.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.583 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -48.1 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.869 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -88.44 -23.9 23.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.114 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 38' ' ' MET . 67.9 mttm 45.53 47.29 11.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.73 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.2 152.51 73.71 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.737 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.81 -17.32 22.9 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.645 2.23 . . . . 0.0 112.673 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.531 HD11 ' CZ2' ' A' ' 62' ' ' TRP . 19.0 tp -60.48 -22.15 63.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.864 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.5 ttp -63.43 -34.23 77.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.735 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.542 HG11 HD11 ' A' ' 101' ' ' LEU . 3.7 t -65.56 -30.79 51.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.257 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 75' ' ' LEU . 1.6 tp -75.54 -51.98 11.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.54 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -54.26 -37.76 65.06 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.283 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -77.23 -41.11 42.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.26 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.674 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -65.69 -48.71 71.12 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.117 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.67 -30.68 71.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 0.0 111.006 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 57' ' ' GLN . 29.1 ttpt -78.36 -57.82 3.58 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.005 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.29 -21.78 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 51' ' ' ALA . 23.8 m -86.13 -53.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.782 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.656 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.1 m-85 -125.72 -1.1 7.36 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 71.04 19.33 5.63 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.175 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -110.79 -167.95 1.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.08 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.15 162.3 42.42 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.008 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.04 169.13 22.73 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.991 2.461 . . . . 0.0 112.049 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.13 131.39 53.27 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.004 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.531 ' CZ2' HD11 ' A' ' 45' ' ' LEU . 5.7 m0 -120.74 141.06 50.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.798 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.67 128.98 4.65 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 p -96.87 119.36 35.2 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.895 0.378 . . . . 0.0 111.5 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.8 t -107.54 148.09 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.229 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -114.19 110.29 19.74 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.848 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.54 156.34 80.2 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -51.59 -15.64 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.614 1.542 . . . . 0.0 111.6 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.61 -17.62 31.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.842 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.42 -114.71 1.26 Allowed Glycine 0 C--N 1.33 0.205 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -133.16 136.49 45.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 65' ' ' VAL . 34.7 tt0 -120.38 118.59 30.76 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.5 mtt -93.38 134.4 35.66 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.332 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.5 p -107.96 128.16 54.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.806 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.43 ' CD1' HD21 ' A' ' 48' ' ' LEU . 10.0 tp -116.63 125.98 52.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.4 mt -120.52 133.16 68.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 120.905 0.383 . . . . 0.0 109.972 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' GLU . 13.0 mt -140.83 -165.56 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.607 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 80' ' ' ILE . 5.6 p30 -49.0 91.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.731 0.301 . . . . 0.0 111.116 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 77' ' ' LEU . 69.5 mm-40 60.43 -6.21 0.09 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.257 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.488 ' H ' ' C ' ' A' ' 78' ' ' ASN . 96.2 mt -99.15 130.6 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.031 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 81' ' ' THR . 12.6 t -132.43 129.39 39.21 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.4 m -141.78 162.79 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.243 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.76 162.84 40.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.194 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.63 149.17 20.98 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -106.75 138.49 42.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.684 0.278 . . . . 0.0 110.342 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.89 160.97 31.61 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.93 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.9 m -74.01 -26.77 60.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.702 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.4 p -117.97 155.49 30.17 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.446 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -37.24 66.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.272 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -59.79 -48.14 82.88 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.678 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.71 -22.44 61.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.262 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.81 76.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.998 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -74.17 -45.68 46.99 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.782 0.325 . . . . 0.0 111.035 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -52.8 -48.77 66.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.869 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -62.67 -35.04 78.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.583 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.34 -49.44 49.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.229 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.14 -31.91 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.103 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.21 -49.95 50.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.735 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -55.14 -33.17 62.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.311 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.43 ' CD1' ' C ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -63.33 -56.91 12.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.005 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.542 HD11 HG11 ' A' ' 47' ' ' VAL . 16.6 mt -52.07 -36.45 50.73 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.704 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -61.05 -45.63 93.96 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.61 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -62.76 -27.86 69.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.766 0.317 . . . . 0.0 111.241 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -64.61 -54.1 34.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.399 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.467 ' H ' HG23 ' A' ' 105' ' ' VAL . 1.4 t -53.9 -41.13 47.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.494 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -60.0 -28.15 67.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.28 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -97.33 20.33 11.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.211 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.85 44.19 5.53 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 111' ' ' GLU . 11.8 tttp -133.37 20.32 3.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.414 . . . . 0.0 110.182 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -48.53 -15.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.901 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 109' ' ' LYS . 90.4 mt-10 -79.71 22.9 0.45 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.622 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.929 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -50.98 -45.09 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.145 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.929 ' H ' HD12 ' A' ' 112' ' ' ILE . 2.0 p90 -118.32 -7.01 10.77 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.572 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 6.7 m-85 98.06 54.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.612 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.484 HD13 HG21 ' A' ' 127' ' ' ILE . 15.6 mt -62.6 114.82 13.27 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.491 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -50.72 128.62 24.62 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.304 1.336 . . . . 0.0 112.32 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.74 91.29 0.13 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 m -91.92 -30.05 16.34 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.9 m -140.65 162.99 34.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.422 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -53.37 -60.65 3.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.486 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -56.72 -25.74 55.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.493 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -72.14 -51.38 21.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.42 -51.46 69.75 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.559 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -62.83 -58.51 7.15 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.575 0.703 . . . . 0.0 110.396 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.3 m -52.15 -36.58 51.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.996 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -58.15 -55.74 31.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.365 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.484 HG21 HD13 ' A' ' 115' ' ' ILE . 27.1 pt -69.1 -34.2 62.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.068 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.438 ' O ' ' OD2' ' A' ' 132' ' ' ASP . 69.9 m-20 -61.8 -39.3 91.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.712 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -69.47 -25.21 63.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.742 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' A' ' 127' ' ' ILE . 67.0 mt -73.68 -23.98 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.064 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 133' ' ' LYS . 0.7 OUTLIER -105.02 -60.71 1.57 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.016 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.438 ' OD2' ' O ' ' A' ' 128' ' ' ASP . 1.7 p30 -72.03 15.37 0.16 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.749 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 131' ' ' SER . 23.9 tttp -39.56 -35.17 0.28 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.749 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 63.39 70.49 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.407 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -57.67 -31.32 66.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.658 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.514 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -119.08 -38.75 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.671 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.419 HG23 ' H ' ' A' ' 37' ' ' GLU . 10.0 t -135.64 159.97 39.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.575 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -66.2 -31.57 72.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.1 mt -55.28 -37.55 67.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.396 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.419 ' H ' HG23 ' A' ' 34' ' ' THR . 42.4 tp10 -60.32 -42.36 95.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.062 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.5 tpt -60.01 -39.0 84.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.535 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -67.34 -37.88 83.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.398 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' A' ' 42' ' ' LYS . 12.5 mt -71.49 -23.48 61.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.887 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.499 ' NZ ' ' OE1' ' A' ' 50' ' ' GLU . 60.7 mttm -69.17 13.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.194 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 40' ' ' LEU . 19.2 mttm -46.35 -25.42 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.0 155.81 41.04 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.641 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.5 -22.39 14.01 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.377 2.051 . . . . 0.0 112.399 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.703 HD22 HH11 ' A' ' 93' ' ' ARG . 24.9 tp -70.05 -25.36 63.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.519 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.1 mmt -64.64 -33.7 76.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.39 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 101' ' ' LEU . 2.1 t -63.98 -56.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.456 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.06 -51.31 64.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.269 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -54.81 -42.49 71.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.775 0.321 . . . . 0.0 111.139 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' OE1' ' NZ ' ' A' ' 41' ' ' LYS . 76.9 tt0 -71.77 -37.87 70.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.032 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.79 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -69.17 -47.35 65.19 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.72 -31.69 68.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.04 0.447 . . . . 0.0 110.301 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -77.12 -47.18 21.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.954 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.95 -21.13 59.36 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.79 HG13 ' O ' ' A' ' 51' ' ' ALA . 17.4 m -85.26 -53.81 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.239 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.649 ' N ' HG23 ' A' ' 55' ' ' VAL . 3.1 m-85 -126.08 -4.8 6.81 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.404 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 3.2 tp-100 71.96 19.89 4.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.67 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -111.02 -167.53 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.299 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.89 161.07 51.14 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.691 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.51 169.01 21.79 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.808 2.339 . . . . 0.0 111.462 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.09 117.07 26.24 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.944 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.598 ' CZ2' HD11 ' A' ' 45' ' ' LEU . 7.9 m0 -112.8 152.78 28.76 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.796 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.68 125.37 2.03 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 78.1 m -97.77 120.7 38.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.058 0.456 . . . . 0.0 111.281 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.548 ' HB ' HD21 ' A' ' 67' ' ' LEU . 1.8 t -107.59 150.63 10.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.365 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.913 ' C ' HD23 ' A' ' 67' ' ' LEU . 14.7 mp0 -119.76 114.21 21.8 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.913 HD23 ' C ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -127.27 160.63 58.92 Favored Pre-proline 0 C--N 1.345 0.403 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.08 -8.21 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.097 1.865 . . . . 0.0 111.234 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -99.65 -10.79 21.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.636 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.32 -120.72 1.83 Allowed Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 3.9 m-85 -141.71 145.09 34.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.643 ' HB2' HD11 ' A' ' 67' ' ' LEU . 60.5 tt0 -119.69 145.72 46.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 7.8 tpp -114.64 133.8 55.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.9 p -116.82 125.89 52.26 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 76' ' ' ILE . 6.7 tp -121.37 135.89 55.03 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 75' ' ' LEU . 3.3 mt -131.58 149.43 33.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 79' ' ' GLU . 35.8 tp -169.11 125.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.751 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 65.1 t30 58.78 -80.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.841 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -147.55 -0.62 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 110.533 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.1 mt -100.18 134.24 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.41 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.15 131.74 42.55 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 96' ' ' ALA . 10.5 m -137.34 162.35 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.13 0.49 . . . . 0.0 111.186 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -160.58 160.81 32.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.047 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.85 155.48 26.32 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.2 140.14 38.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.738 0.304 . . . . 0.0 110.231 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.65 165.51 25.68 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.763 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.4 p -104.14 -0.78 28.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 50.5 m -115.89 152.24 33.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.219 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -80.24 -51.21 9.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.247 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -59.64 -45.77 91.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.112 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.07 67.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.829 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -58.98 -42.75 90.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.434 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.703 HH11 HD22 ' A' ' 45' ' ' LEU . 38.4 ttm180 -73.99 -45.85 47.43 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.035 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 98' ' ' VAL . 94.0 mt-30 -53.59 -43.26 68.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.77 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -64.03 -36.23 83.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.675 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.57 -50.3 32.34 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.681 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.43 -41.39 89.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.451 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 94' ' ' GLN . 79.8 t -65.63 -46.14 90.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.812 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -55.08 -36.2 65.37 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.248 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -60.84 -58.34 8.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.68 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.615 HD22 HD11 ' A' ' 115' ' ' ILE . 19.0 mt -48.9 -36.22 16.66 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.672 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -61.83 -44.62 96.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.403 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -61.86 -27.7 68.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.894 0.378 . . . . 0.0 110.975 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.48 -54.41 26.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.682 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -53.66 -39.79 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.499 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -68.29 -22.9 64.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.462 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -97.25 14.17 26.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.63 40.16 47.36 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.179 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 111' ' ' GLU . 0.5 OUTLIER -133.62 26.48 4.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.815 0.34 . . . . 0.0 110.327 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -48.9 -16.86 0.14 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 109' ' ' LYS . 88.3 mt-10 -84.3 23.81 1.04 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.551 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.942 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -49.8 -45.02 21.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.863 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.942 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -118.73 -17.02 9.3 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.533 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 50.9 t80 110.77 52.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.7 1.25 . . . . 0.0 110.257 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.615 HD11 HD22 ' A' ' 101' ' ' LEU . 35.2 mt -62.49 112.69 6.98 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -51.45 128.56 26.18 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.27 1.314 . . . . 0.0 111.907 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.68 91.53 0.13 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.668 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.8 m -77.25 -38.07 51.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.88 170.56 13.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.449 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.45 -60.5 3.74 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.494 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.411 ' O ' ' OG ' ' A' ' 125' ' ' SER . 93.6 mt-10 -56.43 -24.53 45.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.984 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -69.92 -44.2 70.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.02 83.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.544 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 2.9 mp -66.22 -58.98 4.2 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.906 0.86 . . . . 0.0 109.964 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 91.0 p -52.86 -38.35 61.43 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.804 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -57.54 -58.74 6.96 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.774 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' ILE . 12.2 mt -54.78 -51.69 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.501 0.667 . . . . 0.0 110.1 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -47.15 -35.25 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.589 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -71.71 -27.41 63.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.773 0.32 . . . . 0.0 110.552 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 127' ' ' ILE . 56.4 mt -67.92 -28.66 42.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.2 p -92.8 -27.29 17.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.564 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -65.39 -31.87 73.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.565 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -62.34 -12.67 22.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.817 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.42 -68.11 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.666 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -170.98 63.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.538 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.554 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' THR . 32.5 p-10 . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 48.62 -90.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.639 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 32' ' ' ASN . 49.1 m -73.43 131.14 41.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.552 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -71.56 -33.01 68.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.737 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.41 ' H ' HG22 ' A' ' 34' ' ' THR . 5.8 tp -55.51 -40.18 71.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.585 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -61.73 -42.52 99.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.407 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.4 tpp -58.8 -29.24 66.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 0.0 110.454 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -76.63 -33.45 58.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.105 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 42' ' ' LYS . 2.0 mm? -81.73 -6.98 59.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.702 0.287 . . . . 0.0 111.283 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.31 14.12 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.994 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 40' ' ' LEU . 46.2 mttt -47.98 -58.17 4.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.176 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -86.13 157.74 56.33 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.908 -179.192 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.14 -18.71 18.21 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.615 2.21 . . . . 0.0 112.53 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 45' ' ' LEU . 15.5 tp -71.39 -21.99 61.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.332 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.1 tpt -62.39 -34.32 76.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.112 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.407 HG11 HD11 ' A' ' 101' ' ' LEU . 2.1 t -68.51 -50.65 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.428 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.611 HD11 HD22 ' A' ' 77' ' ' LEU . 4.8 tp -56.07 -52.17 65.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.434 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -60.65 -43.97 96.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 111.557 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.42 -33.84 73.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.048 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.756 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -74.48 -47.68 31.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.26 72.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.993 0.425 . . . . 0.0 109.915 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -77.36 -44.45 29.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.949 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.79 -21.82 57.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 51' ' ' ALA . 19.6 m -85.51 -53.86 9.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.659 ' N ' HG23 ' A' ' 55' ' ' VAL . 3.2 m-85 -125.68 -2.45 7.29 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.688 -0.405 . . . . 0.0 112.035 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 67.22 23.39 9.44 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.348 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -108.93 176.7 5.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.346 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.51 159.42 32.28 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.985 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.31 169.55 19.93 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.054 2.503 . . . . 0.0 111.983 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.05 119.79 33.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.76 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -114.19 150.89 33.56 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.45 130.39 3.93 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 64' ' ' THR . 9.6 t -100.38 115.4 29.92 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 111.33 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.9 t -106.06 148.29 10.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.267 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.31 111.42 21.46 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.896 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.8 156.23 80.31 Favored Pre-proline 0 N--CA 1.456 -0.153 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.232 -178.224 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -51.78 -16.1 3.65 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.516 1.477 . . . . 0.0 111.625 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.07 -15.46 33.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.788 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.35 -116.87 1.51 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -134.0 135.78 43.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.7 tt0 -117.95 121.22 40.12 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.404 ' HB2' ' HB1' ' A' ' 92' ' ' ALA . 44.7 tpp -93.47 130.04 39.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.82 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.2 m -107.63 126.05 52.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.924 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -119.07 130.52 55.66 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.306 0.379 . . . . 0.0 110.203 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.924 ' N ' HD12 ' A' ' 75' ' ' LEU . 45.8 mt -123.22 138.04 54.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.073 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.611 HD22 HD11 ' A' ' 48' ' ' LEU . 5.1 tp -150.22 -154.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.464 ' C ' ' H ' ' A' ' 80' ' ' ILE . 19.9 p-10 -48.52 83.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.775 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 77' ' ' LEU . 5.9 tp10 60.86 -3.33 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.85 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.464 ' H ' ' C ' ' A' ' 78' ' ' ASN . 71.8 mt -102.67 131.84 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.078 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 p -132.58 132.49 42.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.7 m -141.65 160.97 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.464 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -134.54 150.0 50.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.989 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -142.78 133.19 5.43 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -102.74 137.81 40.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.83 164.08 36.08 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.978 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 74.0 p -87.18 -10.88 51.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.364 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.3 m -128.56 155.53 44.76 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.227 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.563 ' H ' ' CD ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -70.31 -42.13 72.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -57.43 -47.93 80.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.98 62.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.696 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 73' ' ' MET . . . -66.93 -46.5 74.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -73.33 -43.1 61.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.725 0.297 . . . . 0.0 111.524 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -52.27 -45.03 65.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.278 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -70.34 -34.92 73.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 111.166 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.554 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -67.65 -48.15 67.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.339 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.17 82.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.338 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.91 -50.67 76.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.676 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -55.35 -37.82 67.97 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.678 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -55.0 40.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.369 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 115' ' ' ILE . 13.2 mt -50.4 -35.41 28.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.255 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.515 ' NH1' ' OE2' ' A' ' 106' ' ' GLU . 64.9 ttp85 -62.18 -47.04 86.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.441 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -27.54 65.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.673 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.56 -54.49 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.683 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.489 ' H ' HG23 ' A' ' 105' ' ' VAL . 1.7 t -52.4 -40.77 33.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.567 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.515 ' OE2' ' NH1' ' A' ' 102' ' ' ARG . 97.9 mt-10 -66.25 -24.96 66.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.107 0.48 . . . . 0.0 109.787 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -93.77 19.72 8.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.419 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.7 38.92 2.44 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.417 ' C ' ' N ' ' A' ' 111' ' ' GLU . 9.3 tptp -132.91 25.1 4.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.534 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -48.82 -15.77 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.611 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.417 ' N ' ' C ' ' A' ' 109' ' ' LYS . 77.0 mm-40 -80.04 23.5 0.46 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.113 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.911 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -50.04 -44.53 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.518 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.911 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.3 p90 -118.15 -19.88 8.86 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.538 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 68.7 t80 116.87 51.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.799 1.312 . . . . 0.0 109.583 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.534 HD11 HD22 ' A' ' 101' ' ' LEU . 22.8 mt -62.75 121.0 65.27 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.48 128.87 13.14 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.552 1.501 . . . . 0.0 112.701 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.32 91.31 0.13 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 64.5 p -61.49 -34.51 75.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.113 0.482 . . . . 0.0 109.723 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.421 ' H ' ' HB3' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -135.81 172.05 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.895 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -57.15 -59.8 4.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.211 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -56.09 -25.19 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.529 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.421 ' HB3' ' H ' ' A' ' 119' ' ' THR . 17.9 tp10 -69.58 -47.97 61.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.844 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.13 74.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.236 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.542 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.2 mp -65.16 -58.24 6.52 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.912 0.863 . . . . 0.0 109.884 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 44.8 m -53.07 -36.57 60.8 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.0 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -63.13 -59.53 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.673 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.5 HG21 HD13 ' A' ' 115' ' ' ILE . 40.3 pt -60.47 -35.0 60.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.375 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -61.98 -33.23 73.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.891 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -71.0 -25.75 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.538 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 58.2 mt -70.19 -30.09 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.7 p -93.02 -35.35 13.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.826 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -87.9 14.46 8.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.715 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.632 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 13.1 tptt -52.4 -29.52 24.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.591 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 133' ' ' LYS . . . 79.72 77.39 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.299 0.571 . . . . 0.0 110.654 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -62.66 -31.31 72.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.589 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.672 179.91 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.75 HD21 ' N ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -56.39 -41.37 76.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.778 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.3 p -64.95 147.92 52.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.613 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -110.52 -40.45 4.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.887 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 36' ' ' LEU . 9.9 mp -71.29 -45.04 64.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.871 0.367 . . . . 0.0 110.636 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -64.54 -26.13 68.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.671 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 40.7 ttm -70.89 -41.7 70.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.373 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -64.77 -45.51 86.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.465 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.9 mt -67.27 -37.46 83.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.772 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -87.71 11.2 15.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.945 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -66.19 80.42 0.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.434 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.52 156.81 42.15 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.951 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.4 -44.06 7.16 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.261 1.974 . . . . 0.0 112.762 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.08 -23.47 62.13 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.31 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.0 mmt -65.75 -34.5 78.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.972 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.617 HG11 HD11 ' A' ' 101' ' ' LEU . 1.8 t -68.21 -43.53 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.468 HD12 ' CE2' ' A' ' 100' ' ' TYR . 4.7 tp -61.3 -52.05 66.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.167 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -56.34 -53.33 58.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.865 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -61.97 -35.68 79.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.044 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.742 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -68.65 -47.37 66.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.997 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.78 -31.37 72.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.039 0.447 . . . . 0.0 109.892 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -77.26 -45.68 25.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.456 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.15 -21.79 58.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 51' ' ' ALA . 19.4 m -85.61 -53.3 10.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.648 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.1 m-85 -125.15 -1.31 7.71 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.5 41.14 7.65 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.168 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -127.89 -179.12 4.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.09 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.54 156.86 39.75 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.95 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 168.59 23.69 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.68 2.254 . . . . 0.0 112.059 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.1 117.26 28.26 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.918 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -114.85 140.63 48.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.8 121.76 1.99 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 m -97.35 112.21 24.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.115 0.483 . . . . 0.0 111.462 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 t -93.16 147.77 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.826 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -122.98 118.81 28.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.572 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 69' ' ' GLU . 4.4 mt -133.41 149.61 72.83 Favored Pre-proline 0 CA--C 1.529 0.16 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.29 -7.15 1.72 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.316 1.344 . . . . 0.0 110.953 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 67' ' ' LEU . 80.3 mm-40 -105.17 -11.48 16.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.776 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.17 -150.28 22.53 Favored Glycine 0 C--N 1.332 0.352 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 14.4 m-85 -129.07 147.63 50.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.88 0.34 . . . . 0.0 110.262 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -118.07 112.72 20.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.031 0.444 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -84.63 129.54 34.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.0 p -113.79 129.77 56.54 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.145 0.278 . . . . 0.0 110.766 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -122.01 126.82 49.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.871 ' N ' HD12 ' A' ' 75' ' ' LEU . 7.2 mt -121.66 132.66 70.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 79' ' ' GLU . 3.2 tp -147.74 -159.41 1.02 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.685 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 80' ' ' ILE . 2.9 p30 -46.15 84.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.877 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 77' ' ' LEU . 17.5 tp10 61.27 -7.14 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.904 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.505 ' H ' ' C ' ' A' ' 78' ' ' ASN . 73.0 mt -99.5 128.37 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.009 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 p -132.64 128.03 36.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 96' ' ' ALA . 2.7 m -141.2 167.05 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.193 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -162.76 168.75 21.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.071 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.36 163.08 33.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.507 ' H ' ' CD ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -109.25 138.69 45.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.836 0.35 . . . . 0.0 110.292 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.0 161.51 39.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.715 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.9 p -97.15 -1.01 45.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.996 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.4 m -130.86 151.92 50.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.077 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -71.95 -39.71 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 0.0 111.28 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -57.92 -47.74 81.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.344 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.13 -20.03 59.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.086 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.38 -53.55 46.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.403 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -72.93 -44.28 61.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.573 0.225 . . . . 0.0 111.152 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -53.06 -47.21 68.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.807 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -63.43 -34.99 78.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.794 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.481 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.73 -50.37 30.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.168 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.59 76.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.45 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.52 -48.96 69.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.503 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -54.25 -34.99 62.01 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.279 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.49 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.58 -57.97 8.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.548 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.617 HD11 HG11 ' A' ' 47' ' ' VAL . 13.8 mt -47.94 -37.93 15.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.184 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -60.79 -44.95 96.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.428 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -60.17 -27.72 67.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.02 0.438 . . . . 0.0 110.91 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -68.81 -53.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.615 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 101' ' ' LEU . 2.0 t -54.84 -41.37 56.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.697 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -62.85 -27.5 69.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 109.865 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -94.15 20.34 8.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.709 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.53 38.96 5.59 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.414 ' C ' ' N ' ' A' ' 111' ' ' GLU . 2.6 tptm -133.73 25.59 4.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.734 0.302 . . . . 0.0 110.897 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.409 ' C ' ' H ' ' A' ' 112' ' ' ILE . 8.2 p80 -49.29 -16.06 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.797 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 109' ' ' LYS . 6.1 pt-20 -75.4 23.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.444 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.95 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -49.95 -44.36 21.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.844 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.95 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.4 p90 -117.48 -19.59 9.41 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' A' ' 114' ' ' PHE . 75.8 t80 118.03 50.05 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.888 1.367 . . . . 0.0 109.543 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.567 HD13 HG21 ' A' ' 127' ' ' ILE . 25.0 mt -62.33 113.4 8.67 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.29 129.26 10.22 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.765 1.643 . . . . 0.0 113.024 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.15 90.67 0.13 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 69.7 m -58.1 -37.02 73.73 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.76 161.46 27.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.84 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -53.8 -59.54 4.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.864 0.364 . . . . 0.0 110.47 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.69 -24.56 49.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.7 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -71.84 -44.77 63.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.013 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.83 -51.17 71.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.092 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.554 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -63.4 -56.76 13.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.019 0.914 . . . . 0.0 109.393 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.1 t -52.11 -37.73 55.08 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.155 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -62.77 -57.59 10.41 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.545 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.567 HG21 HD13 ' A' ' 115' ' ' ILE . 38.5 pt -59.46 -33.99 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 0.0 110.493 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -72.96 -32.59 65.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.85 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -70.02 -25.67 63.69 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.5 pt -90.45 -18.93 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.154 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.0 m -94.83 -53.45 3.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 134' ' ' ALA . 56.4 t0 -87.5 15.21 6.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -40.79 -28.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 132' ' ' ASP . . . -105.89 -90.92 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.765 0.317 . . . . 0.0 110.39 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -172.48 -78.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.48 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.197 179.802 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -67.09 -28.7 68.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.861 0.363 . . . . 0.0 110.333 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 t -84.31 33.64 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.823 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -81.82 3.2 26.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.475 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.51 -38.19 77.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.107 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.03 -40.41 68.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.528 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.513 ' O ' ' N ' ' A' ' 42' ' ' LYS . 35.3 ttm -57.95 -38.12 75.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.581 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -68.76 -49.25 60.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.636 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.2 tp -61.77 -39.22 90.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.701 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.4 -23.29 23.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.937 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 38' ' ' MET . 22.1 tttp 51.07 64.44 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.871 -0.331 . . . . 0.0 110.135 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 94.1 m -124.47 84.11 57.14 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.866 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.45 -24.58 16.77 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.413 2.075 . . . . 0.0 112.047 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -61.67 -20.34 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.204 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.1 tpt -58.79 -33.97 70.94 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 101' ' ' LEU . 2.1 t -58.76 -31.16 43.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 77' ' ' LEU . 3.6 tp -78.78 -51.85 9.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.479 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -60.07 -32.28 70.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -76.29 -43.01 43.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.336 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -71.35 -48.36 50.75 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.231 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.48 -32.2 68.55 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.312 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -78.02 -47.34 18.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.316 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.21 -20.66 60.82 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.855 -0.528 . . . . 0.0 112.387 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 51' ' ' ALA . 18.2 m -85.75 -52.94 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.16 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.645 ' CD1' ' ND2' ' A' ' 78' ' ' ASN . 0.7 OUTLIER -125.49 -7.42 6.91 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.034 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 6.9 tt0 75.27 19.96 2.13 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.308 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -115.28 173.91 6.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.134 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 161.95 21.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.743 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.37 168.74 22.6 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.793 2.328 . . . . 0.0 112.1 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.39 115.95 23.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.533 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -109.32 149.54 29.32 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.08 124.66 1.86 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.3 m -104.25 114.39 28.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.387 . . . . 0.0 111.825 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.567 ' HB ' HD21 ' A' ' 67' ' ' LEU . 2.0 t -97.93 151.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.488 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.92 ' C ' HD23 ' A' ' 67' ' ' LEU . 36.6 mt-10 -117.2 113.42 22.2 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.92 HD23 ' C ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -129.64 158.44 73.51 Favored Pre-proline 0 C--N 1.347 0.469 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.24 -15.59 8.35 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.93 1.753 . . . . 0.0 111.818 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -96.57 -10.98 26.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.558 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.83 -125.97 2.99 Favored Glycine 0 C--N 1.329 0.16 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 16.0 m-85 -138.52 145.23 40.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HB2' HD11 ' A' ' 67' ' ' LEU . 82.8 tt0 -110.2 129.32 55.74 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.202 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 2.0 mpp? -92.09 133.38 35.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.988 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 m -119.19 118.84 32.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 76' ' ' ILE . 11.5 tp -120.63 130.88 54.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 75' ' ' LEU . 26.5 mt -127.33 135.23 63.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 48' ' ' LEU . 13.8 mt -141.51 101.08 3.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.144 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.645 ' ND2' ' CD1' ' A' ' 56' ' ' TYR . 4.5 m120 57.86 -82.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.239 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 77' ' ' LEU . 6.8 tp10 -125.5 -10.51 6.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.399 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.6 mt -94.59 130.35 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.613 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.4 p -132.17 131.34 42.12 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 100' ' ' TYR . 9.0 m -136.46 158.86 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.028 0.442 . . . . 0.0 110.932 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -162.24 166.41 25.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.785 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.504 ' O ' ' SD ' ' A' ' 73' ' ' MET . . . -169.28 177.97 42.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -106.63 135.11 48.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.585 0.231 . . . . 0.0 110.435 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -149.96 160.16 43.82 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.957 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.9 p -118.77 9.39 12.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.566 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.669 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 48.4 t -128.33 154.73 45.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.26 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -80.69 -53.62 6.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.958 0.409 . . . . 0.0 111.385 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -59.76 -44.31 93.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.553 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 88' ' ' SER . . . -74.09 -20.99 60.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.344 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -66.11 -49.89 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.496 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -73.15 -43.62 61.25 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.304 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.504 ' O ' HG23 ' A' ' 98' ' ' VAL . 98.1 mt-30 -56.8 -48.01 78.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.251 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -62.12 -34.64 76.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.003 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.24 -50.83 43.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.856 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.95 -30.08 63.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 94' ' ' GLN . 54.3 t -68.03 -51.59 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.205 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.93 -34.84 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.855 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.405 ' HA ' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -58.57 -56.78 17.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.247 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.642 HD22 HD11 ' A' ' 115' ' ' ILE . 31.6 mt -51.36 -37.02 45.8 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 123.6 0.563 . . . . 0.0 111.907 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -61.34 -47.04 87.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.721 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -60.64 -28.12 68.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.349 . . . . 0.0 110.611 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 104' ' ' VAL . 3.2 t -62.3 -53.21 50.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.808 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.482 HG13 ' CD2' ' A' ' 110' ' ' HIS . 1.5 t -52.87 -37.17 25.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.581 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -71.47 -24.8 62.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -95.97 19.78 11.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.297 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.62 39.2 2.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -130.86 30.95 4.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.062 0.458 . . . . 0.0 110.011 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.482 ' CD2' HG13 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -48.86 -15.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.286 -179.402 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -83.37 23.47 0.91 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.926 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.5 pp -50.22 -47.54 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.02 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.926 ' H ' HD12 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -120.23 -16.89 8.42 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.595 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.535 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 34.9 t80 105.28 57.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.468 1.105 . . . . 0.0 110.277 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.642 HD11 HD22 ' A' ' 101' ' ' LEU . 22.3 mt -64.41 114.1 13.0 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.659 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -51.35 130.33 32.3 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.447 1.431 . . . . 0.0 112.017 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.47 94.72 0.15 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.783 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.432 ' H ' ' HG2' ' A' ' 122' ' ' GLU . 20.8 m -78.4 -35.23 47.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.168 0.508 . . . . 0.0 109.713 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.517 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -136.22 175.93 9.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.617 179.26 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.78 -60.18 4.25 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.338 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.415 ' O ' ' OG ' ' A' ' 125' ' ' SER . 94.5 mt-10 -58.87 -25.15 63.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.476 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.517 ' CB ' ' H ' ' A' ' 119' ' ' THR . 17.4 tp10 -62.05 -47.69 83.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.706 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.78 -49.49 74.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.986 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.553 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.5 mp -63.19 -58.04 8.53 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 109.568 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 27.4 m -52.49 -36.51 55.25 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.996 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -61.91 -58.64 7.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.612 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.532 ' HA ' HD12 ' A' ' 130' ' ' ILE . 18.7 pt -66.11 -35.69 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.782 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -58.58 -40.29 82.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -72.47 -25.97 61.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.178 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 127' ' ' ILE . 53.8 mt -68.77 -23.92 28.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m -103.22 -35.77 8.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.767 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -69.18 -68.08 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 48.3 mttt -126.08 -70.79 0.72 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.995 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 133' ' ' LYS . . . 74.68 10.8 3.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.397 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -74.13 -40.4 62.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.007 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.436 -179.823 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.493 1.449 0 CA-C-O 120.855 0.273 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.453 HD13 ' HD2' ' A' ' 93' ' ' ARG . 24.7 tp -65.3 -23.09 66.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.569 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.4 tpt -62.25 -34.85 77.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.351 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.667 HG11 HD11 ' A' ' 101' ' ' LEU . 2.9 t -68.21 -35.77 72.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.982 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 77' ' ' LEU . 6.8 tp -69.94 -51.74 30.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.206 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -52.8 -40.14 62.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.599 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.32 -32.56 58.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.124 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.676 ' O ' HG22 ' A' ' 55' ' ' VAL . . . -71.07 -48.74 50.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.179 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.28 -31.56 72.44 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.914 0.388 . . . . 0.0 110.667 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 57' ' ' GLN . 62.4 mttm -78.67 -57.19 3.89 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.42 -21.47 64.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 51' ' ' ALA . 25.5 m -86.02 -53.67 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.823 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.648 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.6 m-85 -126.38 4.65 6.96 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 53' ' ' LYS . 88.9 mm-40 59.42 32.76 22.01 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.579 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -125.53 151.37 46.44 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.325 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.04 156.05 74.67 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.953 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.06 168.7 24.15 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.901 2.401 . . . . 0.0 112.107 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.73 124.9 44.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.806 0.336 . . . . 0.0 111.257 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -117.36 152.62 34.56 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.872 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.88 129.78 3.65 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.1 m -102.65 118.72 37.46 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.058 0.456 . . . . 0.0 111.435 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.8 t -108.64 148.34 12.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.276 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 66' ' ' GLU . 4.3 pt-20 -114.81 110.01 19.05 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.881 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -133.17 158.66 75.22 Favored Pre-proline 0 CA--C 1.529 0.16 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -52.25 -20.19 10.71 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.481 1.454 . . . . 0.0 111.331 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -81.16 -19.94 42.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.123 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.64 -114.73 1.25 Allowed Glycine 0 C--N 1.33 0.23 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -133.03 136.5 46.02 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 65' ' ' VAL . 71.9 tt0 -117.12 128.11 54.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.135 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 3.4 tpt -96.8 128.62 43.93 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.661 -0.415 . . . . 0.0 109.988 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 m -107.49 120.27 41.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.7 tp -113.39 128.03 56.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 mp -123.51 133.53 68.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 48' ' ' LEU . 20.6 mt -139.93 88.71 2.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.334 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 56.87 -83.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.627 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 77' ' ' LEU . 91.3 mt-10 -111.44 -17.07 13.18 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.5 mt -98.44 128.11 50.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.275 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 81' ' ' THR . 13.3 t -132.52 131.53 41.69 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -137.26 153.96 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.325 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -134.45 149.47 50.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.854 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.61 142.41 9.93 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -104.87 138.09 41.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.303 . . . . 0.0 110.402 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.73 166.16 34.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.669 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 t -101.0 0.2 37.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.812 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.615 ' OG ' ' HB3' ' A' ' 91' ' ' ALA . 92.6 p -130.82 157.97 41.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.763 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -76.13 -45.64 32.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.974 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -61.79 -46.88 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.387 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.615 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -74.68 -21.18 59.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.162 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -66.22 -48.68 69.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.275 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.453 ' HD2' HD13 ' A' ' 45' ' ' LEU . 55.9 ttp180 -73.1 -43.14 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.757 0.313 . . . . 0.0 111.217 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.576 ' O ' HG23 ' A' ' 98' ' ' VAL . 56.0 tt0 -53.17 -45.7 68.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.961 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -65.82 -36.47 83.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.82 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.53 -51.16 38.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.242 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.73 -30.1 60.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.735 0.302 . . . . 0.0 111.32 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 94' ' ' GLN . 73.2 t -72.06 -47.48 54.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.486 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -55.63 -35.14 65.58 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.155 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -63.58 -58.06 8.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.103 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.667 HD11 HG11 ' A' ' 47' ' ' VAL . 14.4 mt -48.79 -39.25 24.54 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.564 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -60.14 -45.14 94.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.763 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.92 -29.09 68.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.97 0.414 . . . . 0.0 110.782 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.458 HG12 ' C ' ' A' ' 109' ' ' LYS . 2.2 t -64.98 -54.52 28.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.757 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 105' ' ' VAL . 1.1 t -54.05 -37.15 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.83 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -62.1 -32.89 73.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.332 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -96.64 20.93 10.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.806 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.72 49.43 8.86 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.458 ' C ' HG12 ' A' ' 104' ' ' VAL . 9.8 mtpm? -133.23 23.45 4.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.375 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -48.85 -17.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.77 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.408 ' N ' ' C ' ' A' ' 109' ' ' LYS . 83.8 mt-10 -79.13 23.34 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.563 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 1.012 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -50.34 -44.73 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.71 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 1.012 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.9 p90 -117.77 -19.54 9.24 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.536 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 70.4 t80 118.66 48.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.85 1.344 . . . . 0.0 110.285 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.497 HD11 HD22 ' A' ' 101' ' ' LEU . 52.5 mt -62.32 113.01 7.47 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.61 128.99 10.6 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.627 1.551 . . . . 0.0 113.252 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.1 90.97 0.13 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.412 ' CB ' ' OE1' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -56.53 -28.75 60.75 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.448 ' H ' ' HB2' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -135.19 -179.31 5.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.887 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -64.82 -59.7 3.91 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.622 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -56.75 -26.56 57.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.194 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.448 ' HB2' ' H ' ' A' ' 119' ' ' THR . 69.3 mt-10 -66.72 -42.58 86.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.68 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.33 79.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.551 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.534 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 3.0 mp -65.88 -58.7 4.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.991 0.901 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.7 m -52.73 -41.35 63.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.95 -1.477 . . . . 0.0 111.05 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -55.52 -58.52 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.481 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 mt -55.79 -50.92 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.445 0.641 . . . . 0.0 109.898 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -46.84 -37.4 8.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.9 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -71.74 -26.96 62.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.542 0.21 . . . . 0.0 111.005 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.9 -25.47 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.453 ' OG ' ' NE2' ' A' ' 94' ' ' GLN . 31.2 t . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.66 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.492 1.423 0 CA-C-O 120.899 0.291 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.446 HD21 ' CZ2' ' A' ' 62' ' ' TRP . 16.6 tp -71.44 -20.55 62.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.424 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 tpt -58.46 -33.16 69.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.939 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.586 HG11 HD11 ' A' ' 101' ' ' LEU . 1.5 t -63.58 -54.99 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.439 ' N ' HG12 ' A' ' 47' ' ' VAL . 7.4 tp -57.87 -52.3 66.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.955 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -54.4 -51.03 66.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.418 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -65.67 -32.51 74.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.086 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.703 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -70.62 -47.08 61.91 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.244 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 -33.91 69.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.859 0.362 . . . . 0.0 110.717 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.51 -47.21 27.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.111 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 -20.99 59.43 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 51' ' ' ALA . 20.8 m -85.62 -53.86 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.533 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.629 ' N ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -125.85 -3.51 7.1 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 71.1 20.8 5.07 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.828 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -109.51 -173.76 2.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.311 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.5 156.24 58.44 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.522 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 168.66 24.21 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 112.305 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.14 118.67 31.16 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.31 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.446 ' CZ2' HD21 ' A' ' 45' ' ' LEU . 8.7 m0 -110.5 137.84 47.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.285 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.5 129.33 4.99 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.2 m -99.95 118.16 35.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.369 . . . . 0.0 111.541 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 72' ' ' GLU . 3.3 t -104.93 148.4 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.831 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -113.71 109.95 19.41 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.864 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.29 155.31 81.44 Favored Pre-proline 0 C--O 1.227 -0.127 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.38 -7.25 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.851 1.701 . . . . 0.0 111.531 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.488 ' OE2' ' NE2' ' A' ' 85' ' ' GLN . 75.1 tt0 -94.72 -17.35 22.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.916 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.99 -117.77 1.61 Allowed Glycine 0 C--N 1.333 0.365 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -132.12 137.61 47.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.8 tt0 -118.44 121.8 41.2 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.8 mtt -93.13 133.08 36.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.491 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.4 m -111.98 123.58 50.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.9 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.864 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -114.76 126.09 54.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.006 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.864 ' N ' HD12 ' A' ' 75' ' ' LEU . 32.6 mm -118.02 131.66 70.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 tp -175.38 136.29 0.35 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.591 0.557 . . . . 0.0 110.904 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.6 t30 54.24 35.31 22.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.339 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 68.52 6.13 5.24 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.286 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.476 HG21 ' HB2' ' A' ' 103' ' ' LYS . 25.4 mt -99.27 137.72 25.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.01 129.65 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.498 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 96' ' ' ALA . 11.7 m -132.68 161.47 41.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.87 0.367 . . . . 0.0 110.815 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -129.9 139.66 51.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.935 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.16 108.09 0.73 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.488 ' NE2' ' OE2' ' A' ' 69' ' ' GLU . 11.3 pt20 -91.91 136.36 33.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.444 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.53 171.98 16.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.674 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.47 -7.48 47.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.367 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.0 p -129.21 152.84 48.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.205 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -71.85 -42.77 66.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.274 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -60.0 -47.74 84.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.307 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.54 -25.63 62.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.975 0.417 . . . . 0.0 110.707 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.06 -35.04 73.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.053 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.414 ' HD3' HD22 ' A' ' 45' ' ' LEU . 40.2 ttm180 -74.26 -46.61 40.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.046 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.526 ' O ' HG23 ' A' ' 98' ' ' VAL . 7.5 tt0 -53.07 -47.51 68.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.915 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -64.99 -32.28 73.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.723 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.571 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.21 -51.95 21.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.926 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.25 -31.11 69.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.043 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 94' ' ' GLN . 45.4 t -71.26 -51.42 34.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.932 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -55.55 -34.35 64.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.03 0.443 . . . . 0.0 110.352 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.28 -55.54 27.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.512 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.639 HD22 HD11 ' A' ' 115' ' ' ILE . 18.1 mt -50.59 -36.19 33.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.633 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -62.75 -45.21 93.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.499 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.476 ' HB2' HG21 ' A' ' 80' ' ' ILE . 16.7 mmtt -60.37 -28.02 67.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 110.951 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.417 HG23 ' H ' ' A' ' 104' ' ' VAL . 2.1 t -65.92 -53.65 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.243 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.5 t -55.39 -37.51 44.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.602 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.53 -28.76 69.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.553 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -96.73 20.04 11.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.615 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 45.58 44.81 12.03 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.41 ' C ' HG12 ' A' ' 104' ' ' VAL . 3.1 mmtp -133.12 23.93 4.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.707 0.289 . . . . 0.0 110.549 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -50.76 -15.75 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -79.87 22.53 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.293 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.951 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -50.93 -45.86 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.431 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.951 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -118.26 -20.29 8.62 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.538 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 72.3 t80 117.27 51.31 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.871 1.357 . . . . 0.0 109.874 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.639 HD11 HD22 ' A' ' 101' ' ' LEU . 21.5 mt -62.85 118.17 39.46 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.23 128.05 12.56 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.336 1.357 . . . . 0.0 112.62 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 123' ' ' ALA . . . -153.88 94.55 0.15 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.0 m -49.28 -38.24 26.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.149 0.5 . . . . 0.0 109.701 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.484 ' H ' ' HB3' ' A' ' 122' ' ' GLU . 11.4 p -133.46 176.08 8.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.877 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -54.69 -57.25 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.832 0.348 . . . . 0.0 110.623 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.424 ' O ' ' OG ' ' A' ' 125' ' ' SER . 95.5 mt-10 -61.76 -34.7 76.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.275 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.484 ' HB3' ' H ' ' A' ' 119' ' ' THR . 13.0 tp10 -63.34 -31.63 72.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.673 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.486 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . . . -76.28 -53.74 7.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.023 0.439 . . . . 0.0 111.144 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.692 ' C ' HD12 ' A' ' 124' ' ' LEU . 4.1 pp -66.95 -26.12 66.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.861 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.575 ' N ' HD12 ' A' ' 124' ' ' LEU . 71.9 m -76.31 -28.85 57.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.947 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -65.05 -51.03 63.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.028 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.5 ' HA ' HD12 ' A' ' 130' ' ' ILE . 10.4 pt -59.14 -35.48 57.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.923 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -61.71 -41.14 97.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.295 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -71.75 -26.08 62.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.612 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 127' ' ' ILE . 69.7 mt -69.22 -23.63 27.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.033 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.4 p . . . . . 0 C--N 1.331 -0.196 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 -179.855 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo . . . . . 0 N--CA 1.497 1.678 0 N-CA-C 112.758 0.253 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tp -71.93 -19.89 61.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 62.4 mtp -58.58 -33.11 69.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.867 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 101' ' ' LEU . 1.8 t -58.73 -57.33 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.453 ' N ' HG12 ' A' ' 47' ' ' VAL . 8.3 tp -58.04 -51.72 68.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.674 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -57.99 -40.83 81.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 111.041 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -70.76 -35.74 72.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.962 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.716 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -72.8 -47.56 45.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.017 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.0 70.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.092 0.473 . . . . 0.0 110.36 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -74.83 -45.01 46.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.753 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.47 -22.13 54.94 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 51' ' ' ALA . 21.1 m -85.86 -53.73 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.708 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.627 ' N ' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -124.92 -7.69 7.24 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.737 -178.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER 73.24 19.81 3.45 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.876 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -110.07 149.65 29.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.455 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 p -81.87 152.37 68.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.869 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.22 169.8 21.74 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.849 2.366 . . . . 0.0 111.63 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.54 123.26 42.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.398 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -126.05 148.16 49.39 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.623 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.49 135.58 5.53 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.9 m -102.65 121.88 43.3 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.828 0.346 . . . . 0.0 111.343 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.8 t -107.76 148.92 11.51 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.439 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -114.48 112.67 23.35 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.882 ' N ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -133.0 158.2 76.46 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -52.02 -21.67 12.87 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.548 1.498 . . . . 0.0 111.502 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' OE1' ' OE1' ' A' ' 85' ' ' GLN . 57.3 mt-10 -82.78 -17.15 45.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.537 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.18 -115.72 1.35 Allowed Glycine 0 C--N 1.331 0.304 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -132.86 136.94 46.52 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -117.28 121.65 41.75 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.5 mmt -93.3 133.3 36.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.945 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.1 m -116.63 130.07 56.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.783 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.954 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -127.01 132.14 50.83 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.173 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.954 ' N ' HD12 ' A' ' 75' ' ' LEU . 28.8 mt -128.38 148.98 32.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.4 tp -172.0 128.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.367 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 34.9 t30 55.78 -92.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.292 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -136.29 1.9 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.143 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 53.0 mt -96.96 128.85 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.878 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 81' ' ' THR . 6.2 t -132.32 126.88 34.35 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.553 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.1 m -137.73 164.11 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.292 0.568 . . . . 0.0 110.97 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -165.35 163.9 19.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.691 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.82 166.9 35.71 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.421 ' OE1' ' OE1' ' A' ' 69' ' ' GLU . 36.5 mt-30 -114.5 141.59 47.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.507 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.603 ' HB2' ' HZ1' ' A' ' 95' ' ' LYS . . . -157.88 167.36 30.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.513 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.7 p -97.53 -2.41 41.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.639 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 50.3 m -125.98 149.97 48.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.178 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -77.05 -43.69 33.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 111.183 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -62.11 -47.34 85.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.582 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.08 -21.32 60.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.686 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -71.12 -37.64 72.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.028 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -73.99 -44.17 55.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.931 0.396 . . . . 0.0 110.591 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.641 ' O ' HG23 ' A' ' 98' ' ' VAL . 70.6 mt-30 -57.58 -39.82 77.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.829 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.603 ' HZ1' ' HB2' ' A' ' 86' ' ' ALA . 5.1 ttpm? -65.67 -39.43 91.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.041 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.553 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.39 -48.53 49.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 110.999 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.11 -33.76 69.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 94' ' ' GLN . 76.3 t -71.68 -46.18 63.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.516 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -54.72 -35.56 63.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.047 0.451 . . . . 0.0 109.88 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.51 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.74 -60.4 3.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.089 179.536 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.646 HD22 HD11 ' A' ' 115' ' ' ILE . 16.5 mt -48.17 -38.19 17.53 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.397 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -60.01 -43.7 95.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.841 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -63.44 -27.7 69.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.83 0.348 . . . . 0.0 110.899 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.63 -53.78 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.437 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.7 t -53.46 -41.47 45.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.77 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.56 -26.33 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.125 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -93.78 18.04 10.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.853 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.91 39.69 11.6 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.405 ' C ' ' N ' ' A' ' 111' ' ' GLU . 47.6 mtpt -133.28 22.51 4.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.784 0.326 . . . . 0.0 110.812 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 110' ' ' HIS . 5.2 p80 -49.82 -16.13 0.24 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.495 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.405 ' N ' ' C ' ' A' ' 109' ' ' LYS . 97.3 mt-10 -80.07 23.78 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.075 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.938 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -49.21 -44.02 16.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.899 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.938 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.4 p90 -118.33 -20.43 8.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.544 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 74.3 t80 117.09 51.67 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.829 1.33 . . . . 0.0 109.633 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.646 HD11 HD22 ' A' ' 101' ' ' LEU . 24.0 mt -62.16 113.48 8.79 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -51.48 127.89 23.99 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.175 1.25 . . . . 0.0 111.735 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.58 90.98 0.13 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.485 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.442 ' H ' ' HG2' ' A' ' 122' ' ' GLU . 44.1 p -78.33 -32.79 49.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.407 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 17.9 p -139.88 175.45 9.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.329 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -58.92 -60.48 3.79 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.233 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -55.5 -24.78 33.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.544 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 118' ' ' THR . 21.8 tp10 -66.39 -49.51 66.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.722 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.12 66.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.775 0.321 . . . . 0.0 110.778 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.553 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -59.57 -56.5 21.14 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.947 0.88 . . . . 0.0 108.996 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.5 t -51.8 -36.79 49.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.82 -1.536 . . . . 0.0 110.428 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -54.93 -58.81 6.09 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.23 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.597 HG12 HD13 ' A' ' 101' ' ' LEU . 5.6 mt -59.06 -45.82 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.484 0.659 . . . . 0.0 109.553 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -47.27 -46.53 24.84 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.486 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -71.99 -29.18 63.97 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.343 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 127' ' ' ILE . 75.7 mt -65.23 -23.1 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.396 179.78 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 N--CA 1.487 1.139 0 CA-C-O 120.834 0.264 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.6 tp -77.05 -20.74 55.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.189 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 61.1 mtt -58.57 -33.23 69.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.263 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.492 HG11 HD11 ' A' ' 101' ' ' LEU . 1.4 t -63.2 -50.15 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.372 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.459 HD12 ' CE2' ' A' ' 100' ' ' TYR . 9.7 tp -52.18 -50.65 61.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.431 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -59.44 -52.84 63.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.527 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -60.94 -38.93 87.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.752 0.31 . . . . 0.0 111.164 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.755 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -69.23 -47.24 65.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.21 -31.02 72.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.345 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -74.25 -49.34 23.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.338 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -21.12 59.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 51' ' ' ALA . 20.3 m -85.35 -53.94 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 119.974 -0.69 . . . . 0.0 112.213 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.666 ' N ' HG23 ' A' ' 55' ' ' VAL . 7.6 m-85 -126.01 -1.03 7.18 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 58.26 40.84 24.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.298 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 -177.0 3.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.368 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.79 119.53 41.01 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.41 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.89 168.44 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.578 1.519 . . . . 0.0 111.641 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 m -113.25 140.75 47.71 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.814 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -135.55 154.67 51.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.722 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.34 135.64 4.93 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -105.4 114.64 28.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.869 0.366 . . . . 0.0 111.328 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.9 t -99.19 148.48 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.012 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -114.02 110.71 20.47 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.85 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.42 156.03 80.57 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.25 -7.05 2.38 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.845 1.697 . . . . 0.0 111.211 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 67' ' ' LEU . 50.7 mt-10 -94.38 -14.95 24.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.2 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.97 -121.08 2.38 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -132.75 134.16 44.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 65' ' ' VAL . 35.2 tt0 -114.12 120.59 41.07 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.247 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -89.63 125.03 35.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.91 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.4 m -117.51 131.6 56.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -132.92 144.9 50.46 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.391 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 75' ' ' LEU . 36.4 mt -123.07 147.25 27.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.0 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 77' ' ' LEU . 6.3 tp -160.12 108.98 1.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.7 t30 62.74 -80.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.879 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -142.53 3.99 1.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.792 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.8 mt -101.22 127.75 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.1 m -132.78 129.04 38.07 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.628 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.8 m -136.62 164.27 31.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.199 0.523 . . . . 0.0 111.157 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -132.92 145.53 50.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.296 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -139.5 121.8 2.13 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -94.66 135.14 36.47 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.0 163.76 39.3 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.917 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 87' ' ' THR . 0.1 OUTLIER -92.4 -8.41 44.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.439 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.1 p -133.08 158.85 41.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.4 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -67.35 -45.31 76.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.351 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -57.45 -43.53 84.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.196 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.87 -20.01 59.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.4 -54.65 25.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.136 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -70.61 -39.34 73.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.23 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.463 ' O ' HG23 ' A' ' 98' ' ' VAL . 37.7 tt0 -54.32 -52.17 62.35 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.389 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -63.6 -41.46 98.32 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.628 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -69.73 -52.21 27.46 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.79 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.05 -37.14 66.34 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.213 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 94' ' ' GLN . 55.8 t -65.51 -47.01 88.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.541 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -54.55 -36.91 64.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 110.326 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.556 ' CD2' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -60.11 -54.35 46.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.943 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.556 ' N ' ' CD2' ' A' ' 100' ' ' TYR . 6.4 mt -48.76 -39.67 25.88 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.525 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -60.5 -45.63 93.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.679 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -58.81 -27.77 65.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 110.639 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 104' ' ' VAL . 2.1 t -67.46 -54.56 22.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.391 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.6 t -56.47 -39.93 64.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.535 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -67.54 -26.31 66.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.691 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -97.93 19.04 14.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.861 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.07 46.93 15.26 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -131.44 21.31 4.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.925 0.393 . . . . 0.0 110.612 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -54.45 -16.0 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.769 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.33 22.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.654 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.989 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.2 pp -68.15 -46.41 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.732 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.989 ' H ' HD12 ' A' ' 112' ' ' ILE . 0.9 OUTLIER -120.25 -18.36 8.02 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.522 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 13.9 t80 97.83 64.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.15 0.907 . . . . 0.0 110.983 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -63.36 115.16 15.99 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -50.51 127.74 21.45 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 120.973 1.115 . . . . 0.0 111.816 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.9 91.24 0.13 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.465 ' H ' ' HG2' ' A' ' 122' ' ' GLU . 43.9 p -76.08 -35.19 59.47 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.617 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -130.81 172.33 12.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.808 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -56.31 -59.7 4.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.295 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 125' ' ' SER . 98.7 mt-10 -60.31 -24.16 64.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.37 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.617 ' CB ' ' H ' ' A' ' 119' ' ' THR . 15.1 tp10 -61.65 -45.05 95.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.656 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.9 -51.38 48.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.783 0.325 . . . . 0.0 110.838 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.562 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -58.55 -54.94 41.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.155 0.978 . . . . 0.0 109.045 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 46.8 t -51.9 -26.75 10.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.813 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.65 -59.4 3.63 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.597 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.458 HD13 ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -52.55 -47.41 48.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -54.16 -48.87 70.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.26 -1.337 . . . . 0.0 111.211 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -71.85 -27.25 62.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.652 0.263 . . . . 0.0 111.197 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.9 mt -66.12 -19.14 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.212 -179.685 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 N--CA 1.493 1.444 0 CA-C-O 120.688 0.203 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.428 HD11 ' CZ2' ' A' ' 62' ' ' TRP . 13.8 tp -70.93 -21.35 62.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.341 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.3 tpt -59.06 -33.17 70.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.419 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.67 -43.57 96.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.74 -52.15 58.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.862 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.8 -43.91 97.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.474 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.93 -40.44 60.83 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.786 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -74.52 -48.28 28.0 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.295 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.24 -33.11 67.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.059 0.456 . . . . 0.0 110.123 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -77.44 -44.28 29.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.643 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.7 -22.07 56.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.786 HG13 ' O ' ' A' ' 51' ' ' ALA . 16.0 m -85.41 -53.86 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.656 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.8 m-85 -125.8 1.61 7.42 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 60.35 37.24 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.018 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -122.42 -167.83 1.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.107 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.29 159.72 51.05 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.42 ' CG ' ' CZ2' ' A' ' 62' ' ' TRP . 94.4 Cg_endo -76.65 169.26 22.13 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 123.047 2.498 . . . . 0.0 111.967 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.95 111.94 17.68 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.541 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CZ2' HD11 ' A' ' 45' ' ' LEU . 6.7 m0 -109.89 155.13 22.1 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.191 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.31 131.65 3.37 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.28 111.97 24.19 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.476 ' O ' ' CB ' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -91.11 146.3 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.47 178.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -120.68 120.0 34.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.796 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 69' ' ' GLU . 4.7 mt -133.2 150.13 74.53 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.55 -7.16 1.23 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.476 1.451 . . . . 0.0 111.921 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -108.22 -7.18 16.05 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.787 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.21 -145.1 13.73 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.476 ' CB ' ' O ' ' A' ' 65' ' ' VAL . 6.9 p90 -141.87 151.92 43.14 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.116 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -120.27 114.96 22.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.047 0.451 . . . . 0.0 111.084 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.463 ' HG3' ' HB1' ' A' ' 92' ' ' ALA . 4.8 mmt -78.79 128.38 33.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -109.91 120.42 42.42 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.893 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -115.7 128.23 55.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.893 ' N ' HD12 ' A' ' 75' ' ' LEU . 7.6 mt -124.47 143.3 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 79' ' ' GLU . 6.5 tp -158.77 -149.83 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.2 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 80' ' ' ILE . 27.5 t-20 -48.01 83.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.555 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 77' ' ' LEU . 48.1 tt0 57.58 -1.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.033 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.468 ' H ' ' C ' ' A' ' 78' ' ' ASN . 62.8 mt -100.97 131.8 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.587 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.7 p -132.95 130.53 39.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 96' ' ' ALA . 4.1 m -138.01 162.4 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.153 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -134.07 145.75 49.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.014 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.74 106.02 0.5 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -86.86 140.29 29.82 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.33 -179.6 2.31 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.987 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.6 p -120.09 10.18 11.35 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.804 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.538 ' OG ' ' HB3' ' A' ' 91' ' ' ALA . 91.2 p -131.25 153.76 49.17 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -72.06 -50.47 28.08 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.965 0.412 . . . . 0.0 111.103 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -55.64 -44.42 77.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.371 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.538 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -73.17 -20.14 60.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.893 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.463 ' HB1' ' HG3' ' A' ' 73' ' ' MET . . . -64.39 -55.02 23.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.618 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -73.41 -42.29 62.27 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.763 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -53.19 -42.31 66.13 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.442 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.423 ' NZ ' ' HB1' ' A' ' 91' ' ' ALA . 18.9 mttt -72.99 -35.99 66.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.383 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.584 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -72.16 -52.85 14.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.28 -38.94 85.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.0 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -66.29 -49.04 78.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -54.7 -33.87 61.53 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.227 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -63.0 -56.97 12.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.241 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.49 HD13 HG13 ' A' ' 127' ' ' ILE . 11.5 mt -52.65 -35.67 55.38 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.301 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -59.76 -46.27 89.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.621 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -61.69 -28.62 69.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.528 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.87 -54.6 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.4 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.4 t -52.66 -41.32 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.76 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.55 -25.9 67.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 110.059 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -96.72 20.49 10.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.737 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.44 40.54 3.72 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.41 ' C ' ' N ' ' A' ' 111' ' ' GLU . 32.4 tttp -133.94 24.08 3.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -48.4 -19.29 0.3 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.066 0.46 . . . . 0.0 110.171 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 109' ' ' LYS . 82.6 mt-10 -75.65 25.03 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.48 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.507 HG13 ' H ' ' A' ' 113' ' ' PHE . 2.3 pt -48.96 -46.6 16.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.957 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.526 ' O ' ' CD2' ' A' ' 114' ' ' PHE . 44.7 p90 -121.75 11.47 10.46 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 113' ' ' PHE . 3.6 m-85 85.96 54.2 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.043 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.429 HD11 HD22 ' A' ' 101' ' ' LEU . 24.8 mt -63.29 122.29 74.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.46 128.39 14.43 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.372 1.381 . . . . 0.0 112.919 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.75 91.16 0.13 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 62.4 m -59.55 -38.43 81.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.437 ' H ' ' HB2' ' A' ' 122' ' ' GLU . 3.0 p -131.03 -172.68 2.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.792 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -67.42 -59.73 3.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.928 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -55.11 -24.5 26.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.93 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 119' ' ' THR . 73.7 mm-40 -68.63 -41.07 79.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.065 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.72 -52.43 30.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.761 0.315 . . . . 0.0 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.9 mp -55.91 -56.92 14.86 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.924 0.869 . . . . 0.0 108.717 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.2 t -51.7 -28.58 15.32 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.39 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.23 -50.29 74.24 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.849 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.588 ' N ' HD12 ' A' ' 127' ' ' ILE . 1.9 mp -58.62 -44.12 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-O 121.353 0.597 . . . . 0.0 109.7 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -53.13 -47.68 68.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.205 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -71.57 -29.3 64.57 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.166 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 43.2 mt -64.26 -20.04 26.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.038 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.462 0.171 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.437 -179.502 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.496 1.64 0 N-CA-C 112.673 0.22 . . . . 0.0 112.673 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.531 HD11 ' CZ2' ' A' ' 62' ' ' TRP . 19.0 tp -60.48 -22.15 63.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.864 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.5 ttp -63.43 -34.23 77.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.735 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.542 HG11 HD11 ' A' ' 101' ' ' LEU . 3.7 t -65.56 -30.79 51.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.257 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 75' ' ' LEU . 1.6 tp -75.54 -51.98 11.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.54 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -54.26 -37.76 65.06 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.283 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -77.23 -41.11 42.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.26 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.674 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -65.69 -48.71 71.12 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.117 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.67 -30.68 71.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 0.0 111.006 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 57' ' ' GLN . 29.1 ttpt -78.36 -57.82 3.58 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.005 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.29 -21.78 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 51' ' ' ALA . 23.8 m -86.13 -53.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.782 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.656 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.1 m-85 -125.72 -1.1 7.36 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 71.04 19.33 5.63 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.175 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -110.79 -167.95 1.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.08 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.15 162.3 42.42 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.008 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.04 169.13 22.73 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.991 2.461 . . . . 0.0 112.049 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.13 131.39 53.27 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.004 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.531 ' CZ2' HD11 ' A' ' 45' ' ' LEU . 5.7 m0 -120.74 141.06 50.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.798 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.67 128.98 4.65 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 p -96.87 119.36 35.2 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.895 0.378 . . . . 0.0 111.5 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.8 t -107.54 148.09 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.229 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -114.19 110.29 19.74 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.848 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.54 156.34 80.2 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -51.59 -15.64 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.614 1.542 . . . . 0.0 111.6 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.61 -17.62 31.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.842 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.42 -114.71 1.26 Allowed Glycine 0 C--N 1.33 0.205 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -133.16 136.49 45.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 65' ' ' VAL . 34.7 tt0 -120.38 118.59 30.76 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.5 mtt -93.38 134.4 35.66 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.332 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.5 p -107.96 128.16 54.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.806 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.43 ' CD1' HD21 ' A' ' 48' ' ' LEU . 10.0 tp -116.63 125.98 52.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.4 mt -120.52 133.16 68.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 120.905 0.383 . . . . 0.0 109.972 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' GLU . 13.0 mt -140.83 -165.56 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.607 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 80' ' ' ILE . 5.6 p30 -49.0 91.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.731 0.301 . . . . 0.0 111.116 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 77' ' ' LEU . 69.5 mm-40 60.43 -6.21 0.09 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.257 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.488 ' H ' ' C ' ' A' ' 78' ' ' ASN . 96.2 mt -99.15 130.6 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.031 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 81' ' ' THR . 12.6 t -132.43 129.39 39.21 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.4 m -141.78 162.79 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.243 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.76 162.84 40.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.194 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.63 149.17 20.98 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -106.75 138.49 42.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.684 0.278 . . . . 0.0 110.342 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.89 160.97 31.61 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.93 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.9 m -74.01 -26.77 60.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.702 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.4 p -117.97 155.49 30.17 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.446 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -37.24 66.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.272 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -59.79 -48.14 82.88 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.678 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.71 -22.44 61.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.262 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.81 76.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.998 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -74.17 -45.68 46.99 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.782 0.325 . . . . 0.0 111.035 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -52.8 -48.77 66.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.869 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -62.67 -35.04 78.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.583 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.34 -49.44 49.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.229 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.14 -31.91 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.103 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.21 -49.95 50.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.735 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -55.14 -33.17 62.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.311 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.43 ' CD1' ' C ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -63.33 -56.91 12.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.005 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.542 HD11 HG11 ' A' ' 47' ' ' VAL . 16.6 mt -52.07 -36.45 50.73 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.704 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -61.05 -45.63 93.96 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.61 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -62.76 -27.86 69.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.766 0.317 . . . . 0.0 111.241 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -64.61 -54.1 34.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.399 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.467 ' H ' HG23 ' A' ' 105' ' ' VAL . 1.4 t -53.9 -41.13 47.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.494 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -60.0 -28.15 67.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.28 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -97.33 20.33 11.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.211 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.85 44.19 5.53 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 111' ' ' GLU . 11.8 tttp -133.37 20.32 3.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.414 . . . . 0.0 110.182 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.47 ' H ' ' CD2' ' A' ' 110' ' ' HIS . 6.0 p80 -48.53 -15.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.901 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 109' ' ' LYS . 90.4 mt-10 -79.71 22.9 0.45 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.622 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.929 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -50.98 -45.09 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.145 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.929 ' H ' HD12 ' A' ' 112' ' ' ILE . 2.0 p90 -118.32 -7.01 10.77 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.572 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 6.7 m-85 98.06 54.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.612 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.484 HD13 HG21 ' A' ' 127' ' ' ILE . 15.6 mt -62.6 114.82 13.27 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.491 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -50.72 128.62 24.62 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.304 1.336 . . . . 0.0 112.32 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.74 91.29 0.13 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 m -91.92 -30.05 16.34 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.9 m -140.65 162.99 34.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.422 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -53.37 -60.65 3.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.486 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -56.72 -25.74 55.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.493 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -72.14 -51.38 21.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.42 -51.46 69.75 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.559 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -62.83 -58.51 7.15 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.575 0.703 . . . . 0.0 110.396 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.3 m -52.15 -36.58 51.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.996 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -58.15 -55.74 31.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.365 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.484 HG21 HD13 ' A' ' 115' ' ' ILE . 27.1 pt -69.1 -34.2 62.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.068 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -61.8 -39.3 91.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.712 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -69.47 -25.21 63.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.742 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' A' ' 127' ' ' ILE . 67.0 mt -73.68 -23.98 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.064 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.016 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.495 1.56 0 CA-C-O 120.732 0.222 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.703 HD22 HH11 ' A' ' 93' ' ' ARG . 24.9 tp -70.05 -25.36 63.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.519 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.1 mmt -64.64 -33.7 76.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.39 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 101' ' ' LEU . 2.1 t -63.98 -56.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.456 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.06 -51.31 64.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.269 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -54.81 -42.49 71.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.775 0.321 . . . . 0.0 111.139 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -71.77 -37.87 70.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.032 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.79 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -69.17 -47.35 65.19 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.72 -31.69 68.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.04 0.447 . . . . 0.0 110.301 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -77.12 -47.18 21.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.954 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.95 -21.13 59.36 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.79 HG13 ' O ' ' A' ' 51' ' ' ALA . 17.4 m -85.26 -53.81 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.239 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.649 ' N ' HG23 ' A' ' 55' ' ' VAL . 3.1 m-85 -126.08 -4.8 6.81 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.404 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 19.5 tp60 71.96 19.89 4.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.67 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -111.02 -167.53 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.299 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.89 161.07 51.14 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.691 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.51 169.01 21.79 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.808 2.339 . . . . 0.0 111.462 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.09 117.07 26.24 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.944 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.598 ' CZ2' HD11 ' A' ' 45' ' ' LEU . 7.9 m0 -112.8 152.78 28.76 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.796 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.68 125.37 2.03 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 78.1 m -97.77 120.7 38.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.058 0.456 . . . . 0.0 111.281 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.548 ' HB ' HD21 ' A' ' 67' ' ' LEU . 1.8 t -107.59 150.63 10.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.365 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.913 ' C ' HD23 ' A' ' 67' ' ' LEU . 14.7 mp0 -119.76 114.21 21.8 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.913 HD23 ' C ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -127.27 160.63 58.92 Favored Pre-proline 0 C--N 1.345 0.403 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.08 -8.21 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.097 1.865 . . . . 0.0 111.234 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -99.65 -10.79 21.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.636 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.32 -120.72 1.83 Allowed Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 3.9 m-85 -141.71 145.09 34.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.643 ' HB2' HD11 ' A' ' 67' ' ' LEU . 60.5 tt0 -119.69 145.72 46.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 7.8 tpp -114.64 133.8 55.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.9 p -116.82 125.89 52.26 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 76' ' ' ILE . 6.7 tp -121.37 135.89 55.03 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 75' ' ' LEU . 3.3 mt -131.58 149.43 33.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 79' ' ' GLU . 35.8 tp -169.11 125.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.751 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 65.1 t30 58.78 -80.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.841 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -147.55 -0.62 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 110.533 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.1 mt -100.18 134.24 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.41 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.15 131.74 42.55 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 96' ' ' ALA . 10.5 m -137.34 162.35 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.13 0.49 . . . . 0.0 111.186 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -160.58 160.81 32.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.047 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.85 155.48 26.32 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.696 ' H ' HE21 ' A' ' 85' ' ' GLN . 0.0 OUTLIER -104.2 140.14 38.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.738 0.304 . . . . 0.0 110.231 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.65 165.51 25.68 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.763 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.4 p -104.14 -0.78 28.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 50.5 m -115.89 152.24 33.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.219 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -80.24 -51.21 9.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.247 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -59.64 -45.77 91.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.112 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.07 67.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.829 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -58.98 -42.75 90.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.434 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.703 HH11 HD22 ' A' ' 45' ' ' LEU . 38.4 ttm180 -73.99 -45.85 47.43 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.035 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 98' ' ' VAL . 94.0 mt-30 -53.59 -43.26 68.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.77 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -64.03 -36.23 83.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.675 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.57 -50.3 32.34 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.681 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.43 -41.39 89.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.451 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 94' ' ' GLN . 79.8 t -65.63 -46.14 90.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.812 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -55.08 -36.2 65.37 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.248 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -60.84 -58.34 8.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.68 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.615 HD22 HD11 ' A' ' 115' ' ' ILE . 19.0 mt -48.9 -36.22 16.66 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.672 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -61.83 -44.62 96.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.403 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -61.86 -27.7 68.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.894 0.378 . . . . 0.0 110.975 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.48 -54.41 26.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.682 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -53.66 -39.79 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.499 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -68.29 -22.9 64.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.462 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -97.25 14.17 26.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.63 40.16 47.36 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.179 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 111' ' ' GLU . 0.5 OUTLIER -133.62 26.48 4.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.815 0.34 . . . . 0.0 110.327 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -48.9 -16.86 0.14 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 109' ' ' LYS . 88.3 mt-10 -84.3 23.81 1.04 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.551 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.942 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -49.8 -45.02 21.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.863 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.942 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -118.73 -17.02 9.3 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.533 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 50.9 t80 110.77 52.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.7 1.25 . . . . 0.0 110.257 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.615 HD11 HD22 ' A' ' 101' ' ' LEU . 35.2 mt -62.49 112.69 6.98 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -51.45 128.56 26.18 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.27 1.314 . . . . 0.0 111.907 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.68 91.53 0.13 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.668 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.8 m -77.25 -38.07 51.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.88 170.56 13.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.449 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.45 -60.5 3.74 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.494 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.411 ' O ' ' OG ' ' A' ' 125' ' ' SER . 93.6 mt-10 -56.43 -24.53 45.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.984 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -69.92 -44.2 70.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.02 83.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.544 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 2.9 mp -66.22 -58.98 4.2 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.906 0.86 . . . . 0.0 109.964 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 91.0 p -52.86 -38.35 61.43 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.804 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -57.54 -58.74 6.96 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.774 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' ILE . 12.2 mt -54.78 -51.69 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.501 0.667 . . . . 0.0 110.1 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -47.15 -35.25 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.589 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -71.71 -27.41 63.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.773 0.32 . . . . 0.0 110.552 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 127' ' ' ILE . 56.4 mt -67.92 -28.66 42.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.2 p . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.564 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.493 1.495 0 CA-C-O 120.788 0.245 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 45' ' ' LEU . 15.5 tp -71.39 -21.99 61.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.332 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.1 tpt -62.39 -34.32 76.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.112 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.407 HG11 HD11 ' A' ' 101' ' ' LEU . 2.1 t -68.51 -50.65 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.428 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.611 HD11 HD22 ' A' ' 77' ' ' LEU . 4.8 tp -56.07 -52.17 65.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.434 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -60.65 -43.97 96.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 111.557 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.42 -33.84 73.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.048 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.756 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -74.48 -47.68 31.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.26 72.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.993 0.425 . . . . 0.0 109.915 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -77.36 -44.45 29.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.949 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.79 -21.82 57.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 51' ' ' ALA . 19.6 m -85.51 -53.86 9.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.659 ' N ' HG23 ' A' ' 55' ' ' VAL . 3.2 m-85 -125.68 -2.45 7.29 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.688 -0.405 . . . . 0.0 112.035 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 67.22 23.39 9.44 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.348 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -108.93 176.7 5.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.346 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.51 159.42 32.28 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.985 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.31 169.55 19.93 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.054 2.503 . . . . 0.0 111.983 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.05 119.79 33.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.76 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -114.19 150.89 33.56 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.45 130.39 3.93 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 64' ' ' THR . 9.6 t -100.38 115.4 29.92 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 111.33 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.9 t -106.06 148.29 10.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.267 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.31 111.42 21.46 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.896 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.8 156.23 80.31 Favored Pre-proline 0 N--CA 1.456 -0.153 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.232 -178.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -51.78 -16.1 3.65 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.516 1.477 . . . . 0.0 111.625 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.07 -15.46 33.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.788 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.35 -116.87 1.51 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -134.0 135.78 43.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.7 tt0 -117.95 121.22 40.12 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.404 ' HB2' ' HB1' ' A' ' 92' ' ' ALA . 44.7 tpp -93.47 130.04 39.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.82 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.2 m -107.63 126.05 52.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.924 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -119.07 130.52 55.66 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.306 0.379 . . . . 0.0 110.203 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.924 ' N ' HD12 ' A' ' 75' ' ' LEU . 45.8 mt -123.22 138.04 54.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.073 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.611 HD22 HD11 ' A' ' 48' ' ' LEU . 5.1 tp -150.22 -154.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.464 ' C ' ' H ' ' A' ' 80' ' ' ILE . 19.9 p-10 -48.52 83.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.775 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 77' ' ' LEU . 5.9 tp10 60.86 -3.33 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.85 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.464 ' H ' ' C ' ' A' ' 78' ' ' ASN . 71.8 mt -102.67 131.84 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.078 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 p -132.58 132.49 42.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.7 m -141.65 160.97 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.464 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -134.54 150.0 50.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.989 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -142.78 133.19 5.43 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -102.74 137.81 40.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.83 164.08 36.08 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.978 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 74.0 p -87.18 -10.88 51.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.364 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.3 m -128.56 155.53 44.76 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.227 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.563 ' H ' ' CD ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -70.31 -42.13 72.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -57.43 -47.93 80.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.98 62.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.696 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 73' ' ' MET . . . -66.93 -46.5 74.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -73.33 -43.1 61.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.725 0.297 . . . . 0.0 111.524 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -52.27 -45.03 65.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.278 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -70.34 -34.92 73.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 111.166 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.554 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -67.65 -48.15 67.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.339 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.17 82.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.338 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.91 -50.67 76.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.676 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -55.35 -37.82 67.97 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.678 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -55.0 40.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.369 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 115' ' ' ILE . 13.2 mt -50.4 -35.41 28.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.255 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.515 ' NH1' ' OE2' ' A' ' 106' ' ' GLU . 64.9 ttp85 -62.18 -47.04 86.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.441 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -27.54 65.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.673 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.56 -54.49 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.683 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.489 ' H ' HG23 ' A' ' 105' ' ' VAL . 1.7 t -52.4 -40.77 33.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.567 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.515 ' OE2' ' NH1' ' A' ' 102' ' ' ARG . 97.9 mt-10 -66.25 -24.96 66.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.107 0.48 . . . . 0.0 109.787 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -93.77 19.72 8.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.419 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.7 38.92 2.44 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.417 ' C ' ' N ' ' A' ' 111' ' ' GLU . 9.3 tptp -132.91 25.1 4.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.534 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -48.82 -15.77 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.611 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.417 ' N ' ' C ' ' A' ' 109' ' ' LYS . 77.0 mm-40 -80.04 23.5 0.46 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.113 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.911 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -50.04 -44.53 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.518 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.911 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.3 p90 -118.15 -19.88 8.86 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.538 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 68.7 t80 116.87 51.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.799 1.312 . . . . 0.0 109.583 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.534 HD11 HD22 ' A' ' 101' ' ' LEU . 22.8 mt -62.75 121.0 65.27 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.48 128.87 13.14 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.552 1.501 . . . . 0.0 112.701 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.32 91.31 0.13 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 64.5 p -61.49 -34.51 75.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.113 0.482 . . . . 0.0 109.723 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.421 ' H ' ' HB3' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -135.81 172.05 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.895 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -57.15 -59.8 4.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.211 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -56.09 -25.19 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.529 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.421 ' HB3' ' H ' ' A' ' 119' ' ' THR . 17.9 tp10 -69.58 -47.97 61.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.844 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.13 74.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.236 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.542 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.2 mp -65.16 -58.24 6.52 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.912 0.863 . . . . 0.0 109.884 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 44.8 m -53.07 -36.57 60.8 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.0 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -63.13 -59.53 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.673 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.5 HG21 HD13 ' A' ' 115' ' ' ILE . 40.3 pt -60.47 -35.0 60.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.375 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -61.98 -33.23 73.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.891 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -71.0 -25.75 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.538 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 58.2 mt -70.19 -30.09 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.7 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.826 179.933 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 N--CA 1.494 1.507 0 N-CA-C 112.762 0.255 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.08 -23.47 62.13 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.31 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.0 mmt -65.75 -34.5 78.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.972 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.617 HG11 HD11 ' A' ' 101' ' ' LEU . 1.8 t -68.21 -43.53 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.468 HD12 ' CE2' ' A' ' 100' ' ' TYR . 4.7 tp -61.3 -52.05 66.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.167 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -56.34 -53.33 58.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.865 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -61.97 -35.68 79.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.044 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.742 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -68.65 -47.37 66.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.997 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.78 -31.37 72.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.039 0.447 . . . . 0.0 109.892 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -77.26 -45.68 25.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.456 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.15 -21.79 58.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 51' ' ' ALA . 19.4 m -85.61 -53.3 10.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.648 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.1 m-85 -125.15 -1.31 7.71 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.5 41.14 7.65 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.168 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -127.89 -179.12 4.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.09 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.54 156.86 39.75 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.95 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 168.59 23.69 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.68 2.254 . . . . 0.0 112.059 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.1 117.26 28.26 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.918 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -114.85 140.63 48.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.8 121.76 1.99 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 m -97.35 112.21 24.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.115 0.483 . . . . 0.0 111.462 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 t -93.16 147.77 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.826 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -122.98 118.81 28.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.572 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 69' ' ' GLU . 4.4 mt -133.41 149.61 72.83 Favored Pre-proline 0 CA--C 1.529 0.16 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.29 -7.15 1.72 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.316 1.344 . . . . 0.0 110.953 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 67' ' ' LEU . 80.3 mm-40 -105.17 -11.48 16.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.776 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.17 -150.28 22.53 Favored Glycine 0 C--N 1.332 0.352 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 14.4 m-85 -129.07 147.63 50.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.88 0.34 . . . . 0.0 110.262 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -118.07 112.72 20.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.031 0.444 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -84.63 129.54 34.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.0 p -113.79 129.77 56.54 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.145 0.278 . . . . 0.0 110.766 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -122.01 126.82 49.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.871 ' N ' HD12 ' A' ' 75' ' ' LEU . 7.2 mt -121.66 132.66 70.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 79' ' ' GLU . 3.2 tp -147.74 -159.41 1.02 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.685 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 80' ' ' ILE . 2.9 p30 -46.15 84.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.877 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 77' ' ' LEU . 17.5 tp10 61.27 -7.14 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.904 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.505 ' H ' ' C ' ' A' ' 78' ' ' ASN . 73.0 mt -99.5 128.37 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.009 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 p -132.64 128.03 36.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 96' ' ' ALA . 2.7 m -141.2 167.05 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.193 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -162.76 168.75 21.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.071 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.36 163.08 33.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.507 ' H ' ' CD ' ' A' ' 85' ' ' GLN . 0.5 OUTLIER -109.25 138.69 45.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.836 0.35 . . . . 0.0 110.292 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.0 161.51 39.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.715 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.9 p -97.15 -1.01 45.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.996 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.4 m -130.86 151.92 50.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.077 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -71.95 -39.71 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 0.0 111.28 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -57.92 -47.74 81.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.344 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.13 -20.03 59.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.086 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.38 -53.55 46.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.403 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -72.93 -44.28 61.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.573 0.225 . . . . 0.0 111.152 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -53.06 -47.21 68.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.807 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -63.43 -34.99 78.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.794 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.481 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.73 -50.37 30.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.168 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.59 76.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.45 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.52 -48.96 69.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.503 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -54.25 -34.99 62.01 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.279 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.49 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.58 -57.97 8.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.548 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.617 HD11 HG11 ' A' ' 47' ' ' VAL . 13.8 mt -47.94 -37.93 15.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.184 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -60.79 -44.95 96.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.428 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -60.17 -27.72 67.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.02 0.438 . . . . 0.0 110.91 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -68.81 -53.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.615 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 101' ' ' LEU . 2.0 t -54.84 -41.37 56.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.697 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -62.85 -27.5 69.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 109.865 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -94.15 20.34 8.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.709 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.53 38.96 5.59 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.414 ' C ' ' N ' ' A' ' 111' ' ' GLU . 2.6 tptm -133.73 25.59 4.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.734 0.302 . . . . 0.0 110.897 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.409 ' C ' ' H ' ' A' ' 112' ' ' ILE . 8.2 p80 -49.29 -16.06 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.797 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 109' ' ' LYS . 6.1 pt-20 -75.4 23.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.444 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.95 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -49.95 -44.36 21.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.844 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.95 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.4 p90 -117.48 -19.59 9.41 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' A' ' 114' ' ' PHE . 75.8 t80 118.03 50.05 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.888 1.367 . . . . 0.0 109.543 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.567 HD13 HG21 ' A' ' 127' ' ' ILE . 25.0 mt -62.33 113.4 8.67 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.29 129.26 10.22 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.765 1.643 . . . . 0.0 113.024 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.15 90.67 0.13 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 69.7 m -58.1 -37.02 73.73 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.76 161.46 27.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.84 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -53.8 -59.54 4.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.864 0.364 . . . . 0.0 110.47 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.69 -24.56 49.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.7 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -71.84 -44.77 63.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.013 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.83 -51.17 71.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.092 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.554 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -63.4 -56.76 13.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.019 0.914 . . . . 0.0 109.393 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.1 t -52.11 -37.73 55.08 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.155 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -62.77 -57.59 10.41 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.545 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.567 HG21 HD13 ' A' ' 115' ' ' ILE . 38.5 pt -59.46 -33.99 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 0.0 110.493 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -72.96 -32.59 65.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.85 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -70.02 -25.67 63.69 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.5 pt -90.45 -18.93 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.154 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.0 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.874 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 N--CA 1.496 1.643 0 CA-C-O 120.758 0.233 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -61.67 -20.34 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.204 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.1 tpt -58.79 -33.97 70.94 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 101' ' ' LEU . 2.1 t -58.76 -31.16 43.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 77' ' ' LEU . 3.6 tp -78.78 -51.85 9.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.479 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -60.07 -32.28 70.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -76.29 -43.01 43.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.336 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -71.35 -48.36 50.75 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.231 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.48 -32.2 68.55 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.312 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -78.02 -47.34 18.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.316 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.21 -20.66 60.82 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.855 -0.528 . . . . 0.0 112.387 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 51' ' ' ALA . 18.2 m -85.75 -52.94 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.16 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.616 ' N ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -125.49 -7.42 6.91 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.034 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 6.9 tt0 75.27 19.96 2.13 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.308 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -115.28 173.91 6.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.134 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 161.95 21.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.743 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.37 168.74 22.6 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.793 2.328 . . . . 0.0 112.1 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.39 115.95 23.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.533 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -109.32 149.54 29.32 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.08 124.66 1.86 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.3 m -104.25 114.39 28.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.387 . . . . 0.0 111.825 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.567 ' HB ' HD21 ' A' ' 67' ' ' LEU . 2.0 t -97.93 151.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.488 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.92 ' C ' HD23 ' A' ' 67' ' ' LEU . 36.6 mt-10 -117.2 113.42 22.2 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.92 HD23 ' C ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -129.64 158.44 73.51 Favored Pre-proline 0 C--N 1.347 0.469 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.24 -15.59 8.35 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.93 1.753 . . . . 0.0 111.818 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -96.57 -10.98 26.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.558 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.83 -125.97 2.99 Favored Glycine 0 C--N 1.329 0.16 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 16.0 m-85 -138.52 145.23 40.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HB2' HD11 ' A' ' 67' ' ' LEU . 82.8 tt0 -110.2 129.32 55.74 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.202 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 2.0 mpp? -92.09 133.38 35.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.988 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 m -119.19 118.84 32.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 76' ' ' ILE . 11.5 tp -120.63 130.88 54.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 75' ' ' LEU . 26.5 mt -127.33 135.23 63.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 48' ' ' LEU . 13.8 mt -141.51 101.08 3.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.144 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.507 ' OD1' ' CD1' ' A' ' 56' ' ' TYR . 14.1 m-80 57.86 -82.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.239 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 77' ' ' LEU . 6.8 tp10 -125.5 -10.51 6.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.399 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.6 mt -94.59 130.35 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.613 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.4 p -132.17 131.34 42.12 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 100' ' ' TYR . 9.0 m -136.46 158.86 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.028 0.442 . . . . 0.0 110.932 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -162.24 166.41 25.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.785 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.504 ' O ' ' SD ' ' A' ' 73' ' ' MET . . . -169.28 177.97 42.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -106.63 135.11 48.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.585 0.231 . . . . 0.0 110.435 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -149.96 160.16 43.82 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.957 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.9 p -118.77 9.39 12.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.566 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.669 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 48.4 t -128.33 154.73 45.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.26 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -80.69 -53.62 6.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.958 0.409 . . . . 0.0 111.385 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -59.76 -44.31 93.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.553 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 88' ' ' SER . . . -74.09 -20.99 60.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.344 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -66.11 -49.89 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.496 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -73.15 -43.62 61.25 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.304 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.504 ' O ' HG23 ' A' ' 98' ' ' VAL . 98.1 mt-30 -56.8 -48.01 78.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.251 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -62.12 -34.64 76.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.003 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.24 -50.83 43.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.856 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.95 -30.08 63.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 94' ' ' GLN . 54.3 t -68.03 -51.59 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.205 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.93 -34.84 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.855 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.405 ' HA ' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -58.57 -56.78 17.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.247 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.642 HD22 HD11 ' A' ' 115' ' ' ILE . 31.6 mt -51.36 -37.02 45.8 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 123.6 0.563 . . . . 0.0 111.907 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -61.34 -47.04 87.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.721 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -60.64 -28.12 68.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.349 . . . . 0.0 110.611 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 104' ' ' VAL . 3.2 t -62.3 -53.21 50.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.808 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.497 HG22 ' CE1' ' A' ' 110' ' ' HIS . 1.5 t -52.87 -37.17 25.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.581 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -71.47 -24.8 62.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -95.97 19.78 11.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.297 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.62 39.2 2.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -130.86 30.95 4.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.062 0.458 . . . . 0.0 110.011 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.497 ' CE1' HG22 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -48.86 -15.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.286 -179.402 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -83.37 23.47 0.91 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.926 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.5 pp -50.22 -47.54 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.02 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.926 ' H ' HD12 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -120.23 -16.89 8.42 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.535 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 34.9 t80 105.28 57.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.468 1.105 . . . . 0.0 110.277 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.642 HD11 HD22 ' A' ' 101' ' ' LEU . 22.3 mt -64.41 114.1 13.0 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.659 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -51.35 130.33 32.3 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.447 1.431 . . . . 0.0 112.017 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.47 94.72 0.15 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.783 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.432 ' H ' ' HG2' ' A' ' 122' ' ' GLU . 20.8 m -78.4 -35.23 47.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.168 0.508 . . . . 0.0 109.713 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.517 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -136.22 175.93 9.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.617 179.26 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.78 -60.18 4.25 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.338 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.415 ' O ' ' OG ' ' A' ' 125' ' ' SER . 94.5 mt-10 -58.87 -25.15 63.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.476 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.517 ' CB ' ' H ' ' A' ' 119' ' ' THR . 17.4 tp10 -62.05 -47.69 83.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.706 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.78 -49.49 74.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.986 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.553 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.5 mp -63.19 -58.04 8.53 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 109.568 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 27.4 m -52.49 -36.51 55.25 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.996 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -61.91 -58.64 7.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.612 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.532 ' HA ' HD12 ' A' ' 130' ' ' ILE . 18.7 pt -66.11 -35.69 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.782 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -58.58 -40.29 82.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -72.47 -25.97 61.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.178 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 127' ' ' ILE . 53.8 mt -68.77 -23.92 28.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.767 -179.94 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 33' ' ' ARG . 27.1 p-10 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.452 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 58.6 ttt85 -54.45 -41.27 69.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.352 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.6 m -130.09 150.51 51.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.478 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -56.67 -34.16 67.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.679 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.1 tp -54.89 -38.04 67.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.28 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -58.79 -41.73 87.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.298 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.5 mtp -57.75 -38.77 75.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.531 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -68.45 -43.28 77.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.725 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 42' ' ' LYS . 8.4 mp -67.75 -17.66 64.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.566 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -69.86 10.56 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.434 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 40' ' ' LEU . 48.3 tttp -56.21 -43.18 78.28 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.994 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.21 154.44 40.48 Favored Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.673 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.38 -25.61 15.24 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.34 2.026 . . . . 0.0 112.138 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.453 HD13 ' HD2' ' A' ' 93' ' ' ARG . 24.7 tp -65.3 -23.09 66.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.569 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.4 tpt -62.25 -34.85 77.33 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.351 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.667 HG11 HD11 ' A' ' 101' ' ' LEU . 2.9 t -68.21 -35.77 72.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.982 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 77' ' ' LEU . 6.8 tp -69.94 -51.74 30.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.206 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -52.8 -40.14 62.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.599 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -76.32 -32.56 58.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.124 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.676 ' O ' HG22 ' A' ' 55' ' ' VAL . . . -71.07 -48.74 50.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.179 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.28 -31.56 72.44 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.914 0.388 . . . . 0.0 110.667 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 57' ' ' GLN . 62.4 mttm -78.67 -57.19 3.89 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.42 -21.47 64.15 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 51' ' ' ALA . 25.5 m -86.02 -53.67 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.823 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.648 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.6 m-85 -126.38 4.65 6.96 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 53' ' ' LYS . 88.9 mm-40 59.42 32.76 22.01 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.579 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -125.53 151.37 46.44 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.325 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.04 156.05 74.67 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.953 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.06 168.7 24.15 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.901 2.401 . . . . 0.0 112.107 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.73 124.9 44.43 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.806 0.336 . . . . 0.0 111.257 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -117.36 152.62 34.56 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.872 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.88 129.78 3.65 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.1 m -102.65 118.72 37.46 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.058 0.456 . . . . 0.0 111.435 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.8 t -108.64 148.34 12.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.276 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.459 ' CG ' ' O ' ' A' ' 66' ' ' GLU . 4.3 pt-20 -114.81 110.01 19.05 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.881 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -133.17 158.66 75.22 Favored Pre-proline 0 CA--C 1.529 0.16 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -52.25 -20.19 10.71 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 121.481 1.454 . . . . 0.0 111.331 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.6 tp10 -81.16 -19.94 42.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.123 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.64 -114.73 1.25 Allowed Glycine 0 C--N 1.33 0.23 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -133.03 136.5 46.02 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 65' ' ' VAL . 71.9 tt0 -117.12 128.11 54.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.135 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 3.4 tpt -96.8 128.62 43.93 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.661 -0.415 . . . . 0.0 109.988 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 m -107.49 120.27 41.73 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.7 tp -113.39 128.03 56.32 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 mp -123.51 133.53 68.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 48' ' ' LEU . 20.6 mt -139.93 88.71 2.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.334 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 56.87 -83.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.627 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 77' ' ' LEU . 91.3 mt-10 -111.44 -17.07 13.18 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.5 mt -98.44 128.11 50.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.275 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 81' ' ' THR . 13.3 t -132.52 131.53 41.69 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 m -137.26 153.96 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 C-N-CA 120.105 -0.638 . . . . 0.0 111.325 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -134.45 149.47 50.75 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.854 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.61 142.41 9.93 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -104.87 138.09 41.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.737 0.303 . . . . 0.0 110.402 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.73 166.16 34.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.669 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 t -101.0 0.2 37.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.812 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.615 ' OG ' ' HB3' ' A' ' 91' ' ' ALA . 92.6 p -130.82 157.97 41.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.763 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -76.13 -45.64 32.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.974 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -61.79 -46.88 87.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.387 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.615 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -74.68 -21.18 59.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.162 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -66.22 -48.68 69.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.275 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.453 ' HD2' HD13 ' A' ' 45' ' ' LEU . 55.9 ttp180 -73.1 -43.14 62.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.757 0.313 . . . . 0.0 111.217 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.576 ' O ' HG23 ' A' ' 98' ' ' VAL . 56.0 tt0 -53.17 -45.7 68.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.961 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -65.82 -36.47 83.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.82 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.53 -51.16 38.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.242 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.73 -30.1 60.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.735 0.302 . . . . 0.0 111.32 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 94' ' ' GLN . 73.2 t -72.06 -47.48 54.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.486 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -55.63 -35.14 65.58 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.155 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.2 OUTLIER -63.58 -58.06 8.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.103 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.667 HD11 HG11 ' A' ' 47' ' ' VAL . 14.4 mt -48.79 -39.25 24.54 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.564 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -60.14 -45.14 94.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.763 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.92 -29.09 68.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.97 0.414 . . . . 0.0 110.782 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.458 HG12 ' C ' ' A' ' 109' ' ' LYS . 2.2 t -64.98 -54.52 28.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.757 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 105' ' ' VAL . 1.1 t -54.05 -37.15 33.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.83 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -62.1 -32.89 73.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.332 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 22.4 mttm -96.64 20.93 10.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.806 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.72 49.43 8.86 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.458 ' C ' HG12 ' A' ' 104' ' ' VAL . 9.8 mtpm? -133.23 23.45 4.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.862 0.363 . . . . 0.0 110.375 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -48.85 -17.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.77 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.408 ' N ' ' C ' ' A' ' 109' ' ' LYS . 83.8 mt-10 -79.13 23.34 0.37 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.563 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 1.012 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -50.34 -44.73 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.71 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 1.012 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.9 p90 -117.77 -19.54 9.24 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.536 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 70.4 t80 118.66 48.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 O-C-N 124.85 1.344 . . . . 0.0 110.285 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.497 HD11 HD22 ' A' ' 101' ' ' LEU . 52.5 mt -62.32 113.01 7.47 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.61 128.99 10.6 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.627 1.551 . . . . 0.0 113.252 -177.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.1 90.97 0.13 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.412 ' CB ' ' OE1' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -56.53 -28.75 60.75 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.448 ' H ' ' HB2' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -135.19 -179.31 5.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.887 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -64.82 -59.7 3.91 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.622 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -56.75 -26.56 57.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.194 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.448 ' HB2' ' H ' ' A' ' 119' ' ' THR . 69.3 mt-10 -66.72 -42.58 86.1 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.68 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.52 -48.33 79.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.551 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.534 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 3.0 mp -65.88 -58.7 4.98 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.991 0.901 . . . . 0.0 109.769 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.7 m -52.73 -41.35 63.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.95 -1.477 . . . . 0.0 111.05 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -55.52 -58.52 7.45 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.481 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 mt -55.79 -50.92 65.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 121.445 0.641 . . . . 0.0 109.898 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -46.84 -37.4 8.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.9 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -71.74 -26.96 62.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.542 0.21 . . . . 0.0 111.005 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.9 -25.47 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.453 ' OG ' ' NE2' ' A' ' 94' ' ' GLN . 31.2 t -83.85 -44.37 14.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.66 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -66.43 -36.87 83.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -68.9 1.69 3.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.687 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.32 -37.59 65.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.521 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -91.05 -84.29 0.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.447 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.491 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -52.62 -39.06 61.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.567 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.81 115.63 18.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.704 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -104.55 11.56 34.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.435 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 36' ' ' LEU . 9.6 mp -75.14 -38.04 61.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.257 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -57.6 -50.41 73.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.158 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.479 ' O ' ' SD ' ' A' ' 38' ' ' MET . 0.8 OUTLIER -58.42 -40.11 81.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.331 179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -60.19 -43.14 96.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.712 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 mt -73.29 -43.05 61.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.097 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 42' ' ' LYS . 20.4 mmtp -71.7 -24.11 61.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.695 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER 37.6 49.38 1.03 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.728 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.25 98.58 52.07 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.686 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.86 -24.48 13.66 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.014 1.809 . . . . 0.0 111.862 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.446 HD21 ' CZ2' ' A' ' 62' ' ' TRP . 16.6 tp -71.44 -20.55 62.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.424 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 11.6 tpt -58.46 -33.16 69.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.939 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.586 HG11 HD11 ' A' ' 101' ' ' LEU . 1.5 t -63.58 -54.99 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.439 ' N ' HG12 ' A' ' 47' ' ' VAL . 7.4 tp -57.87 -52.3 66.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.955 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -54.4 -51.03 66.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.418 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -65.67 -32.51 74.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.086 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.703 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -70.62 -47.08 61.91 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.244 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 -33.91 69.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.859 0.362 . . . . 0.0 110.717 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.51 -47.21 27.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.111 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 -20.99 59.43 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 51' ' ' ALA . 20.8 m -85.62 -53.86 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.533 -178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.629 ' N ' HG23 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -125.85 -3.51 7.1 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 71.1 20.8 5.07 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.828 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -109.51 -173.76 2.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.311 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.5 156.24 58.44 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.522 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 168.66 24.21 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.609 2.206 . . . . 0.0 112.305 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.14 118.67 31.16 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.31 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.446 ' CZ2' HD21 ' A' ' 45' ' ' LEU . 8.7 m0 -110.5 137.84 47.66 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.285 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.5 129.33 4.99 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.2 m -99.95 118.16 35.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.369 . . . . 0.0 111.541 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 72' ' ' GLU . 3.3 t -104.93 148.4 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.831 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -113.71 109.95 19.41 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.864 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.29 155.31 81.44 Favored Pre-proline 0 C--O 1.227 -0.127 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.38 -7.25 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.851 1.701 . . . . 0.0 111.531 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' OE2' ' NE2' ' A' ' 85' ' ' GLN . 75.1 tt0 -94.72 -17.35 22.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.916 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.99 -117.77 1.61 Allowed Glycine 0 C--N 1.333 0.365 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -132.12 137.61 47.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.317 -0.624 . . . . 0.0 109.317 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 65' ' ' VAL . 30.8 tt0 -118.44 121.8 41.2 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.8 mtt -93.13 133.08 36.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.491 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.4 m -111.98 123.58 50.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.9 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.864 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -114.76 126.09 54.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.006 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.864 ' N ' HD12 ' A' ' 75' ' ' LEU . 32.6 mm -118.02 131.66 70.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 tp -175.38 136.29 0.35 Allowed 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.591 0.557 . . . . 0.0 110.904 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.6 t30 54.24 35.31 22.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.339 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 68.52 6.13 5.24 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.286 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.476 HG21 ' HB2' ' A' ' 103' ' ' LYS . 25.4 mt -99.27 137.72 25.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -132.01 129.65 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.498 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 96' ' ' ALA . 11.7 m -132.68 161.47 41.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.87 0.367 . . . . 0.0 110.815 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -129.9 139.66 51.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.935 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.16 108.09 0.73 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.488 ' NE2' ' OE2' ' A' ' 69' ' ' GLU . 11.3 pt20 -91.91 136.36 33.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.0 110.444 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.53 171.98 16.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.674 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.47 -7.48 47.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.367 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 80.0 p -129.21 152.84 48.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.205 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -71.85 -42.77 66.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.274 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -60.0 -47.74 84.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.307 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.54 -25.63 62.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.975 0.417 . . . . 0.0 110.707 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.06 -35.04 73.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.053 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.414 ' HD3' HD22 ' A' ' 45' ' ' LEU . 40.2 ttm180 -74.26 -46.61 40.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.83 0.348 . . . . 0.0 111.046 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.526 ' O ' HG23 ' A' ' 98' ' ' VAL . 7.5 tt0 -53.07 -47.51 68.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.915 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -64.99 -32.28 73.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.723 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.571 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.21 -51.95 21.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.926 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.25 -31.11 69.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.043 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 94' ' ' GLN . 45.4 t -71.26 -51.42 34.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.932 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -55.55 -34.35 64.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.03 0.443 . . . . 0.0 110.352 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -62.28 -55.54 27.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.512 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.639 HD22 HD11 ' A' ' 115' ' ' ILE . 18.1 mt -50.59 -36.19 33.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.633 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -62.75 -45.21 93.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.499 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.476 ' HB2' HG21 ' A' ' 80' ' ' ILE . 16.7 mmtt -60.37 -28.02 67.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.928 0.394 . . . . 0.0 110.951 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.417 HG23 ' H ' ' A' ' 104' ' ' VAL . 2.1 t -65.92 -53.65 35.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.243 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.465 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.5 t -55.39 -37.51 44.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.602 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -64.53 -28.76 69.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.553 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -96.73 20.04 11.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.615 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 45.58 44.81 12.03 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.41 ' C ' HG12 ' A' ' 104' ' ' VAL . 3.1 mmtp -133.12 23.93 4.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.707 0.289 . . . . 0.0 110.549 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -50.76 -15.75 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -79.87 22.53 0.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.293 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.951 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -50.93 -45.86 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.431 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.951 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -118.26 -20.29 8.62 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.538 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 72.3 t80 117.27 51.31 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.871 1.357 . . . . 0.0 109.874 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.639 HD11 HD22 ' A' ' 101' ' ' LEU . 21.5 mt -62.85 118.17 39.46 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.23 128.05 12.56 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.336 1.357 . . . . 0.0 112.62 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 123' ' ' ALA . . . -153.88 94.55 0.15 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 27.0 m -49.28 -38.24 26.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.149 0.5 . . . . 0.0 109.701 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.484 ' H ' ' HB3' ' A' ' 122' ' ' GLU . 11.4 p -133.46 176.08 8.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.877 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -54.69 -57.25 12.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.832 0.348 . . . . 0.0 110.623 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.424 ' O ' ' OG ' ' A' ' 125' ' ' SER . 95.5 mt-10 -61.76 -34.7 76.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.275 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.484 ' HB3' ' H ' ' A' ' 119' ' ' THR . 13.0 tp10 -63.34 -31.63 72.84 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.673 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.486 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . . . -76.28 -53.74 7.79 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.023 0.439 . . . . 0.0 111.144 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.692 ' C ' HD12 ' A' ' 124' ' ' LEU . 4.1 pp -66.95 -26.12 66.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.861 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.575 ' N ' HD12 ' A' ' 124' ' ' LEU . 71.9 m -76.31 -28.85 57.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.947 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -65.05 -51.03 63.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.028 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.5 ' HA ' HD12 ' A' ' 130' ' ' ILE . 10.4 pt -59.14 -35.48 57.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.923 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -61.71 -41.14 97.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.295 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -71.75 -26.08 62.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.612 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 127' ' ' ILE . 69.7 mt -69.22 -23.63 27.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.033 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.4 p -106.27 -43.84 4.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -56.54 -34.67 67.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.148 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.506 ' O ' ' N ' ' A' ' 135' ' ' GLU . 16.7 mttm -54.25 -63.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.672 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 40.62 22.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.492 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 133' ' ' LYS . 49.7 tt0 62.5 43.67 7.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.621 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.516 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.5 t30 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.57 9.77 7.15 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.456 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.7 p -95.63 25.14 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.549 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -84.48 8.87 15.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.681 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 60.1 mt -65.81 -47.05 76.37 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.955 0.407 . . . . 0.0 110.028 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 38' ' ' MET . 12.2 pt-20 -62.35 -40.15 95.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.113 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.408 ' N ' ' CG ' ' A' ' 37' ' ' GLU . 2.0 ttp -57.31 -40.05 77.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.678 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -61.56 -46.51 89.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.689 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 tp -68.67 -41.13 79.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.933 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 tttp -70.71 -23.79 62.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.236 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 mttt 47.86 72.13 0.29 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.803 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' SD ' ' A' ' 46' ' ' MET . 1.5 p -140.57 84.72 13.67 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.805 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -50.14 -17.65 2.65 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 C-N-CA 122.67 2.247 . . . . 0.0 112.758 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 tp -71.93 -19.89 61.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.129 0.49 . . . . 0.0 110.052 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.448 ' SD ' ' OG1' ' A' ' 43' ' ' THR . 62.4 mtp -58.58 -33.11 69.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.867 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.639 HG11 HD11 ' A' ' 101' ' ' LEU . 1.8 t -58.73 -57.33 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.453 ' N ' HG12 ' A' ' 47' ' ' VAL . 8.3 tp -58.04 -51.72 68.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.674 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -57.99 -40.83 81.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 0.0 111.041 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -70.76 -35.74 72.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.962 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.716 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -72.8 -47.56 45.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.017 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.0 70.92 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.092 0.473 . . . . 0.0 110.36 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -74.83 -45.01 46.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.753 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.47 -22.13 54.94 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 51' ' ' ALA . 21.1 m -85.86 -53.73 9.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.708 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.627 ' N ' HG23 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -124.92 -7.69 7.24 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.737 -178.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.425 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER 73.24 19.81 3.45 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.876 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -110.07 149.65 29.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.455 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.7 p -81.87 152.37 68.82 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.869 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.22 169.8 21.74 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.849 2.366 . . . . 0.0 111.63 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.54 123.26 42.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.398 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -126.05 148.16 49.39 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.623 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.49 135.58 5.53 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 26.9 m -102.65 121.88 43.3 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.828 0.346 . . . . 0.0 111.343 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.8 t -107.76 148.92 11.51 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.439 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -114.48 112.67 23.35 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.882 ' N ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -133.0 158.2 76.46 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -178.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -52.02 -21.67 12.87 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.548 1.498 . . . . 0.0 111.502 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.421 ' OE1' ' OE1' ' A' ' 85' ' ' GLN . 57.3 mt-10 -82.78 -17.15 45.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.537 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.18 -115.72 1.35 Allowed Glycine 0 C--N 1.331 0.304 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -132.86 136.94 46.52 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -117.28 121.65 41.75 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 11.5 mmt -93.3 133.3 36.67 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.945 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 56.1 m -116.63 130.07 56.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.783 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.954 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -127.01 132.14 50.83 Favored 'General case' 0 C--N 1.335 -0.056 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.173 -179.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.954 ' N ' HD12 ' A' ' 75' ' ' LEU . 28.8 mt -128.38 148.98 32.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.4 tp -172.0 128.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.367 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 34.9 t30 55.78 -92.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.292 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -136.29 1.9 2.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.143 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 53.0 mt -96.96 128.85 47.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.878 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 81' ' ' THR . 6.2 t -132.32 126.88 34.35 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.553 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.1 m -137.73 164.11 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.292 0.568 . . . . 0.0 110.97 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -165.35 163.9 19.83 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.691 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.82 166.9 35.71 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.421 ' OE1' ' OE1' ' A' ' 69' ' ' GLU . 36.5 mt-30 -114.5 141.59 47.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.717 0.294 . . . . 0.0 110.507 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.603 ' HB2' ' HZ1' ' A' ' 95' ' ' LYS . . . -157.88 167.36 30.21 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.513 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.7 p -97.53 -2.41 41.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.639 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 50.3 m -125.98 149.97 48.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.178 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -77.05 -43.69 33.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 111.183 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -62.11 -47.34 85.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.582 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.08 -21.32 60.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.686 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -71.12 -37.64 72.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.028 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 77.2 mtp85 -73.99 -44.17 55.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.931 0.396 . . . . 0.0 110.591 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.641 ' O ' HG23 ' A' ' 98' ' ' VAL . 70.6 mt-30 -57.58 -39.82 77.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.829 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.603 ' HZ1' ' HB2' ' A' ' 86' ' ' ALA . 5.1 ttpm? -65.67 -39.43 91.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.041 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.553 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.39 -48.53 49.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.758 0.313 . . . . 0.0 110.999 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.11 -33.76 69.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.157 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 94' ' ' GLN . 76.3 t -71.68 -46.18 63.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.516 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -54.72 -35.56 63.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.047 0.451 . . . . 0.0 109.88 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.51 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.74 -60.4 3.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.089 179.536 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.646 HD22 HD11 ' A' ' 115' ' ' ILE . 16.5 mt -48.17 -38.19 17.53 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.397 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -60.01 -43.7 95.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.841 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -63.44 -27.7 69.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.83 0.348 . . . . 0.0 110.899 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.63 -53.78 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.437 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.7 t -53.46 -41.47 45.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.77 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.56 -26.33 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.125 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -93.78 18.04 10.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.853 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.91 39.69 11.6 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.405 ' C ' ' N ' ' A' ' 111' ' ' GLU . 47.6 mtpt -133.28 22.51 4.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.784 0.326 . . . . 0.0 110.812 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 110' ' ' HIS . 5.2 p80 -49.82 -16.13 0.24 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.495 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.405 ' N ' ' C ' ' A' ' 109' ' ' LYS . 97.3 mt-10 -80.07 23.78 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.075 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.938 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -49.21 -44.02 16.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.899 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.938 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.4 p90 -118.33 -20.43 8.52 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.544 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 74.3 t80 117.09 51.67 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 124.829 1.33 . . . . 0.0 109.633 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.646 HD11 HD22 ' A' ' 101' ' ' LEU . 24.0 mt -62.16 113.48 8.79 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -51.48 127.89 23.99 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 121.175 1.25 . . . . 0.0 111.735 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.58 90.98 0.13 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.485 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.442 ' H ' ' HG2' ' A' ' 122' ' ' GLU . 44.1 p -78.33 -32.79 49.37 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.407 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 17.9 p -139.88 175.45 9.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.329 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -58.92 -60.48 3.79 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.233 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -55.5 -24.78 33.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.544 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 118' ' ' THR . 21.8 tp10 -66.39 -49.51 66.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.722 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.12 66.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.775 0.321 . . . . 0.0 110.778 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.553 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -59.57 -56.5 21.14 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.947 0.88 . . . . 0.0 108.996 179.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.5 t -51.8 -36.79 49.01 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.82 -1.536 . . . . 0.0 110.428 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.519 ' ND2' ' OE2' ' A' ' 135' ' ' GLU . 15.4 t-20 -54.93 -58.81 6.09 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.801 -0.359 . . . . 0.0 110.23 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.597 HG12 HD13 ' A' ' 101' ' ' LEU . 5.6 mt -59.06 -45.82 92.18 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.484 0.659 . . . . 0.0 109.553 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -47.27 -46.53 24.84 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.486 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 134' ' ' ALA . 95.6 mm-40 -71.99 -29.18 63.97 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.343 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 127' ' ' ILE . 75.7 mt -65.23 -23.1 32.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.7 t -97.82 -33.06 11.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.396 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.85 -70.89 0.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.664 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 134' ' ' ALA . 61.5 mttm -103.01 -70.54 0.75 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.795 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 129' ' ' GLN . . . 175.74 -45.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.623 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.519 ' OE2' ' ND2' ' A' ' 126' ' ' ASN . 44.5 tp10 -168.4 -75.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.418 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.454 179.937 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.4 m120 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 70.7 mtt85 -61.72 -43.49 98.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.689 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.4 p -138.97 82.55 1.9 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.424 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -109.41 26.99 10.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.873 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.7 mt -71.67 -47.61 53.05 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.735 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -62.73 -39.91 95.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.546 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 56.3 mtm -68.29 -31.41 70.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.368 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -47.75 84.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.504 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.68 -25.32 65.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.165 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 42' ' ' LYS . 8.5 tttt -90.34 13.44 15.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.285 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 41' ' ' LYS . 14.7 mtmm 60.66 142.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.116 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.4 p -135.92 67.96 63.96 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.466 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -80.99 -75.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.777 2.318 . . . . 0.0 111.658 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.6 tp -77.05 -20.74 55.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.189 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 61.1 mtt -58.57 -33.23 69.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.263 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.492 HG11 HD11 ' A' ' 101' ' ' LEU . 1.4 t -63.2 -50.15 80.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.372 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.459 HD12 ' CE2' ' A' ' 100' ' ' TYR . 9.7 tp -52.18 -50.65 61.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.431 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -59.44 -52.84 63.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.527 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -60.94 -38.93 87.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.752 0.31 . . . . 0.0 111.164 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.755 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -69.23 -47.24 65.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.04 0.448 . . . . 0.0 110.578 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.21 -31.02 72.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.345 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -74.25 -49.34 23.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.338 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -21.12 59.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.755 HG13 ' O ' ' A' ' 51' ' ' ALA . 20.3 m -85.35 -53.94 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 119.974 -0.69 . . . . 0.0 112.213 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.666 ' N ' HG23 ' A' ' 55' ' ' VAL . 7.6 m-85 -126.01 -1.03 7.18 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 58.26 40.84 24.26 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.298 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.2 -177.0 3.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.368 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.79 119.53 41.01 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.41 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -49.89 168.44 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 121.578 1.519 . . . . 0.0 111.641 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.2 m -113.25 140.75 47.71 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.814 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -135.55 154.67 51.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.722 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.34 135.64 4.93 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -105.4 114.64 28.94 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.869 0.366 . . . . 0.0 111.328 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.9 t -99.19 148.48 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.012 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -114.02 110.71 20.47 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.85 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.42 156.03 80.57 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.25 -7.05 2.38 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.845 1.697 . . . . 0.0 111.211 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 67' ' ' LEU . 50.7 mt-10 -94.38 -14.95 24.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.2 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.97 -121.08 2.38 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -132.75 134.16 44.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 65' ' ' VAL . 35.2 tt0 -114.12 120.59 41.07 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.247 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -89.63 125.03 35.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.91 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 87.4 m -117.51 131.6 56.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -132.92 144.9 50.46 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.391 -179.285 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 75' ' ' LEU . 36.4 mt -123.07 147.25 27.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.0 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 77' ' ' LEU . 6.3 tp -160.12 108.98 1.73 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.407 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.7 t30 62.74 -80.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.879 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -142.53 3.99 1.52 Allowed 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.792 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.8 mt -101.22 127.75 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 58.1 m -132.78 129.04 38.07 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.628 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.8 m -136.62 164.27 31.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.199 0.523 . . . . 0.0 111.157 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -132.92 145.53 50.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.296 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -139.5 121.8 2.13 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -94.66 135.14 36.47 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.0 163.76 39.3 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.917 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.443 HG22 ' H ' ' A' ' 87' ' ' THR . 0.1 OUTLIER -92.4 -8.41 44.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.439 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.1 p -133.08 158.85 41.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.4 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -67.35 -45.31 76.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.351 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -57.45 -43.53 84.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.196 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -74.87 -20.01 59.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.801 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.4 -54.65 25.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.136 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -70.61 -39.34 73.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.23 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.463 ' O ' HG23 ' A' ' 98' ' ' VAL . 37.7 tt0 -54.32 -52.17 62.35 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.389 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -63.6 -41.46 98.32 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.628 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -69.73 -52.21 27.46 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.79 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.05 -37.14 66.34 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.213 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 94' ' ' GLN . 55.8 t -65.51 -47.01 88.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 120.866 -0.334 . . . . 0.0 111.541 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -54.55 -36.91 64.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.058 0.456 . . . . 0.0 110.326 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.556 ' CD2' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -60.11 -54.35 46.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.943 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.556 ' N ' ' CD2' ' A' ' 100' ' ' TYR . 6.4 mt -48.76 -39.67 25.88 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.525 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -60.5 -45.63 93.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.679 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -58.81 -27.77 65.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 110.639 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.403 ' H ' HG23 ' A' ' 104' ' ' VAL . 2.1 t -67.46 -54.56 22.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.391 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.482 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.6 t -56.47 -39.93 64.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.535 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -67.54 -26.31 66.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.691 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.3 mmtt -97.93 19.04 14.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.861 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 46.07 46.93 15.26 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.44 -0.664 . . . . 0.0 111.44 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -131.44 21.31 4.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.925 0.393 . . . . 0.0 110.612 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -54.45 -16.0 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.769 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -76.33 22.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.654 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.989 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.2 pp -68.15 -46.41 81.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 119.794 -0.762 . . . . 0.0 109.732 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.989 ' H ' HD12 ' A' ' 112' ' ' ILE . 0.9 OUTLIER -120.25 -18.36 8.02 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.522 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 13.9 t80 97.83 64.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.15 0.907 . . . . 0.0 110.983 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -63.36 115.16 15.99 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -50.51 127.74 21.45 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 120.973 1.115 . . . . 0.0 111.816 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.9 91.24 0.13 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.465 ' H ' ' HG2' ' A' ' 122' ' ' GLU . 43.9 p -76.08 -35.19 59.47 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.617 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -130.81 172.33 12.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.808 179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -56.31 -59.7 4.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.295 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.402 ' O ' ' CB ' ' A' ' 125' ' ' SER . 98.7 mt-10 -60.31 -24.16 64.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.37 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.617 ' CB ' ' H ' ' A' ' 119' ' ' THR . 15.1 tp10 -61.65 -45.05 95.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.656 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.9 -51.38 48.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.783 0.325 . . . . 0.0 110.838 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.562 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -58.55 -54.94 41.34 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.155 0.978 . . . . 0.0 109.045 179.208 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 46.8 t -51.9 -26.75 10.89 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.24 -1.345 . . . . 0.0 109.813 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.65 -59.4 3.63 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.597 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.458 HD13 ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -52.55 -47.41 48.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.155 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.428 ' OD1' ' OD2' ' A' ' 132' ' ' ASP . 48.6 t0 -54.16 -48.87 70.41 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.26 -1.337 . . . . 0.0 111.211 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.547 ' O ' ' N ' ' A' ' 134' ' ' ALA . 91.1 mt-30 -71.85 -27.25 62.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.652 0.263 . . . . 0.0 111.197 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.9 mt -66.12 -19.14 25.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.9 t -112.54 -32.47 6.45 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.212 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.428 ' OD2' ' OD1' ' A' ' 128' ' ' ASP . 88.3 m-20 -84.14 -70.76 0.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.546 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 89.3 mttt -95.28 -71.42 0.67 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.845 0.355 . . . . 0.0 111.113 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 133' ' ' LYS . . . 72.55 -15.93 0.47 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.509 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 133' ' ' LYS . 96.5 mt-10 -105.85 -27.54 11.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.366 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 . . . . . 0 N--CA 1.464 0.238 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.568 -179.855 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.7 m120 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -59.84 -38.23 81.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.39 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 34' ' ' THR . 10.0 t -135.15 109.01 8.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.686 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -106.8 16.7 24.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.502 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.4 tp -61.57 -43.06 99.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.711 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -66.13 -44.19 84.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.551 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.49 ' O ' ' N ' ' A' ' 42' ' ' LYS . 27.5 ttt -57.8 -41.25 81.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.727 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -66.06 -38.76 89.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.712 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 tp -64.58 -45.25 87.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.077 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 42' ' ' LYS . 37.3 mttp -88.91 -23.67 22.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.242 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 38' ' ' MET . 11.9 pttm 30.92 69.32 0.1 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.686 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.81 156.61 68.72 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.688 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.41 -21.95 22.16 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.357 2.038 . . . . 0.0 112.538 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.428 HD11 ' CZ2' ' A' ' 62' ' ' TRP . 13.8 tp -70.93 -21.35 62.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.341 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.3 tpt -59.06 -33.17 70.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.419 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.67 -43.57 96.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.74 -52.15 58.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.862 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -60.8 -43.91 97.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.474 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -74.93 -40.44 60.83 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.786 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -74.52 -48.28 28.0 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.295 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.24 -33.11 67.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.059 0.456 . . . . 0.0 110.123 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -77.44 -44.28 29.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.643 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.7 -22.07 56.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.786 HG13 ' O ' ' A' ' 51' ' ' ALA . 16.0 m -85.41 -53.86 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.656 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.8 m-85 -125.8 1.61 7.42 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 60.35 37.24 20.28 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.594 -0.443 . . . . 0.0 110.018 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -122.42 -167.83 1.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.107 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.29 159.72 51.05 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.96 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.42 ' CG ' ' CZ2' ' A' ' 62' ' ' TRP . 94.4 Cg_endo -76.65 169.26 22.13 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 123.047 2.498 . . . . 0.0 111.967 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.95 111.94 17.68 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.541 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CZ2' HD11 ' A' ' 45' ' ' LEU . 6.7 m0 -109.89 155.13 22.1 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.191 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -153.31 131.65 3.37 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.28 111.97 24.19 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.476 ' O ' ' CB ' ' A' ' 71' ' ' PHE . 0.9 OUTLIER -91.11 146.3 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.47 178.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -120.68 120.0 34.44 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.796 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 69' ' ' GLU . 4.7 mt -133.2 150.13 74.53 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.55 -7.16 1.23 Allowed 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 121.476 1.451 . . . . 0.0 111.921 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -108.22 -7.18 16.05 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.787 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.21 -145.1 13.73 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.476 ' CB ' ' O ' ' A' ' 65' ' ' VAL . 6.9 p90 -141.87 151.92 43.14 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.116 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -120.27 114.96 22.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.047 0.451 . . . . 0.0 111.084 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.463 ' HG3' ' HB1' ' A' ' 92' ' ' ALA . 4.8 mmt -78.79 128.38 33.31 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -109.91 120.42 42.42 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.893 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.2 OUTLIER -115.7 128.23 55.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.893 ' N ' HD12 ' A' ' 75' ' ' LEU . 7.6 mt -124.47 143.3 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 79' ' ' GLU . 6.5 tp -158.77 -149.83 0.23 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.2 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 80' ' ' ILE . 27.5 t-20 -48.01 83.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.555 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 77' ' ' LEU . 48.1 tt0 57.58 -1.6 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.033 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.468 ' H ' ' C ' ' A' ' 78' ' ' ASN . 62.8 mt -100.97 131.8 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.587 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.7 p -132.95 130.53 39.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 96' ' ' ALA . 4.1 m -138.01 162.4 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.153 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.0 pttt -134.07 145.75 49.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.014 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.74 106.02 0.5 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -86.86 140.29 29.82 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -172.33 -179.6 2.31 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.987 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 72.6 p -120.09 10.18 11.35 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.804 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.538 ' OG ' ' HB3' ' A' ' 91' ' ' ALA . 91.2 p -131.25 153.76 49.17 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -72.06 -50.47 28.08 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.965 0.412 . . . . 0.0 111.103 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -55.64 -44.42 77.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.371 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.538 ' HB3' ' OG ' ' A' ' 88' ' ' SER . . . -73.17 -20.14 60.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.893 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.463 ' HB1' ' HG3' ' A' ' 73' ' ' MET . . . -64.39 -55.02 23.86 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.618 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -73.41 -42.29 62.27 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.763 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -53.19 -42.31 66.13 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.442 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.423 ' NZ ' ' HB1' ' A' ' 91' ' ' ALA . 18.9 mttt -72.99 -35.99 66.97 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.383 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.584 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -72.16 -52.85 14.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.28 -38.94 85.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.0 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 25.0 t -66.29 -49.04 78.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -54.7 -33.87 61.53 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.227 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -63.0 -56.97 12.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.241 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.49 HD13 HG13 ' A' ' 127' ' ' ILE . 11.5 mt -52.65 -35.67 55.38 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.301 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.4 ttm-85 -59.76 -46.27 89.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.621 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -61.69 -28.62 69.53 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.528 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.87 -54.6 29.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.4 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 105' ' ' VAL . 1.4 t -52.66 -41.32 37.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.76 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -61.55 -25.9 67.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 110.059 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -96.72 20.49 10.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.737 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.44 40.54 3.72 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.41 ' C ' ' N ' ' A' ' 111' ' ' GLU . 32.4 tttp -133.94 24.08 3.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -48.4 -19.29 0.3 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.066 0.46 . . . . 0.0 110.171 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.41 ' N ' ' C ' ' A' ' 109' ' ' LYS . 82.6 mt-10 -75.65 25.03 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.48 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.507 HG13 ' H ' ' A' ' 113' ' ' PHE . 2.3 pt -48.96 -46.6 16.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.957 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.526 ' O ' ' CD2' ' A' ' 114' ' ' PHE . 44.7 p90 -121.75 11.47 10.46 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 113' ' ' PHE . 3.6 m-85 85.96 54.2 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.043 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.429 HD11 HD22 ' A' ' 101' ' ' LEU . 24.8 mt -63.29 122.29 74.76 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.46 128.39 14.43 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.372 1.381 . . . . 0.0 112.919 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.75 91.16 0.13 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 62.4 m -59.55 -38.43 81.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.437 ' H ' ' HB2' ' A' ' 122' ' ' GLU . 3.0 p -131.03 -172.68 2.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.792 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.1 ttpt -67.42 -59.73 3.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.928 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -55.11 -24.5 26.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.93 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 119' ' ' THR . 73.7 mm-40 -68.63 -41.07 79.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.065 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.72 -52.43 30.79 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.761 0.315 . . . . 0.0 110.862 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.9 mp -55.91 -56.92 14.86 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.924 0.869 . . . . 0.0 108.717 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.2 t -51.7 -28.58 15.32 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.97 -1.468 . . . . 0.0 110.39 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.23 -50.29 74.24 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.849 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.588 ' N ' HD12 ' A' ' 127' ' ' ILE . 1.9 mp -58.62 -44.12 88.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-O 121.353 0.597 . . . . 0.0 109.7 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -53.13 -47.68 68.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.205 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 134' ' ' ALA . 79.2 mm-40 -71.57 -29.3 64.57 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.166 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 43.2 mt -64.26 -20.04 26.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.038 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.5 p -118.39 -24.98 6.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.437 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -87.71 -70.93 0.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.258 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 48.7 mttp -114.19 -63.15 1.49 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.796 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 133' ' ' LYS . . . 80.36 3.02 1.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.483 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -120.57 50.63 1.3 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.244 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 69.8 tt0 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.747 -179.86 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' ARG . 54.8 t30 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASN . 49.7 ttt180 -54.26 -35.28 62.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.349 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 34' ' ' THR . 4.4 t -92.5 65.06 4.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.48 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.27 18.02 10.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.493 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mt -72.19 -36.52 69.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.494 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -62.21 -48.09 81.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.392 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.43 ' O ' ' N ' ' A' ' 42' ' ' LYS . 24.7 ttp -57.99 -40.8 81.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.317 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -68.56 -22.95 64.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.583 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.71 -48.1 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.869 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -88.44 -23.9 23.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.114 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 38' ' ' MET . 67.9 mttm 45.53 47.29 11.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.73 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.2 152.51 73.71 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.737 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.81 -17.32 22.9 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.645 2.23 . . . . 0.0 112.673 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.531 HD11 ' CZ2' ' A' ' 62' ' ' TRP . 19.0 tp -60.48 -22.15 63.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.864 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.5 ttp -63.43 -34.23 77.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.735 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.542 HG11 HD11 ' A' ' 101' ' ' LEU . 3.7 t -65.56 -30.79 51.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.257 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' A' ' 75' ' ' LEU . 1.6 tp -75.54 -51.98 11.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.54 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -54.26 -37.76 65.06 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.283 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -77.23 -41.11 42.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.26 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.674 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -65.69 -48.71 71.12 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.117 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.67 -30.68 71.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.808 0.337 . . . . 0.0 111.006 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 57' ' ' GLN . 29.1 ttpt -78.36 -57.82 3.58 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.684 -0.406 . . . . 0.0 112.005 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.29 -21.78 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 51' ' ' ALA . 23.8 m -86.13 -53.36 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.782 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.656 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.1 m-85 -125.72 -1.1 7.36 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER 71.04 19.33 5.63 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.175 -179.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -110.79 -167.95 1.25 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.08 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.15 162.3 42.42 Favored Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.008 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.04 169.13 22.73 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.991 2.461 . . . . 0.0 112.049 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.13 131.39 53.27 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.004 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.531 ' CZ2' HD11 ' A' ' 45' ' ' LEU . 5.7 m0 -120.74 141.06 50.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.798 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.67 128.98 4.65 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.8 p -96.87 119.36 35.2 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.895 0.378 . . . . 0.0 111.5 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.8 t -107.54 148.09 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.229 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -114.19 110.29 19.74 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.848 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.54 156.34 80.2 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -51.59 -15.64 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.614 1.542 . . . . 0.0 111.6 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.61 -17.62 31.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.842 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 135.42 -114.71 1.26 Allowed Glycine 0 C--N 1.33 0.205 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -133.16 136.49 45.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.636 ' O ' HG23 ' A' ' 65' ' ' VAL . 34.7 tt0 -120.38 118.59 30.76 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.5 mtt -93.38 134.4 35.66 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.332 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.5 p -107.96 128.16 54.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.806 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.43 ' CD1' HD21 ' A' ' 48' ' ' LEU . 10.0 tp -116.63 125.98 52.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.4 mt -120.52 133.16 68.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 120.905 0.383 . . . . 0.0 109.972 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' GLU . 13.0 mt -140.83 -165.56 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.607 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 80' ' ' ILE . 5.6 p30 -49.0 91.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.731 0.301 . . . . 0.0 111.116 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 77' ' ' LEU . 69.5 mm-40 60.43 -6.21 0.09 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.257 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.488 ' H ' ' C ' ' A' ' 78' ' ' ASN . 96.2 mt -99.15 130.6 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.031 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 81' ' ' THR . 12.6 t -132.43 129.39 39.21 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.4 m -141.78 162.79 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.243 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.76 162.84 40.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.194 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.63 149.17 20.98 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -106.75 138.49 42.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.684 0.278 . . . . 0.0 110.342 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -160.89 160.97 31.61 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.93 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 91.9 m -74.01 -26.77 60.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.702 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.4 p -117.97 155.49 30.17 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.446 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -37.24 66.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.272 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -59.79 -48.14 82.88 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.678 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -71.71 -22.44 61.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.262 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.77 -37.81 76.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.998 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -74.17 -45.68 46.99 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.782 0.325 . . . . 0.0 111.035 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -52.8 -48.77 66.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.869 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -62.67 -35.04 78.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.583 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.34 -49.44 49.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.229 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.14 -31.91 63.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.103 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.21 -49.95 50.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.735 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -55.14 -33.17 62.68 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.311 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.43 ' CD1' ' C ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -63.33 -56.91 12.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.005 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.542 HD11 HG11 ' A' ' 47' ' ' VAL . 16.6 mt -52.07 -36.45 50.73 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.704 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -61.05 -45.63 93.96 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.61 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -62.76 -27.86 69.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.766 0.317 . . . . 0.0 111.241 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.4 t -64.61 -54.1 34.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.399 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.467 ' H ' HG23 ' A' ' 105' ' ' VAL . 1.4 t -53.9 -41.13 47.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.494 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -60.0 -28.15 67.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.28 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -97.33 20.33 11.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.211 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 42.85 44.19 5.53 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.41 ' C ' ' H ' ' A' ' 111' ' ' GLU . 11.8 tttp -133.37 20.32 3.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.414 . . . . 0.0 110.182 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.47 ' H ' ' CD2' ' A' ' 110' ' ' HIS . 6.0 p80 -48.53 -15.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.901 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 109' ' ' LYS . 90.4 mt-10 -79.71 22.9 0.45 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.622 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.929 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -50.98 -45.09 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.145 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.929 ' H ' HD12 ' A' ' 112' ' ' ILE . 2.0 p90 -118.32 -7.01 10.77 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.572 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 6.7 m-85 98.06 54.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.612 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.484 HD13 HG21 ' A' ' 127' ' ' ILE . 15.6 mt -62.6 114.82 13.27 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.491 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -50.72 128.62 24.62 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.304 1.336 . . . . 0.0 112.32 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.74 91.29 0.13 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.1 m -91.92 -30.05 16.34 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.9 m -140.65 162.99 34.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.422 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -53.37 -60.65 3.03 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.312 -0.555 . . . . 0.0 110.486 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -56.72 -25.74 55.21 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.493 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -72.14 -51.38 21.6 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.42 -51.46 69.75 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.559 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.0 OUTLIER -62.83 -58.51 7.15 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.575 0.703 . . . . 0.0 110.396 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.3 m -52.15 -36.58 51.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.996 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -58.15 -55.74 31.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.365 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.484 HG21 HD13 ' A' ' 115' ' ' ILE . 27.1 pt -69.1 -34.2 62.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.068 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.438 ' O ' ' OD2' ' A' ' 132' ' ' ASP . 69.9 m-20 -61.8 -39.3 91.24 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.436 -0.506 . . . . 0.0 109.712 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -69.47 -25.21 63.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.742 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.447 HD12 ' HA ' ' A' ' 127' ' ' ILE . 67.0 mt -73.68 -23.98 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.064 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 133' ' ' LYS . 0.7 OUTLIER -105.02 -60.71 1.57 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.016 -179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.438 ' OD2' ' O ' ' A' ' 128' ' ' ASP . 1.7 p30 -72.03 15.37 0.16 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.749 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 131' ' ' SER . 23.9 tttp -39.56 -35.17 0.28 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.749 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 63.39 70.49 0.53 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.407 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -57.67 -31.32 66.22 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.658 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.514 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -119.08 -38.75 3.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.671 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.419 HG23 ' H ' ' A' ' 37' ' ' GLU . 10.0 t -135.64 159.97 39.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.575 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -66.2 -31.57 72.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.908 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.1 mt -55.28 -37.55 67.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.396 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.419 ' H ' HG23 ' A' ' 34' ' ' THR . 42.4 tp10 -60.32 -42.36 95.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.062 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.5 tpt -60.01 -39.0 84.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.535 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -67.34 -37.88 83.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.398 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' A' ' 42' ' ' LYS . 12.5 mt -71.49 -23.48 61.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.887 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.499 ' NZ ' ' OE1' ' A' ' 50' ' ' GLU . 60.7 mttm -69.17 13.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.194 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.497 ' H ' ' C ' ' A' ' 40' ' ' LEU . 19.2 mttm -46.35 -25.42 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.899 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.0 155.81 41.04 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.641 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.5 -22.39 14.01 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.377 2.051 . . . . 0.0 112.399 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.703 HD22 HH11 ' A' ' 93' ' ' ARG . 24.9 tp -70.05 -25.36 63.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.519 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 8.1 mmt -64.64 -33.7 76.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.39 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 101' ' ' LEU . 2.1 t -63.98 -56.43 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.456 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.7 tp -54.06 -51.31 64.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.269 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -54.81 -42.49 71.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.775 0.321 . . . . 0.0 111.139 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' OE1' ' NZ ' ' A' ' 41' ' ' LYS . 76.9 tt0 -71.77 -37.87 70.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.032 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.79 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -69.17 -47.35 65.19 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.974 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.72 -31.69 68.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.04 0.447 . . . . 0.0 110.301 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -77.12 -47.18 21.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.954 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.95 -21.13 59.36 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.79 HG13 ' O ' ' A' ' 51' ' ' ALA . 17.4 m -85.26 -53.81 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.017 -0.673 . . . . 0.0 112.239 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.649 ' N ' HG23 ' A' ' 55' ' ' VAL . 3.1 m-85 -126.08 -4.8 6.81 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.404 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 19.5 tp60 71.96 19.89 4.57 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.67 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -111.02 -167.53 1.19 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.299 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -124.89 161.07 51.14 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.691 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.51 169.01 21.79 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.808 2.339 . . . . 0.0 111.462 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.09 117.07 26.24 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.944 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.598 ' CZ2' HD11 ' A' ' 45' ' ' LEU . 7.9 m0 -112.8 152.78 28.76 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.796 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.68 125.37 2.03 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 78.1 m -97.77 120.7 38.63 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.058 0.456 . . . . 0.0 111.281 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.548 ' HB ' HD21 ' A' ' 67' ' ' LEU . 1.8 t -107.59 150.63 10.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.365 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.913 ' C ' HD23 ' A' ' 67' ' ' LEU . 14.7 mp0 -119.76 114.21 21.8 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.913 HD23 ' C ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -127.27 160.63 58.92 Favored Pre-proline 0 C--N 1.345 0.403 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.08 -8.21 5.95 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.097 1.865 . . . . 0.0 111.234 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -99.65 -10.79 21.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.636 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.32 -120.72 1.83 Allowed Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 3.9 m-85 -141.71 145.09 34.45 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.643 ' HB2' HD11 ' A' ' 67' ' ' LEU . 60.5 tt0 -119.69 145.72 46.24 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 7.8 tpp -114.64 133.8 55.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.9 p -116.82 125.89 52.26 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 76' ' ' ILE . 6.7 tp -121.37 135.89 55.03 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.521 ' N ' HD12 ' A' ' 75' ' ' LEU . 3.3 mt -131.58 149.43 33.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 79' ' ' GLU . 35.8 tp -169.11 125.7 0.93 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.751 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 65.1 t30 58.78 -80.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.841 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -147.55 -0.62 0.64 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.799 0.333 . . . . 0.0 110.533 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.1 mt -100.18 134.24 40.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.41 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.15 131.74 42.55 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 96' ' ' ALA . 10.5 m -137.34 162.35 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-O 121.13 0.49 . . . . 0.0 111.186 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -160.58 160.81 32.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.047 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.85 155.48 26.32 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.696 ' H ' HE21 ' A' ' 85' ' ' GLN . 0.0 OUTLIER -104.2 140.14 38.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.738 0.304 . . . . 0.0 110.231 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.65 165.51 25.68 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.763 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 81.4 p -104.14 -0.78 28.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.538 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 50.5 m -115.89 152.24 33.79 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.219 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -80.24 -51.21 9.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.247 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -59.64 -45.77 91.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.112 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.13 -30.07 67.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.829 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -58.98 -42.75 90.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.434 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.703 HH11 HD22 ' A' ' 45' ' ' LEU . 38.4 ttm180 -73.99 -45.85 47.43 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.035 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 98' ' ' VAL . 94.0 mt-30 -53.59 -43.26 68.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.77 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.6 mttm -64.03 -36.23 83.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.675 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.57 -50.3 32.34 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.681 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.43 -41.39 89.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.451 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 94' ' ' GLN . 79.8 t -65.63 -46.14 90.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.812 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -55.08 -36.2 65.37 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.248 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.428 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.4 OUTLIER -60.84 -58.34 8.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.68 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.615 HD22 HD11 ' A' ' 115' ' ' ILE . 19.0 mt -48.9 -36.22 16.66 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.672 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -61.83 -44.62 96.49 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.403 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -61.86 -27.7 68.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.894 0.378 . . . . 0.0 110.975 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.48 -54.41 26.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.682 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 101' ' ' LEU . 1.0 OUTLIER -53.66 -39.79 39.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.499 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -68.29 -22.9 64.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.462 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -97.25 14.17 26.94 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.151 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.63 40.16 47.36 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.406 -0.426 . . . . 0.0 112.179 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 111' ' ' GLU . 0.5 OUTLIER -133.62 26.48 4.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.815 0.34 . . . . 0.0 110.327 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -48.9 -16.86 0.14 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.4 ' N ' ' C ' ' A' ' 109' ' ' LYS . 88.3 mt-10 -84.3 23.81 1.04 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.551 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.942 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -49.8 -45.02 21.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.863 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.942 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -118.73 -17.02 9.3 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.533 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 50.9 t80 110.77 52.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.7 1.25 . . . . 0.0 110.257 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.615 HD11 HD22 ' A' ' 101' ' ' LEU . 35.2 mt -62.49 112.69 6.98 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -51.45 128.56 26.18 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.27 1.314 . . . . 0.0 111.907 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.68 91.53 0.13 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.668 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.8 m -77.25 -38.07 51.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.88 170.56 13.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.449 179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.45 -60.5 3.74 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.494 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.411 ' O ' ' OG ' ' A' ' 125' ' ' SER . 93.6 mt-10 -56.43 -24.53 45.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.984 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -69.92 -44.2 70.12 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.2 -48.02 83.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.817 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.544 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 2.9 mp -66.22 -58.98 4.2 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.906 0.86 . . . . 0.0 109.964 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 91.0 p -52.86 -38.35 61.43 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.804 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -57.54 -58.74 6.96 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.774 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' ILE . 12.2 mt -54.78 -51.69 49.51 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.407 0 CA-C-O 121.501 0.667 . . . . 0.0 110.1 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -47.15 -35.25 7.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.589 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -71.71 -27.41 63.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.773 0.32 . . . . 0.0 110.552 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.426 ' N ' ' O ' ' A' ' 127' ' ' ILE . 56.4 mt -67.92 -28.66 42.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 53.2 p -92.8 -27.29 17.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.564 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -65.39 -31.87 73.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.565 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -62.34 -12.67 22.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.817 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.42 -68.11 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.666 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -170.98 63.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.538 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.554 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' THR . 32.5 p-10 . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 48.62 -90.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.639 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.485 ' N ' ' O ' ' A' ' 32' ' ' ASN . 49.1 m -73.43 131.14 41.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.552 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -71.56 -33.01 68.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.737 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.41 ' H ' HG22 ' A' ' 34' ' ' THR . 5.8 tp -55.51 -40.18 71.46 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.585 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -61.73 -42.52 99.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.407 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.4 tpp -58.8 -29.24 66.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.903 0.382 . . . . 0.0 110.454 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -76.63 -33.45 58.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.105 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 42' ' ' LYS . 2.0 mm? -81.73 -6.98 59.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.702 0.287 . . . . 0.0 111.283 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.31 14.12 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.994 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 40' ' ' LEU . 46.2 mttt -47.98 -58.17 4.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.176 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -86.13 157.74 56.33 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.908 -179.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.14 -18.71 18.21 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.615 2.21 . . . . 0.0 112.53 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 45' ' ' LEU . 15.5 tp -71.39 -21.99 61.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.332 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.1 tpt -62.39 -34.32 76.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.112 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.407 HG11 HD11 ' A' ' 101' ' ' LEU . 2.1 t -68.51 -50.65 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.428 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.611 HD11 HD22 ' A' ' 77' ' ' LEU . 4.8 tp -56.07 -52.17 65.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.434 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -60.65 -43.97 96.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 111.557 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.42 -33.84 73.57 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.048 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.756 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -74.48 -47.68 31.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.094 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.17 -32.26 72.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.993 0.425 . . . . 0.0 109.915 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -77.36 -44.45 29.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.949 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.79 -21.82 57.01 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 51' ' ' ALA . 19.6 m -85.51 -53.86 9.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.659 ' N ' HG23 ' A' ' 55' ' ' VAL . 3.2 m-85 -125.68 -2.45 7.29 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.688 -0.405 . . . . 0.0 112.035 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 67.22 23.39 9.44 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.348 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -108.93 176.7 5.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.346 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.51 159.42 32.28 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.985 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -78.31 169.55 19.93 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.054 2.503 . . . . 0.0 111.983 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.05 119.79 33.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.76 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -114.19 150.89 33.56 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.45 130.39 3.93 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 64' ' ' THR . 9.6 t -100.38 115.4 29.92 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 111.33 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 72' ' ' GLU . 2.9 t -106.06 148.29 10.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.267 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.31 111.42 21.46 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.896 ' H ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -132.8 156.23 80.31 Favored Pre-proline 0 N--CA 1.456 -0.153 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.232 -178.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -51.78 -16.1 3.65 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.516 1.477 . . . . 0.0 111.625 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.07 -15.46 33.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.788 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.35 -116.87 1.51 Allowed Glycine 0 C--N 1.331 0.259 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -134.0 135.78 43.66 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.501 ' O ' HG23 ' A' ' 65' ' ' VAL . 3.7 tt0 -117.95 121.22 40.12 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.404 ' HB2' ' HB1' ' A' ' 92' ' ' ALA . 44.7 tpp -93.47 130.04 39.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.82 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.2 m -107.63 126.05 52.09 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.924 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -119.07 130.52 55.66 Favored 'General case' 0 C--N 1.328 -0.351 0 O-C-N 123.306 0.379 . . . . 0.0 110.203 -179.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.924 ' N ' HD12 ' A' ' 75' ' ' LEU . 45.8 mt -123.22 138.04 54.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.073 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.611 HD22 HD11 ' A' ' 48' ' ' LEU . 5.1 tp -150.22 -154.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.645 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.464 ' C ' ' H ' ' A' ' 80' ' ' ILE . 19.9 p-10 -48.52 83.33 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.775 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 77' ' ' LEU . 5.9 tp10 60.86 -3.33 0.15 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.85 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.464 ' H ' ' C ' ' A' ' 78' ' ' ASN . 71.8 mt -102.67 131.84 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.078 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.1 p -132.58 132.49 42.6 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 96' ' ' ALA . 3.7 m -141.65 160.97 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.464 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -134.54 150.0 50.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.989 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -142.78 133.19 5.43 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -102.74 137.81 40.47 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.83 164.08 36.08 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.978 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 74.0 p -87.18 -10.88 51.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.364 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.3 m -128.56 155.53 44.76 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.227 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.563 ' H ' ' CD ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -70.31 -42.13 72.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -57.43 -47.93 80.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.95 -19.98 62.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.696 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 73' ' ' MET . . . -66.93 -46.5 74.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -73.33 -43.1 61.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.725 0.297 . . . . 0.0 111.524 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -52.27 -45.03 65.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.278 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -70.34 -34.92 73.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.855 0.359 . . . . 0.0 111.166 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.554 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -67.65 -48.15 67.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.339 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.17 82.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.338 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.91 -50.67 76.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.676 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -55.35 -37.82 67.97 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.678 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -55.0 40.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.369 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 115' ' ' ILE . 13.2 mt -50.4 -35.41 28.18 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.255 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.515 ' NH1' ' OE2' ' A' ' 106' ' ' GLU . 64.9 ttp85 -62.18 -47.04 86.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.441 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -27.54 65.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.673 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.56 -54.49 22.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.683 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.489 ' H ' HG23 ' A' ' 105' ' ' VAL . 1.7 t -52.4 -40.77 33.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.567 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.515 ' OE2' ' NH1' ' A' ' 102' ' ' ARG . 97.9 mt-10 -66.25 -24.96 66.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.107 0.48 . . . . 0.0 109.787 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? -93.77 19.72 8.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.419 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.7 38.92 2.44 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.417 ' C ' ' N ' ' A' ' 111' ' ' GLU . 9.3 tptp -132.91 25.1 4.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 110.534 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -48.82 -15.77 0.1 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.611 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.417 ' N ' ' C ' ' A' ' 109' ' ' LYS . 77.0 mm-40 -80.04 23.5 0.46 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.113 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.911 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.4 pp -50.04 -44.53 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.518 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.911 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.3 p90 -118.15 -19.88 8.86 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.538 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 68.7 t80 116.87 51.47 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.799 1.312 . . . . 0.0 109.583 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.534 HD11 HD22 ' A' ' 101' ' ' LEU . 22.8 mt -62.75 121.0 65.27 Favored Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.48 128.87 13.14 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.552 1.501 . . . . 0.0 112.701 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.32 91.31 0.13 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 64.5 p -61.49 -34.51 75.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.113 0.482 . . . . 0.0 109.723 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.421 ' H ' ' HB3' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -135.81 172.05 13.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.895 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -57.15 -59.8 4.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.211 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -56.09 -25.19 44.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.529 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.421 ' HB3' ' H ' ' A' ' 119' ' ' THR . 17.9 tp10 -69.58 -47.97 61.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.844 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.13 74.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.236 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.542 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.2 mp -65.16 -58.24 6.52 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.912 0.863 . . . . 0.0 109.884 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 44.8 m -53.07 -36.57 60.8 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.0 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -63.13 -59.53 4.65 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.673 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.5 HG21 HD13 ' A' ' 115' ' ' ILE . 40.3 pt -60.47 -35.0 60.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.375 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -61.98 -33.23 73.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.891 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -71.0 -25.75 62.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.538 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 58.2 mt -70.19 -30.09 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.7 p -93.02 -35.35 13.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.826 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -87.9 14.46 8.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.715 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.632 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 13.1 tptt -52.4 -29.52 24.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.591 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' A' ' 133' ' ' LYS . . . 79.72 77.39 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.299 0.571 . . . . 0.0 110.654 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -62.66 -31.31 72.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.589 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.672 179.91 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -56.39 -41.37 76.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.778 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.3 p -64.95 147.92 52.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.613 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -110.52 -40.45 4.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.887 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 36' ' ' LEU . 9.9 mp -71.29 -45.04 64.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.871 0.367 . . . . 0.0 110.636 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -64.54 -26.13 68.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.671 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 40.7 ttm -70.89 -41.7 70.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.373 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -64.77 -45.51 86.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.465 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.9 mt -67.27 -37.46 83.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.772 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -87.71 11.2 15.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.945 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -66.19 80.42 0.09 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.434 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.52 156.81 42.15 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.951 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.4 -44.06 7.16 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.261 1.974 . . . . 0.0 112.762 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -71.08 -23.47 62.13 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.31 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.0 mmt -65.75 -34.5 78.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.972 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.617 HG11 HD11 ' A' ' 101' ' ' LEU . 1.8 t -68.21 -43.53 84.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.468 HD12 ' CE2' ' A' ' 100' ' ' TYR . 4.7 tp -61.3 -52.05 66.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.167 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -56.34 -53.33 58.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.865 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -61.97 -35.68 79.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.044 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.742 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -68.65 -47.37 66.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.841 -0.343 . . . . 0.0 110.997 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.78 -31.37 72.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.039 0.447 . . . . 0.0 109.892 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -77.26 -45.68 25.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.456 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.15 -21.79 58.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 51' ' ' ALA . 19.4 m -85.61 -53.3 10.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.648 ' N ' HG23 ' A' ' 55' ' ' VAL . 2.1 m-85 -125.15 -1.31 7.71 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.5 41.14 7.65 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.168 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -127.89 -179.12 4.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.09 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.54 156.86 39.75 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.95 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.2 168.59 23.69 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.68 2.254 . . . . 0.0 112.059 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.1 117.26 28.26 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.918 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.6 m0 -114.85 140.63 48.8 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.8 121.76 1.99 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.0 m -97.35 112.21 24.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.115 0.483 . . . . 0.0 111.462 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 t -93.16 147.77 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.826 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -122.98 118.81 28.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.572 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 69' ' ' GLU . 4.4 mt -133.41 149.61 72.83 Favored Pre-proline 0 CA--C 1.529 0.16 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.29 -7.15 1.72 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.316 1.344 . . . . 0.0 110.953 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.443 ' H ' ' C ' ' A' ' 67' ' ' LEU . 80.3 mm-40 -105.17 -11.48 16.54 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.776 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.17 -150.28 22.53 Favored Glycine 0 C--N 1.332 0.352 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 14.4 m-85 -129.07 147.63 50.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.88 0.34 . . . . 0.0 110.262 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -118.07 112.72 20.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.031 0.444 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -84.63 129.54 34.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.0 p -113.79 129.77 56.54 Favored 'General case' 0 C--N 1.332 -0.17 0 O-C-N 123.145 0.278 . . . . 0.0 110.766 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -122.01 126.82 49.38 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.871 ' N ' HD12 ' A' ' 75' ' ' LEU . 7.2 mt -121.66 132.66 70.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 79' ' ' GLU . 3.2 tp -147.74 -159.41 1.02 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.685 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 80' ' ' ILE . 2.9 p30 -46.15 84.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.877 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' A' ' 77' ' ' LEU . 17.5 tp10 61.27 -7.14 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.904 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.505 ' H ' ' C ' ' A' ' 78' ' ' ASN . 73.0 mt -99.5 128.37 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.009 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 p -132.64 128.03 36.19 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 96' ' ' ALA . 2.7 m -141.2 167.05 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.193 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -162.76 168.75 21.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.071 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.36 163.08 33.25 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.507 ' H ' ' CD ' ' A' ' 85' ' ' GLN . 0.5 OUTLIER -109.25 138.69 45.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.836 0.35 . . . . 0.0 110.292 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -157.0 161.51 39.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.715 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 80.9 p -97.15 -1.01 45.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.996 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 35.4 m -130.86 151.92 50.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.077 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -71.95 -39.71 69.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 0.0 111.28 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -57.92 -47.74 81.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.344 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.13 -20.03 59.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.086 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.38 -53.55 46.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.403 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -72.93 -44.28 61.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.573 0.225 . . . . 0.0 111.152 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -53.06 -47.21 68.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.807 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -63.43 -34.99 78.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.794 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.481 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.73 -50.37 30.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.168 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -59.66 -36.59 76.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.45 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.9 t -68.52 -48.96 69.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.503 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -54.25 -34.99 62.01 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.564 -0.455 . . . . 0.0 110.279 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.49 ' CG ' ' N ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -63.58 -57.97 8.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.548 179.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.617 HD11 HG11 ' A' ' 47' ' ' VAL . 13.8 mt -47.94 -37.93 15.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.184 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -60.79 -44.95 96.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.428 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.7 tptp -60.17 -27.72 67.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.02 0.438 . . . . 0.0 110.91 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -68.81 -53.88 24.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.615 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 101' ' ' LEU . 2.0 t -54.84 -41.37 56.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.697 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -62.85 -27.5 69.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.087 0.47 . . . . 0.0 109.865 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.7 tttp -94.15 20.34 8.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.709 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 44.53 38.96 5.59 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.414 ' C ' ' N ' ' A' ' 111' ' ' GLU . 2.6 tptm -133.73 25.59 4.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.734 0.302 . . . . 0.0 110.897 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.409 ' C ' ' H ' ' A' ' 112' ' ' ILE . 8.2 p80 -49.29 -16.06 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.797 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 109' ' ' LYS . 6.1 pt-20 -75.4 23.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.444 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.95 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.3 pp -49.95 -44.36 21.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.844 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.95 ' H ' HD12 ' A' ' 112' ' ' ILE . 1.4 p90 -117.48 -19.59 9.41 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' A' ' 114' ' ' PHE . 75.8 t80 118.03 50.05 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.888 1.367 . . . . 0.0 109.543 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.567 HD13 HG21 ' A' ' 127' ' ' ILE . 25.0 mt -62.33 113.4 8.67 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.29 129.26 10.22 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.765 1.643 . . . . 0.0 113.024 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -153.15 90.67 0.13 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 69.7 m -58.1 -37.02 73.73 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.76 161.46 27.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.84 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -53.8 -59.54 4.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.864 0.364 . . . . 0.0 110.47 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -56.69 -24.56 49.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.7 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -71.84 -44.77 63.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.013 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.83 -51.17 71.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.092 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.554 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -63.4 -56.76 13.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.019 0.914 . . . . 0.0 109.393 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.1 t -52.11 -37.73 55.08 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.155 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -62.77 -57.59 10.41 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.545 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.567 HG21 HD13 ' A' ' 115' ' ' ILE . 38.5 pt -59.46 -33.99 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.128 0.49 . . . . 0.0 110.493 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -72.96 -32.59 65.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.85 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -70.02 -25.67 63.69 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 111.838 0.311 . . . . 0.0 111.838 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.5 pt -90.45 -18.93 7.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.154 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.0 m -94.83 -53.45 3.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.734 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 134' ' ' ALA . 56.4 t0 -87.5 15.21 6.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.864 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.0 tttm -40.79 -28.12 0.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 132' ' ' ASP . . . -105.89 -90.92 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.765 0.317 . . . . 0.0 110.39 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -172.48 -78.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.48 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.197 179.802 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -67.09 -28.7 68.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.861 0.363 . . . . 0.0 110.333 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 t -84.31 33.64 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.823 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -81.82 3.2 26.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.865 0.364 . . . . 0.0 110.475 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.51 -38.19 77.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.107 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.03 -40.41 68.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.528 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.513 ' O ' ' N ' ' A' ' 42' ' ' LYS . 35.3 ttm -57.95 -38.12 75.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.581 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -68.76 -49.25 60.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.636 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 39.2 tp -61.77 -39.22 90.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.701 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -88.4 -23.29 23.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.937 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 38' ' ' MET . 22.1 tttp 51.07 64.44 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.871 -0.331 . . . . 0.0 110.135 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 94.1 m -124.47 84.11 57.14 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.866 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.45 -24.58 16.77 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.413 2.075 . . . . 0.0 112.047 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -61.67 -20.34 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.204 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.1 tpt -58.79 -33.97 70.94 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 101' ' ' LEU . 2.1 t -58.76 -31.16 43.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 77' ' ' LEU . 3.6 tp -78.78 -51.85 9.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.479 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -60.07 -32.28 70.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.677 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -76.29 -43.01 43.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.336 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.732 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -71.35 -48.36 50.75 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.231 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.48 -32.2 68.55 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.312 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -78.02 -47.34 18.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.316 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.21 -20.66 60.82 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.855 -0.528 . . . . 0.0 112.387 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 51' ' ' ALA . 18.2 m -85.75 -52.94 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.16 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.616 ' N ' HG23 ' A' ' 55' ' ' VAL . 0.7 OUTLIER -125.49 -7.42 6.91 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.034 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.469 ' CB ' ' O ' ' A' ' 56' ' ' TYR . 6.9 tt0 75.27 19.96 2.13 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.308 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -115.28 173.91 6.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.134 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 161.95 21.41 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.743 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.37 168.74 22.6 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.793 2.328 . . . . 0.0 112.1 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.39 115.95 23.16 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.533 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -109.32 149.54 29.32 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.91 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.08 124.66 1.86 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.3 m -104.25 114.39 28.59 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.914 0.387 . . . . 0.0 111.825 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.567 ' HB ' HD21 ' A' ' 67' ' ' LEU . 2.0 t -97.93 151.28 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.488 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.92 ' C ' HD23 ' A' ' 67' ' ' LEU . 36.6 mt-10 -117.2 113.42 22.2 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.92 HD23 ' C ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -129.64 158.44 73.51 Favored Pre-proline 0 C--N 1.347 0.469 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.378 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.24 -15.59 8.35 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.93 1.753 . . . . 0.0 111.818 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -96.57 -10.98 26.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.558 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.83 -125.97 2.99 Favored Glycine 0 C--N 1.329 0.16 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 71' ' ' PHE . 16.0 m-85 -138.52 145.23 40.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.427 ' HB2' HD11 ' A' ' 67' ' ' LEU . 82.8 tt0 -110.2 129.32 55.74 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.202 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 84' ' ' GLY . 2.0 mpp? -92.09 133.38 35.81 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.669 -0.412 . . . . 0.0 109.988 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 m -119.19 118.84 32.42 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 76' ' ' ILE . 11.5 tp -120.63 130.88 54.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 75' ' ' LEU . 26.5 mt -127.33 135.23 63.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 48' ' ' LEU . 13.8 mt -141.51 101.08 3.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.144 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.507 ' OD1' ' CD1' ' A' ' 56' ' ' TYR . 14.1 m-80 57.86 -82.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.239 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 77' ' ' LEU . 6.8 tp10 -125.5 -10.51 6.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.399 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 87.6 mt -94.59 130.35 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 120.949 -0.3 . . . . 0.0 110.613 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.4 p -132.17 131.34 42.12 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 100' ' ' TYR . 9.0 m -136.46 158.86 38.07 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.028 0.442 . . . . 0.0 110.932 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -162.24 166.41 25.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.785 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.504 ' O ' ' SD ' ' A' ' 73' ' ' MET . . . -169.28 177.97 42.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -106.63 135.11 48.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.585 0.231 . . . . 0.0 110.435 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -149.96 160.16 43.82 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.671 -0.412 . . . . 0.0 110.957 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.9 p -118.77 9.39 12.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.566 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.669 ' O ' ' HB2' ' A' ' 92' ' ' ALA . 48.4 t -128.33 154.73 45.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.26 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -80.69 -53.62 6.36 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.958 0.409 . . . . 0.0 111.385 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -59.76 -44.31 93.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.553 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 88' ' ' SER . . . -74.09 -20.99 60.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.344 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 88' ' ' SER . . . -66.11 -49.89 65.93 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.496 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -73.15 -43.62 61.25 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.304 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.504 ' O ' HG23 ' A' ' 98' ' ' VAL . 98.1 mt-30 -56.8 -48.01 78.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.251 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -62.12 -34.64 76.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.003 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.24 -50.83 43.53 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.856 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.95 -30.08 63.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.915 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 94' ' ' GLN . 54.3 t -68.03 -51.59 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.205 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -55.93 -34.84 66.0 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.855 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.405 ' HA ' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -58.57 -56.78 17.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.247 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.642 HD22 HD11 ' A' ' 115' ' ' ILE . 31.6 mt -51.36 -37.02 45.8 Favored 'General case' 0 C--O 1.238 0.473 0 O-C-N 123.6 0.563 . . . . 0.0 111.907 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -61.34 -47.04 87.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.721 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -60.64 -28.12 68.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.349 . . . . 0.0 110.611 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 104' ' ' VAL . 3.2 t -62.3 -53.21 50.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.808 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.497 HG22 ' CE1' ' A' ' 110' ' ' HIS . 1.5 t -52.87 -37.17 25.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.581 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -71.47 -24.8 62.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -95.97 19.78 11.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.297 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 41.62 39.2 2.46 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -130.86 30.95 4.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.062 0.458 . . . . 0.0 110.011 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.497 ' CE1' HG22 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -48.86 -15.94 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.286 -179.402 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -83.37 23.47 0.91 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.926 HD12 ' H ' ' A' ' 113' ' ' PHE . 1.5 pp -50.22 -47.54 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.02 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.926 ' H ' HD12 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -120.23 -16.89 8.42 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.535 ' CB ' ' O ' ' A' ' 113' ' ' PHE . 34.9 t80 105.28 57.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 O-C-N 124.468 1.105 . . . . 0.0 110.277 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.642 HD11 HD22 ' A' ' 101' ' ' LEU . 22.3 mt -64.41 114.1 13.0 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.659 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -51.35 130.33 32.3 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 121.447 1.431 . . . . 0.0 112.017 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -152.47 94.72 0.15 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.783 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.432 ' H ' ' HG2' ' A' ' 122' ' ' GLU . 20.8 m -78.4 -35.23 47.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.168 0.508 . . . . 0.0 109.713 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.517 ' H ' ' CB ' ' A' ' 122' ' ' GLU . 0.2 OUTLIER -136.22 175.93 9.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.617 179.26 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -58.78 -60.18 4.25 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.338 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.415 ' O ' ' OG ' ' A' ' 125' ' ' SER . 94.5 mt-10 -58.87 -25.15 63.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.476 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.517 ' CB ' ' H ' ' A' ' 119' ' ' THR . 17.4 tp10 -62.05 -47.69 83.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.706 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.78 -49.49 74.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.986 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.553 ' N ' ' CD1' ' A' ' 124' ' ' LEU . 1.5 mp -63.19 -58.04 8.53 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.948 0.88 . . . . 0.0 109.568 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 121' ' ' GLU . 27.4 m -52.49 -36.51 55.25 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.996 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -61.91 -58.64 7.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.612 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.532 ' HA ' HD12 ' A' ' 130' ' ' ILE . 18.7 pt -66.11 -35.69 75.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.782 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -58.58 -40.29 82.74 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 66.6 mm-40 -72.47 -25.97 61.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.178 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 127' ' ' ILE . 53.8 mt -68.77 -23.92 28.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 75.3 m -103.22 -35.77 8.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.767 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -69.18 -68.08 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 48.3 mttt -126.08 -70.79 0.72 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.995 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 133' ' ' LYS . . . 74.68 10.8 3.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.397 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -74.13 -40.4 62.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.007 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.436 -179.823 . . . . . . . . 0 0 . 1 stop_ save_